Mineral supplement |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Multivitamin with Minerals Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Mineral supplement |
Thiamine Mononitrate |
IP |
10 mg |
Riboflavin |
IP |
3.0 mg |
Pyridoxin Hydrochloride |
IP |
15 mcg |
Vitamin B12 |
IP |
100mg |
Niacinamide |
IP |
50 mg |
Calcium Pantothenate |
IP |
1.5 mg |
Folic Acid |
USP |
100 mcg |
Biotin |
IP |
150 mg |
Ascorbic Acid (as Coated ) |
|
q.s. |
Excipients |
|
|
Approved colored used in Hard Gelatin Capsule shell |
|
|
Multivitamin and Multimineral capsules. |
Each Hard Gelatin Capsule contains: |
IP |
5000 IU |
Mineral supplement |
Vitamin A concentrate ( powder form) |
IP |
5 mg |
Vitamin B1 |
IP |
5 mg |
Vitamin B2 |
IP |
2 mg |
Vitamin B6 |
IP |
25 mcg |
Methylcobalamin |
IP |
75 mg |
Vitamin c (coated) |
IP |
400 IU |
Vitamin D3 |
IP |
15 mg |
Vitamin E acetate |
IP |
50 mg |
Nicotinamide |
IP |
5 mg |
Calcium D-Pantothenate |
IP |
1 mg |
Folic Acid |
BP |
0.5 mg |
Copper sulphate |
|
|
Equ. to Copper |
USP |
2 mg |
Potassium( as Potassium Sulphate) |
USP |
0.5 mg |
Manganese sulphate Monohydrate |
IP |
|
Magnesium sulphate |
|
3 mg |
Equ. to Magnesium |
IP |
75 mg |
Calcium dibasic phosphate equ. to Calcium |
IP |
25 mg |
Zinc Sulphate monohydrate |
IP |
0.1 mg |
Potassium iodide equ. to Iodine. |
|
q.s. |
Excipients |
|
|
Approved colored used in Hard Gelatin Capsule shell |
|
|
Antibaterial |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Prebiotic and Probiotic Capsules |
Each Hard Gelatin Capsule contains: |
|
0.48 billion |
Antibaterial |
Lactobacillus acidophillus |
0.48 billion |
Lactobacillus rhamnosus |
0.48 billion |
Bifidobacterium Longum |
0.48 billion |
Bifidobacterium Bifidum |
0.1 billion |
Saccharomyces noulardii |
0.48 billion |
Streptococcus thermophilus |
300 mg |
Fructo oligo saccharide |
q.s. |
Excipients |
|
Approved colored used in Hard Gelatin Capsule shell |
|
Ciprofloxacin, Metronidazole, Terbinafine HCl & Clobetasol Propionate Cream |
Composition : |
IP |
1.0% w/w |
Antibaterial |
Ciprofloxacin Hydrochloride |
IP |
1.0% w/w |
Eq. to. Ciprofloxacin |
IP |
1.0% w/w |
Metronidazole benzoate |
IP |
0.05% w/w |
Eq. to. Metronidazole |
|
|
Terbinafine Hydrochloride |
|
|
Clobetasol Propionate |
IP |
0.16% w/w |
Preservative |
IP |
0.033% w/w |
Methyl Paraben |
|
q.s. |
Propyl Paraben |
|
|
Cream Base |
|
|
Clobetasol Propionate, Gentamicin, Miconazole Nitrate &Chlorcresol Cream |
Composition: |
IP |
0.05% |
Antibaterial |
Clobetasol Propionate |
IP |
0.10% |
Gentamicin |
|
|
(As Gentamicin Sulphate) |
IP |
2.00% |
Miconazole Nitrate |
IP |
0.10% |
Chlorcresol |
|
q.s. |
Cream Base |
|
|
Clotrimazole, Beclomethasone & Neomycin cream |
Composition : |
IP |
1 % w/w |
Antibaterial |
Clotrimazole |
IP |
0.025 %w/w |
Beclomethasone |
|
|
Dipropionate |
IP |
|
Neomycin Sulphate |
|
0.5 %w/w |
Eq. to Neomycin |
|
|
Chlorocresol |
IP |
0.1%w/w |
( as preservative) |
|
q.s. |
Cream base |
|
|
Silver Sulfadiazine with chlorhexidine Cream |
Composition : |
IP |
1.0%w/w |
Antibaterial |
Silver Sulfadiazine |
IP |
5.0% w/w |
Chlorhexidine Gluconate solution Equivalent to Chlorhexidine Gluconate |
|
q.s |
Cream Base |
|
|
Fradiomycin Cream |
Composition : |
JP |
5.0 mg |
Antibaterial |
Fradiomycin sulphate |
IP |
0.01%w/w |
Chlorocresol |
|
|
(as preservative) |
|
q.s. |
In cream base |
|
|
Mupirocin Cream USP |
Composition :- |
IP |
2.0%w/w |
Antibaterial |
Mupirocin |
q.s. |
Cream Base |
|
Sodium fusidate ointment BP |
Each gram contains : |
IP |
20 mg |
Antibacterial |
Sodium fusidate |
q.s. |
Ointment Base |
|
Clotrimazole, Menthol,Ichthammol, Boric AcidandzincoxideCream |
Composition : |
|
|
Antibaterial |
Clotrimazole IP0.5%w/w |
|
|
Menthol IP1.0%w/w |
|
|
Ichthammol USP0.2%w/w |
|
|
BoricAcid IP 1.0%w/w |
|
|
ZincOxide IP 5.0%w/w |
|
|
Preservatives: |
|
|
Phenoxyethanol IP0.2%w/w |
|
|
Benzylalcohol IP1.0%w/w |
|
|
CreamBase q.s |
|
|
Pre probiotic Capsule |
Each hard gelatin capsule contains: |
|
30Millions |
Antibacterial |
Sterptococcus Faecalis T-110 |
|
2 Millions |
Clostridium Butyeicum T0-A |
|
1 Millions |
Bacillus mesentericus T0-A |
|
50Millions |
Lactobacillus Sporogens |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Streptococcus Faecails, Clostridium Butyricum, Bacillus Mesentericus and Lactic Acid Bacillus Capsules |
Each Hard Gelatin Capsule Contains: |
|
30 million |
Antibacterial |
Streptococcus Faecails |
2 million |
Clostridium Butyricum |
1 million |
Bacillus Mesentericus |
50 million |
Lactic Acid Bacillus |
q.s. |
(Lactobacillus Sporogenes) |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Pre & Probiotic Capsules |
Each hard gelatin capsule contains:- |
|
30Million |
Antibacterial |
Streptococcus Faecalis |
2Million |
Clostridium Butyricum |
1Million |
Bacillus Mesentericus |
50Million |
Lactic Acid Bacillus |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Tetracycline HCl capsules IP |
Each hard gelatin capsule contains:- |
IP |
500mg |
Antibacterial |
Tetracycline Hydrochloride |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Clindamycin Hydrochloride Capsule IP |
Each hard gelatin capsule contain: |
IP |
150 mg |
Antibacterial |
Clindamycin Hydrochloride |
|
Equivalent to Clindamycin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule |
|
Oxytetracycline HCl capsules IP |
Each hard gelatin capsule contains: |
IP |
500mg |
Antibacterial |
Oxytetracycline Hydrochloride |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Micanazole Nitrate and Flucinolone Acetonide cream |
Composition: |
IP |
2.0%w/w |
Antibacterial |
Micanazole Nitrate |
IP |
0.01% w/w |
Flucinolone Acetonide |
|
q.s. |
In a Cream base |
|
|
Mupirocin ointment IP |
Composition :- |
IP |
2.0%w/w |
Antibacterial |
Mupirocin |
q.s. |
Ointment Base |
|
Clotrimazole & Beclomethasone Dipropionate Cream |
Composition : |
IP |
1.0%w/w |
Antibacterial |
Clotrimazole |
IP |
0.025%w/w |
Beclomethasone Dipropionate |
|
|
Preservatives: |
IP |
1.0%w/w |
Benzyl Alcohol |
IP |
0.15%w/w |
Methyl Paraben |
|
q.s |
Cream base |
|
|
Fusidic Acid Cream IP |
Composition:- |
IP |
2.00%w/w |
Antibacterial |
Fusidic Acid |
q.s. |
Cream Base |
|
Sodium fusidate ointment BP |
Each gram contains : |
IP |
20 mg |
Antibacterial |
Sodium fusidate |
q.s. |
Ointment Base |
|
Nanocrystalline Silver Gel |
Composition: |
|
0.002%w/w |
Antibacterial |
Nanocrystalline Silver |
|
q.s. |
Gel Base |
|
|
Nadifloxacin Gel |
Composition: |
IP |
1.00% |
Antibacterial |
Nadifloxacin |
q.s. |
Cream base |
|
Clarithromycin Tablets IP 500 mg |
Each Film Coated Tablet Contains:- |
IP |
500 mg |
Antibacterial |
Clarithromycin |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Clotrimazole Vaginal Tablets IP 100 mg |
Each Uncoated Vaginal Tablet Contains:- |
IP |
100 mg |
Antibacterial |
Clotrimazole |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Clotrimazole Vaginal Tablets IP 200 mg |
Each Uncoated Vaginal Tablet Contains:- |
IP |
200 mg |
Antibacterial |
Clotrimazole |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Clotrimazole Vaginal Tablets IP 500 mg |
Each Uncoated Vaginal Tablet Contains:- |
IP |
500 mg |
Antibacterial |
Clotrimazole |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Sertaconazole Nitrate Vaginal Tablets 500 mg |
Each Uncoated vaginal Tablet Contains:- |
BP |
500 mg |
Antibacterial |
Sertaconazole Nitrate |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Azithromycin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Azithromycin Dihydrate IP |
|
|
Eq. to Azithromycin ——- 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Norfloxacin Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Norfloxacin IP ——————-400mg |
|
|
Excipients————————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Norfloxacin Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Norfloxacin IP 200mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Norfloxacin Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Norfloxacin IP 800mg |
|
|
Excipients—————–q.s. |
|
|
Colour-Approved colour used. |
|
|
Levofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Levofloxacin Hemihydrate IP |
|
|
Eq. to Levofloxacin ——–750 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Levofloxacin Hemihydrate IP |
|
|
Eq. to Levofloxacin ——–250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ciprofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ciprofloxacin Hydrochloride IP |
|
|
Eq. to Ciprofloxacin ———500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Azithromycin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Azithromycin Dihydrate IP |
|
|
Eq. to Azithromycin (Anhydrous)—250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ciprofloxacin and Tinidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ciprofloxacin Hydrochloride IP |
|
|
Eq. to Ciprofloxacin ———500 mg |
|
|
Tinidazole IP ————— 600 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin and Ornidazole Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ofloxacin IP —————-200 mg |
|
|
Ornidazole IP ————— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ciprofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ciprofloxacin Hydrochloride IP |
|
|
Eq. to Ciprofloxacin ———250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ciprofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ciprofloxacin Hydrochloride IP |
|
|
Eq. to Ciprofloxacin ———750 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ofloxacin IP ————– 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ofloxacin IP ————– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ofloxacin IP ————– 300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin and Tinidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ofloxacin IP ————– 200 mg |
|
|
Tinidazole —————- 600 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Erythromycin Stearate Tablets IP |
Each film Coated Tablet Contains: |
|
|
Antibacterial |
Erythromycin Stearate IP |
|
|
Eq. to Erythromycin —————– 125 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Azithromycin and Lactic Acid Bacillus Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Azithromycin Dihydrate IP |
|
|
Eq. to Azithromycin ——- 250 mg |
|
|
Lactic Acid Bacillus ————60 million Spores |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Azithromycin and Lactic Acid Bacillus Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Azithromycin Dihydrate IP |
|
|
Eq. to Azithromycin ——- 500 mg |
|
|
Lactic Acid Bacillus ————60 million Spores |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Clarithromycin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Clarithromycin IP ————— 250 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Norfloxacin &Tinidazole Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Norfloxacin IP ————— 400 mg |
|
|
Tinidazole IP ————– 600 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Roxithromycin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Roxithromycin IP ————— 150 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Erythromycin Stearate Tablets IP |
Each film Coated Tablet Contains: |
|
|
Antibacterial |
Erythromycin Stearate IP |
|
|
Eq. to Erythromycin —————– 250 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Ciprofloxacin and Tinidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Ciprofloxacin Hydrochloride IP |
|
|
Eq. to Ciprofloxacin ——— 250 mg |
|
|
Tinidazole IP ————— 300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ofloxacin TabletsIP |
EachFilmCoatedTabletContains:- |
|
|
Antibacterial |
Ofloxacin—— 200mg |
|
|
Excipients————q.s. |
|
|
Colour-Approvedcolour used. |
|
|
Doxycycline HCl With Lactic Acid Bacillus Capsule |
Each Hard gelatin capsule Contains: |
|
|
Antibacterial |
Doxycycline Hydrochloride…………………IP100mg |
|
|
Lactic Acid Bacillus ………………………………..100 Million |
|
|
Excipients …………………………………….IP Spores |
|
|
Approved colour used in empty hard gelatin capsule shell…….q.s |
|
|
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet |
Each Enteric Coated Tablet |
|
|
Antibacterial |
Contains:- USP 20mg |
|
|
Doxylamine Succinate……………………IP 20 mg |
|
|
Pyridoxine Hydrochloride……………….IP 5 mg |
|
|
Folic Acid………………………………………….q.S |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Riboflavin, Folic Acid, Niacinamide with lactic acid bacillus Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Riboflavin IP …………………… 10 mg |
|
|
Folic Acid IP ……………………..1.5 mg |
|
|
Niacinamide IP ………………… 50 mg |
|
|
lactic acid bacillus 60 million Spores |
|
|
Excipients……………………………..q.s. |
|
|
Metronidazole, Sucralfate & Lignocaine Hcl ointment. |
Composition: |
IP |
1.0%w/w |
Antibacterial |
Metronidazole |
IP |
4.0% w/w |
Lignocaine Hydrochloride |
IP |
7.0% w/w |
Sucralfate |
|
q.s. |
Cream base |
|
|
Vitamin E & Aloevera cream |
Composition: |
I.P. |
0.50% w/w |
Antibacterial |
Vitamin E Acetate |
|
Moisturizing cream base with Aloevera |
q.s. |
Clarithromycin Gel 1.0%w/w |
Composition: |
I.P. |
1.0%w/w |
Antibacterial |
Clarithromycin |
I.P. |
1.0% w/w |
Phenoxyethanol |
|
q.s. |
(As preservative) |
|
|
Gel Base |
|
|
Rifaximin Tablets BP |
Each Film Coated Tablet Contains:- |
B.P. |
400 mg |
Antibacterial |
Rifaximin |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Rifaximin Tablets BP |
Each Film Coated Tablet Contains:- |
B.P. |
550 mg |
Antibacterial |
Rifaximin |
q.s. |
Excipients |
|
Colour-Approved colour used. |
|
Levofloxacin and Ornidazole Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Levofloxacin Hemihydrate IP |
|
|
Eq. to Levofloxacin ————–250 mg |
|
|
Ornidazole IP ————— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Moxifloxacin Tablets 400 mg |
Each Uncoated Tablet Contains: |
IP |
400 mg |
Antibacterial |
Moxifloxacin Hydrochloride |
q.s |
Eq. to Moxifloxacin |
|
Excipients |
|
Colour-Approved colour used. |
|
Metronidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Metronidazole IP—————250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levofloxacin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial |
Levofloxacin Hemihydrate IP |
|
|
Eq. to Levofloxacin ——–500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ornidazole Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antibacterial |
Ornidazole IP———–500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tetracycline HCl capsules IP |
Each hard gelatin capsule contains: |
IP |
250mg |
Antibacterial |
Tetracycline Hydrochloride |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Oxytetracycline HCl capsules IP |
Each hard gelatin capsule contains: |
IP |
250mg |
Antibacterial |
Oxytetracycline Hydrochloride |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Minocycline HCl capsules |
Each hard gelatin capsule contains: |
USP |
100mg |
Antibacterial |
Minocycline Hydrochloride |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells. |
|
Antifungal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Itraconazole capsule BP 100mg |
Each hard gelatin capsule contains: |
BP |
100 mg |
Antifungal |
Itraconazole Pellets |
q.s. |
Eq to Itraconazole |
|
Excipients |
|
Colour: Approved Colours Used. in Empty Shell & Pellet |
|
Itraconazole capsule BP200mg |
Each hard gelatin capsule contains: |
BP |
200 mg |
Antifungal |
Itraconazole Pellets |
q.s. |
Eq to Itraconazole |
|
Excipients |
|
Colour: Approved Colours Used. in Empty Shell & Pellet |
|
Fungal Diastase & Lactic acid Bacillus Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Antifungal |
Fungal Diastase |
150×106Spores |
Lactic acid bacillus |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Fluconazole Capsules IP |
Each Hard Gelatin Capsule Contains:- |
IP |
50.0 mg |
Antifungal |
Fluconazole |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Fluconazole Capsules IP |
Each Hard Gelatin Capsule Contains:- |
IP |
150.0 mg |
Antifungal |
Fluconazole |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Fluconazole Capsules IP |
Each Hard Gelatin Capsule Contains:- |
IP |
200.0 mg |
Antifungal |
Fluconazole |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Ketoconazole Cream |
Composition: |
IP |
2.0% w/w |
Antifungal |
Ketoconazole |
|
|
Preservation |
IP |
0.1% w/w |
Methyl Paraben |
IP |
0.05% w/w |
Phenoxyenthol |
|
q.s. |
Cream Base |
|
|
Ketoconazole Cream |
Composition: |
IP |
2.0% w/w |
Antifungal |
Ketoconazole |
|
|
Preservation |
IP |
0.1% w/w |
Methyl Paraben |
IP |
0.05% w/w |
Phenoxyethanol |
|
q.s. |
Cream Base |
|
|
Itraconazole, Ofloxacin, Ornidazole & Clobetasol propionate Cream |
Composition: |
IP |
1.0% w/w |
Antifungal |
Itraconazole |
IP |
0.75 % w/w |
Ofloxacin |
IP |
2 0 w/w |
Ornidazole |
IP |
0.05%w/w |
Clobetasol Propionate |
|
|
Preservation |
IP |
16% |
Methyl Paraben |
IP |
0.03% |
Propyl Paraben |
|
q.s. |
Cream base |
|
|
Clobetasol Propionate , Miconazole Nitrate, Neomycin Sulphate Cream |
Composition : |
IP |
0.05%w/w |
Antifungal |
Clobetasol Propionate |
IP |
2%w/w |
Miconazole Nitrate |
IP |
|
Neomycin Sulphate |
|
0.1%w/w |
Equ. to Neomycin Base |
IP |
0.1%w/w |
Chlorocresol |
|
|
(as preservative) |
|
q.s. |
Cream base |
|
|
Itraconazole & Terbinafine Cream 1% w/w |
Composition |
BP |
1 % w/w |
Antifungal |
Itraconazole |
IP |
1 % w/w |
Terbinafine hydrochloride |
|
|
Preservative: |
IP |
0.16% w/w |
Methyl Paraben |
IP |
0.05% w/w |
Propyl Paraben |
|
q.s. |
Cream base |
|
|
Miconazole Nitrate Gel |
Composition : |
IP |
2.0 %w/w |
Antifungal |
Miconazole Nitrate |
q.s |
Gel Base |
|
Clotrimazole Cream IP |
Composition : |
IP |
2.0 %w/w |
Antifungal |
Clotrimazole |
IP |
0.10% w/w |
Chlorocresol |
|
|
( as preservative) |
|
q.s |
Cream Base |
|
|
Miconazole Nitrate, Nadifloxacin & Mometasone Furoate & Cream |
Composition:- |
IP |
2% w/w |
Antifungal |
Miconazole Nitrate |
USP |
1% w/w |
Nadifloxacin |
IP |
0.1%w/w |
Mometasone Furoate |
|
q.s. |
Cream Base |
|
|
Terbinafine Hydrochloride Cream IP |
Composition:- |
IP |
1% w/w |
Antifungal |
Terbinafine Hydrochloride |
q.s. |
Cream Base |
|
Ketoconazole with Beclomethasone Dipropionate Cream |
Composition : |
IP |
2.0% w/w |
Antifungal |
Ketoconazole |
IP |
0025% w/w |
Beclomethasone dipropionate |
|
|
Preservatives: |
IP |
0.15% w/w |
Methyl Paraben |
IP |
0.05% w/w |
Propyl Paraben |
|
q.s. |
Cream Base |
|
|
Voriconazole Tablet IP 50 mg |
Each Film coated Tablet Contains:- |
IP |
50 mg |
Antifungal |
Voriconazole |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Voriconazole Tablet IP 200 mg |
Each Film coated Tablet Contains:- |
IP |
200 mg |
Antifungal |
Voriconazole |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Trimethoprim IP———————40mg |
|
|
Sulphamethoxazole IP————-200mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Trimethoprim And Sulphamethoxazole Tablets IP. (Co-trimoxazole Tablets I.P.) |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Trimethoprim IP———————80mg |
|
|
Sulphamethoxazole IP————-400mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Metronidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antifungal |
Metronidazole IP————— 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metronidazole Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antifungal |
Metronidazole IP—————200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fluconazole Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Fluconazole IP———–50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fluconazole Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Fluconazole IP———–100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fluconazole Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Fluconazole IP———–150 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fluconazole Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Fluconazole IP———–200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ketoconazole Tablet IP |
Each Uncoated tablet contains : |
|
|
Antifungal |
Ketoconazole IP—————200.0 mg |
|
|
Excipients ————————-q.s. |
|
|
Colour :- Approved colour used. |
|
|
Terbinafine Tablets I.P. |
Each Uncoated Tablet Contains:- |
|
|
Antifungal |
Terbinafine Hydrochloride IP |
|
|
Eq.to Terbinafine 500 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Fluconazole & Tinidazole Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antifungal |
Fluconazole IP —————75 mg |
|
|
Tinidazole IP —————- 1000 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ketoconazole,Clobetasol Propionate &Neomycin SulphateCream |
Composition: |
|
|
Antifungal |
Ketoconazole IP1.0%w/w |
|
|
ClobetasolPropionate IP0.025%w/w |
|
|
Neomycin Sulphate IP 5000IU |
|
|
CreamBase q.s |
|
|
Itraconazole Gel 1 %w/w |
Composition: |
|
|
Antifungal |
Itraconazole B.P1.0%w/w |
|
|
Preservatives: |
|
|
MethylParaben IP0.1%w/w |
|
|
PropylParaben IP0.05%w/w |
|
|
CreamBase q.s |
|
|
Itraconazole capsule |
Each hard gelatin capsule Contains: |
USP |
200 mg |
Antifungal |
Itraconazole |
q.s. |
Approved colored used in empty capsule shells. |
|
Excipients |
|
Metronidazole Benzoate and Chlorhexidine Gluconate Gel |
Composition: |
IP |
1.0%w/w |
Antifungal |
Metronidazole Benzoate |
|
0.5 %w/w |
Eq to Metronidazole |
IP |
qs |
Chlorhexidine Gluconate Solution |
|
|
(as preservative) |
|
|
Gel Base |
|
|
Itraconazole capsule |
Each hard gelatin capsule Contains: |
USP |
100 mg |
Antifungal |
Itraconazole |
q.s. |
Approved colored used in empty capsule shells. |
|
Excipients |
|
Ketoconazole with ZPTO Sampoo |
Composition: |
IP |
2.0%w/w |
Antifungal |
Ketoconazole |
1.0%w/w |
Zinc pyrithone (ZPTO) |
qs |
Sampoo base |
|
Eberconazole cream1.0%w/w |
Composition: |
IP |
1.0% w/w |
Antifungal |
Eberconazole Nitrate |
IP |
|
Eq. to Eberconazole |
|
0.1% w/w |
preservative |
|
0.025% w/w |
Methyl paraben |
|
qs |
Propyl paraben |
|
|
Cream base |
|
|
Clindamycin Phosphate Gel |
Composition: |
IP |
1.0% w/w |
Antifungal |
Clindamycin Phosphate |
|
0.1%w/w |
Eq. to Clindamycin |
IP |
0.05%w/w |
Sodium methyl paraben |
IP |
q.s. |
Sodium Propyl paraben |
|
|
Allanton base |
|
|
Metronidazole, & sucralfate cream. |
Composition: |
IP |
1.0% w/w |
Antifungal |
Metronidazole |
IP |
7.0 % w/w |
Sucralfate |
|
q.s. |
Cream Base |
|
|
Ofloxacin and Ornidazole Tablets I.P. |
Each Film Coated Tablet Contains:- |
I.P. |
200 mg |
Antifungal |
Ofloxacin |
I.P. |
500 mg |
Ornidazole |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Itraconazole capsule BP 100mg |
Each hard gelatin capsule contains: |
BP |
100 mg |
Antifungal |
Itraconazole |
q.s. |
Excipients |
|
Colour: Approved colours used in empty Shell & Pellets |
|
Ornidazole Tablets I.P. 500 mg |
Each Film Coated Tablet |
I.P. |
500 mg |
Antifungal |
Contains :- |
q.s. |
Ornidazole |
|
Excipients |
|
Colour-Approved colour used |
|
Calamine Lotion IP |
Calamine |
I.P. |
15.0% w/v |
Antifungal |
Zinc oxide |
I.P. |
5.0% w/v |
Bentonite |
I.P. |
3.0%w/v |
Sodium citrate |
I.P. |
0.5% w/v |
Liquefied phenol, |
I.P. |
0.5% w/v |
Glycerin |
I.P. |
5.0% w/v |
Purified water |
|
q.s. |
Clotrimazole Topical Solution USP. |
Composition: |
I.P. |
1.0 %w/v |
Antifungal |
Clotrimazole |
q.s. |
Non aqueous Base |
|
Metronidazole and Benzocaine Gel |
Composition: |
IP |
0.01%w/w |
Antifungal |
Metronidazole |
IP |
0.2 %w/w |
Benzocaine |
|
q.s. |
Gel Base |
|
|
Micanazole Nitrate and FlucinoloneAcetanide cream |
Composition: |
IP |
2.0%w/w |
Antifingal |
Micanazole Nitrate |
IP |
0.01% w/w |
FlucinoloneAcetanide |
|
q.s. |
In a Cream base |
|
|
Ciprofloxacin Hcl, Fluocinolone acetonde, Chlorocresol & Clotrimazole & Clotrimazole & Clotrimazole Cream |
Composition: |
IP |
0.5% w/w |
Antibaterial , Antifugal |
Ciprofloxacin Hydrochloride |
IP |
0.01%w/w |
Eq. to. Ciprofloxacin |
IP |
1.0% w/w |
Fluocinolone acetonide |
IP |
0.1% w/w |
Clotrimazole |
|
q.s |
Chlorocresol ( as preservative) |
|
|
Cream Base |
|
|
Antibiotics, Antiviral & Antifungal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Doxycycline HCl With Lactic Acid Bacillus Capsule |
Each Hard gelatin capsule Contains: |
IP |
100 mg |
Antibiotics, Antiviral & Antifungal |
Doxycycline Hydrochloride |
IP |
5 Billion Spores |
Lactic Acid Bacillus |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Chloramphenicol Capsule IP 500 mg |
Each Hard Gelatin Capsule Contains: Chloramphenicol |
IP |
500 mg |
Antibiotics, Antiviral & Antifungal |
Excipients |
q.s. |
Approved colour used in empty hard gelatin capsule shell |
|
Racecadotril Capsules IP |
Each Hard Gelatin Capsules Contains: |
IP |
100 mg |
Antibiotics, Antiviral & Antifungal |
Racecadotril |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Chloramphenicol Capsule IP 500 mg |
Each Hard Gelatin Capsule Contains: |
IP |
500 mg |
Antibiotics, Antiviral & Antifungal |
Chloramphenicol |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Oseltamivir Capsules IP |
Each hard gelatin capsule contains: |
IP |
30.0 mg |
Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate |
q.s. |
eq. to Oseltamivir |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Oseltamivir Capsules IP |
Each hard gelatin capsule contains: |
IP |
45.0 mg |
Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate |
q.s. |
equ. to Oseltamivir |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Oseltamivir Capsules IP |
Each hard gelatin capsule contains: |
IP |
75.0 mg |
Antibiotics, Antiviral & Antifungal |
Oseltamivir Phosphate |
q.s. |
equ. to Oseltamivir |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Linezolid Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antibacterial & Antiviral |
Linezolid IP—————600 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Doxycycline capsules IP |
Each hard gelatin capsule contains: |
IP |
50mg |
Antibiotics, Antiviral |
Doxycycline Hydrochloride |
q.s. |
eq. to Doxycycline |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Doxycycline capsules IP |
Each hard gelatin capsule contains: |
IP |
100mg |
Antibiotics, Antiviral |
Doxycycline Hydrochloride |
q.s. |
eq. to Doxycycline |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Doxycycline capsules IP |
Each hard gelatin capsule contains: |
IP |
200mg |
Antibiotics, Antiviral |
Doxycycline Hydrochloride |
q.s. |
eq. to Doxycycline |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Doxycycline and Ambroxol capsule |
Each hard gelatin capsule contains: |
IP |
100mg |
Antibiotics & Antiviral |
Doxycycline Hydrochloride |
|
7.5mg |
eq. to Doxycycline |
IP |
q.s. |
Ambroxol Hydrochloride |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Acyclovir & Hydrocortisone Cream |
Compositions |
IP |
5% w/w |
Antibiotics & Antiviral |
Acyclovir |
IP |
1 % w/w |
Hydrocortisone acetate |
|
q.s. |
In a cream base |
|
|
Antifungal, Antiseptic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Povidone Iodine & Metronidazole Ointment |
Composition: |
IP |
5.0 % w/w |
Antifungal, Antiseptic |
Povidone Iodine |
IP |
1 % w/w |
Metronidazole |
|
q.s. |
Ointment base |
|
|
Povidone Iodine & Metronidazole Ointment |
Composition: |
IP |
10.0 % w/w |
Antifungal, Antiseptic |
Povidone Iodine |
IP |
1 % w/w |
Metronidazole |
|
q.s. |
Ointment base |
|
|
Povidone Iodine, Metronidazole &Dexapanthanol |
Composition: |
IP |
5.0 % w/w |
Antiseptic, Antifungal |
Ointment |
Povidone Iodine |
IP |
1 % w/w |
|
Metronidazole |
IP |
5.0 % w/w |
|
Dexapanthanol |
|
q.s. |
|
Ointment base |
|
|
Povidone-Iodine & Ornidazole Ointment. |
Composition: |
IP |
1.0%w/w |
Antifungal& Antiseptic |
Ornidazole |
IP |
5.0%w/w |
Povidone-Iodine (available iodine 0.5% w/w) |
|
|
Ointment base |
|
qs |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Betamethasone Dipropionate & Neomycin Cream |
Composition: |
IP |
0.025% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone Dipropionate |
IP |
0.5% w/w |
Neomycin sulphate |
|
qs |
Cream Base |
|
|
Econazole Betamethasone Dipropionate & Neomycin cream . |
Composition: |
IP |
0.025% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone Dipropionate |
IP |
0.5% w/w |
Neomycin sulphate |
|
1.0%w/w |
Econazole |
|
qs |
In Cream Base |
|
|
Clindamycin Phosphate & Nicotinamide Gel |
Composition: |
IP |
1.0% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clindamycin Phosphate |
|
4.0%w/w |
eq. to Clindamycin |
IP |
q.s. |
Nicotinamide |
|
|
Aloe Allantoin Gel Base with ethyl lactate |
|
|
Clobetasol Propionate with salicylic Acid Ointment |
Composition: |
IP |
0.05% w/w |
antifungal, corticosteroid, antibacterial & anti-inflammatory |
Clobetasol Propionate |
IP |
3.00% |
Salicyclic Acid |
|
q.s. |
Ointment base |
|
|
Betamethasone & Neomycin Cream |
Composition: |
IP |
0.05 % w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone propionate eq. to. Betamethasone |
|
0.5 % w/w |
Neomycin sulphate |
IP |
|
Eq. to Neomycin |
|
q.s. |
In a cream base |
|
|
Beclomethasone Dipropionate with salicyclic Acid Cream |
Composition: |
IP |
0.025%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone Dipropionate |
IP |
3.00% |
Salicylic Acid |
|
q.s. |
Cream base |
|
|
Clobetasol Propionate with salicyclic Acid Ointment |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
3.00% |
Salicyclic Acid |
|
q.s. |
Ointment base |
|
|
Mometasone Cream IP |
Composition:- |
IP |
0.10%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone Furoate |
|
|
Preservatives: |
IP |
0.20%w/w |
Methyl Paraben |
IP |
0.20%w/w |
Propyl Paraben |
|
q.s. |
Cream Base |
|
|
Neomycin and Polymyxin B Sulfate and Bacitracin Zinc Ointment USP |
Composition : |
USP |
5000 units |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Each gm Contains : |
|
|
Polymyxin B Sulfate |
IP |
|
Equ. to Polymyxin |
|
400units |
Bacitracin Zinc |
IP |
|
Equ. to Bacitracin |
|
3400units |
Neomycin Sulphate |
|
|
Equ. to Neomycin |
IP |
0.1%w/w |
Preservative: |
|
q.s |
Benzyl Alcohol |
|
|
Ointment Base |
|
|
Mometasone &Fusidic Acid Cream |
Composition:- |
IP |
0.10%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone furoate |
IP |
2.00%w/w |
Fusidic Acid |
|
q.s. |
Cream Base |
|
|
Beclomethasone Dipropionate, Phenylephrine Hydrochloride & Lignocaine Hydrochloride Cream |
Composition: |
IP |
0.020%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone Dipropionate |
IP |
0.10% w/w |
Phenylephrine Hydrochloride |
IP |
2.50% w/w |
Lignocaine Hydrochloride |
IP |
0.1% w/w |
Chlorocresol |
|
|
(as Preservative) |
|
q.s. |
Cream base |
|
|
Betamethasone Dipropionate Cream IP |
Composition |
|
0.05 % w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone propionate |
q.s. |
eq. to. Betamethasone |
|
In a cream base |
|
Mometasone Furoate Ointment |
Composition: |
IP |
0.1% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Mometasone Furoate |
q.s. |
Excipients |
|
Fluticasone Propionate Ointment |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate |
q.s |
Ointment Base |
|
Fluticasone Propionate cream IP |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate |
q.s |
Cream Base |
|
Mometasone & Salicylic Acid Cream |
Composition:- |
IP |
0.10%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
Mometasone furoate |
IP |
5.00%w/w |
Salicylic Acid |
|
q.s. |
Cream Base |
|
|
Clobetasol Propionate with salicyclic Acid cream |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory , Analgesic |
Clobetasol Propionate |
IP |
6.0% w/w |
Salicyclic Acid |
|
q.s. |
Cream base |
|
|
Halobetasol Cream |
Composition : |
USP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate |
q.s |
Equivalent to Halobetasol |
|
Cream Base |
|
Fluticasone Cream IP |
Composition : |
IP |
0.05 %w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Fluticasone Propionate |
q.s |
Cream Base |
|
Clobetasol Propionate with salicyclic Acid Ointment |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
6.00% |
Salicyclic Acid |
|
q.s. |
Ointment base |
|
|
Clobetasol Propionate& Miconazole Cream |
Composition: |
IP |
0.05 % w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
2.0 % w/w |
Miconazole Nitrate |
|
q.s. |
Cream Base |
|
|
Clobetasol propionate and Ammonium lactate Gel |
Composition: |
IP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol propionate |
12.0%w/w |
Ammonium lactate |
q.s. |
Gel Base |
|
Clobetasol Cream IP |
Composition: |
IP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol propionate |
q.s. |
Cream Base |
|
Clobetasol Propionate, Neomycin sulphate, Miconazole &Chlorhexidine Gluconate, Cream |
Composition : |
IP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
0.50%w/w |
Neomycin sulphate |
IP |
2.0%w/w |
Miconazole Nitrate |
IP |
0.2%w/w |
Chlorhexidine Gluconate Solution |
|
q.s |
Cream Base |
|
|
Halobetasol& Salicylic acid Cream |
Composition : |
USP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate Equivalent to Halobetasol |
IP |
6.0 % w/w |
Salicylic Acid |
|
q.s |
Cream Base |
|
|
Beclomethasone dipropionate, Econazole & Neomycin cream |
Composition : |
IP |
0.025 %w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Beclomethasone |
|
|
Dipropionate |
IP |
1.0 %w/w |
Econazole Nitrate |
IP |
|
Neomycin Sulphate |
|
0.5 %w/w |
Eq. to Neomycin |
|
q.s. |
Cream base |
|
|
Halobetasol&Salicylic acid Ointment |
Composition : |
USP |
0.05%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Halobetasol Propionate |
|
6.0 % w/w |
Equivalent to Halobetasol |
IP |
q.s |
Salicylic Acid |
|
|
Ointment Base |
|
|
Clobetasol Propionate and Ammonium lactate Gel |
Composition: |
IP |
0.05% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
|
Ammonium Lactate |
12.00% |
equ. to Lactic Acid |
q.s. |
Gel base |
|
Clobetasol Propionate, Gentamicin, Tolnaftate, Iodochlorhydroxyquinoline & Clotrimazole Cream |
Composition: |
IP |
0.05 % w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
|
Gentamicin Sulphate |
|
0.1 % w/w |
equ. to Gentamicin |
IP |
1.0% w/w |
Tolnaftate |
IP |
1.0% w/w |
Iodochlorhydroxyquinoline |
IP |
1.0% w/w |
Clotrimazole |
IP |
0.1%w/w |
Chlorocresol |
|
|
(as preservative) |
|
q.s. |
In a cream base |
|
|
Diphenhydramine HCl, Clotrimazole, Lignocaine HCl, Menthol &Aloe Vera cream |
Composition: |
IP |
2.0%w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Diphenhydramine HCl |
IP |
1.0%w/w |
Clotrimazole |
IP |
0.5%w/w |
Lignocaine HCl |
IP |
1.0%w/w |
Menthol |
|
0.5%w/w |
Aloe Vera |
|
q.s. |
Cream Base |
|
|
Diclofenac Diethylamine , Oleum Lini,Methyl Salicylate & Menthol gel |
Composition: |
IP |
1.16% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Diclofenac Diethylamine |
|
|
eq. to Diclofenac sodium |
IP |
1.0% w/w |
Oleum Lini (containing predominantly alpha linolenic acid) |
BP |
3.0% w/w |
Methyl Salicylate |
|
|
Menthol |
IP |
10.0% w/w |
|
IP |
5.0%w/w |
Gel Base |
|
q.s. |
Chlorhexidine, Metronidazole & Lignocaine Gel |
Composition: |
IP |
1.0% w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Chlorhexidine Gluconate solution |
|
1.0 %w/w |
equ. to Chlorhexidine |
IP |
2.0%w/w |
Metronidazole |
IP |
q.s. |
Lignocaine Hydrochloride |
|
|
Gel Base |
|
|
Clobetasol Propionate& Gentamicin Cream |
Composition: |
IP |
0.05 % w/w |
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Clobetasol Propionate |
IP |
|
Gentamicin Sulphate |
|
0.1 % w/w |
Equ. to Gentamicin |
IP |
0.1 % w/w |
Chlorcresol |
|
q.s. |
Cream Base |
|
|
Nicotinamide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Nicotinamide IP ———— 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Betamethasone Tablets IP |
Each Uncoated Tablet Contains: – |
|
|
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
Betamethasone IP ————– 0.5 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Clobetasol Propionate,Salicylic acid,Urea,Lactic acid &Sodium Lactate Ointment |
Composition: |
|
|
Antifungal, Corticosteroid, Antibacterial & Anti-Inflammatory |
ClobetasolPropionate USP0.05%w/w |
|
|
SalicylicAcid IP3.0%w/w |
|
|
Urea IP10.0%w/w |
|
|
LacticAcid IP3.0%w/w |
|
|
SodiumLactatesolution USP |
|
|
Equ.toLactic Acid 2.0%w/w |
|
|
OintmentBase q.s |
|
|
Antiacne & Antifungal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Isotretinoin Capsule IP. |
Each Hard gelatin capsule Contains: |
IP |
10 mg |
Antiacne |
Isotretinoin |
qs |
Excipients |
|
Approved colour used |
|
Isotretinoin Capsule IP |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antiacne |
Isotretinoin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Clindamycin Phosphate & Nicotinamide Gel |
Composition: |
IP |
1.0% w/w |
Antiacne |
Clindamycin Phosphate |
|
4.0%w/w |
eq. to Clindamycin |
IP |
q.s. |
Nicotinamide |
|
|
Aloe Allantoin Gel Base with ethyl lactate |
|
|
Luliconazole Cream |
Composition: |
IP |
1 % w/w |
Antiacne & Antifungal |
Luliconazole |
|
|
Preservative: |
IP |
1% w/w |
Benzyl Alcohol |
|
q.s. |
Cream Base |
|
|
Ofloxacin, Fluocinolone Acetonide & Clotrimazole Cream IP |
Composition : |
IP |
0.5 %w/w |
Antibaterial, Antifungal |
Ofloxacin |
IP |
0.01%w/w |
Fluocinolone |
IP |
1.0%w/w |
Acetonide |
|
0.12%w/w |
Clotrimazole |
|
q.s |
Cream Base |
|
|
Adapalene and clindamycin Gel |
Composition: |
BP |
0.1%w/w |
Antiacne & Antifungal |
Adapalene |
IP |
1.0 %w/w |
Clindamycin Phosphate |
|
q.s. |
equivalent to Clindamycin |
|
|
Gel Base |
|
|
Hydroquinone, |
Composition: |
USP |
2.0% w/w |
Antiacne & Antifungal |
Tretinoin & |
Hydroquinone |
USP |
0.05%w/w |
Hydrocortisone Acetate Cream |
Tretinoin |
IP |
1.0% w/w |
|
Hydrocortisone Acetate |
|
q.s. |
|
In a Cream Base |
|
|
Adapalene and Benzoyl Peroxide Gel |
Composition: |
BP |
0.1%w/w |
Antiacne & Antifungal |
Adapalene |
USP |
2.5 %w/w |
Benzoyl Peroxide |
|
q.s |
Gel Base |
|
|
Tretinoin Gel USP |
Composition : |
USP |
0.05 %w/w |
Antiacne & Antifungal |
|
Tretinoin |
q.s |
|
Gel Base |
|
ClobetasolPropionate,GentamicinSulphate,Miconazole Nitrate &ZincOxide Cream |
Composition: |
|
|
Antiacne & antifungal |
ClobetasolPropionate IP 0.05%w/w |
|
|
GentamicinSulphate IP0.2%w/w |
|
|
Eq.toGentamicin |
|
|
MiconazoleNitrate IP2.0%w/w |
|
|
ZincOxide IP0.1% w/w |
|
|
CreamBase q.s |
|
|
Clindamycin Phosphate&TretinointopicalGel |
Composition: |
|
|
Antiacne & antifungal |
ClindamycinPhosphate eq.to IP1.0%w/w |
|
|
Clindamycin |
|
|
Tretinoin USP0.025%w/w |
|
|
Gelbase q.s |
|
|
Hydroquinone, Tretinoin & Mometasone Furoate Cream |
Composition: |
USP |
2.0% w/w |
Anti Acne & Anti Fungal |
Hydroquinone |
USP |
0.025%w/w |
Tretinoin |
IP |
0.10%w/w |
Mometasone Furoate |
IP |
0.1% w/w |
Chlorocresol (as preservative) |
|
q.s. |
In a Cream Base |
|
|
Amorolfine Hydrochloride cream |
Composition: |
IP |
0.25%w/w |
Anti Acne & Anti Fungal |
Amorolfine Hydrochloride |
IP |
1.0%w/w |
Phenoxyethanol |
|
|
Cream base |
|
|
Clindamycin Phosphate & Isotretinoin topical Gel |
Composition: |
IP |
1.0% w/w |
Anti Acne & Anti Fungal |
Clindamycin Phosphate |
|
0.05%w/w. |
eq. to Clindamycin |
IP |
q.s. |
Isotretinoin |
|
|
Gel base |
|
|
Tretinoin Cream USP |
Composition : |
USP |
0.05 %w/w |
Anti Acne & Anti Fungal |
Tretinoin |
q.s |
Cream Base |
|
Sertaconazole Nitrate Cream |
Composition: |
IP |
2.00% |
Anti Acne & Anti Fungal |
Sertaconazole |
q.s. |
Cream Base |
|
Tretinoin Cream USP |
Composition : |
USP |
0.025 %w/w |
Anti Acne & Anti Fungal |
Tretinoin |
q.s |
Cream Base |
|
Hydroquinone, Tretinoin & Fluocinolone Acetonide Cream |
Composition: |
USP |
2.0% w/w |
Anti Acne & Anti Fungal |
Hydroquinone |
USP |
0.025%w/w |
Tretinoin |
IP |
0.01%w/w |
Fluocinolone Acetonide |
|
q.s. |
Cream Base |
|
|
Antihypertensive |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Rosuvastatin &Clopidogrel Capsules |
Each hard gelatin capsule contains: |
IP |
5.0 mg |
Antihypertensive |
Rosuvastatin Calcium |
|
|
Eq.to Rosuvastatin |
|
|
(As pellets) |
|
75 mg |
Clopidogrel Bisulphate |
IP |
|
Eq. to Clopidogrel |
|
q.s. |
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Rosuvastatin &Clopidogrel Capsules |
Each hard gelatin capsule contains: |
IP |
10 mg |
Antihypertensive |
Rosuvastatin Calcium |
|
|
Eq.to Rosuvastatin |
|
75 mg |
(As pellets) |
IP |
|
Clopidogrel Bisulphate |
|
|
Eq. to Clopidogrel |
|
q.s. |
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Rosuvastatin &Clopidogrel Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Antihypertensive |
Rosuvastatin Calcium |
|
|
Eq.to Rosuvastatin |
|
|
(As pellets) |
|
75 mg |
Clopidogrel Bisulphate |
IP |
|
Eq. to Clopidogrel |
|
q.s. |
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Atorvastatin Tablets IP 10 mg |
Each Film coated Tablets contains: |
IP |
10 mg |
Antihypertensive |
Atorvastatin Calcium |
q.s. |
eq. to. Atorvastatin |
|
Excipients |
|
Colour: Approved ColourUsed |
|
Atorvastatin Tablets IP 20 mg |
Each Film coated Tablets contains: |
|
20 mg |
Antihypertensive |
Atorvastatin Calcium |
IP |
q.s. |
eq. to. Atorvastatin |
|
|
Excipients |
|
|
Colour: Approved ColourUsed |
|
|
Atorvastatin Tablets IP 40 mg |
Each Film coated Tablets contains: |
IP |
40 mg |
Antihypertensive |
Atorvastatin Calcium |
q.s. |
eq. to. Atorvastatin |
|
Excipients |
|
Colour: Approved ColourUsed |
|
Atorvastatin Tablets IP 80 mg |
Each Film coated Tablets contains: |
IP |
80 mg |
Antihypertensive |
Atorvastatin Calcium |
q.s. |
eq. to. Atorvastatin |
|
Excipients |
|
Colour: Approved ColourUsed |
|
Ramipril and Hydrochlorothiazide Tablets |
Each Uncoated Sustained release Tablet Contains:- |
IP |
2.5 mg |
Antihypertensive |
Ramipril |
IP |
12.5mg |
Hydrochlorothiazide |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Tofacitinib Tablets 5 mg |
Each Film coated Tablet Contains:- |
|
5 mg |
Antihypertensive |
Tofacitinib Citrate |
q.s |
Eq. to Tofacitinib |
|
Excipients |
|
Colour-Approved colour used. |
|
Telmisartan & Atorvastatin Tablets |
Each Film coated Tablets contains: |
IP |
40 mg |
Antihypertensive |
Telmisartan |
IP |
|
Atorvastatin Calcium |
|
10 mg |
eq. to. Atorvastatin |
|
|
Excipients |
|
q.s |
Colour: Approved Colour Used |
|
|
Losartan Potassium and Hydrochlorothiazide Tablets I.P |
Each film coated tablet contains: |
|
|
Antihypertensive |
Losartan Potassium IP————50 mg |
|
|
Hydrochlorothiazide IP————12.5 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Aspirin Gastro- resistant Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Aspirin IP —————– 75 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aspirin Gastro- resistant Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Aspirin IP —————– 150 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lisinopril and Amlodipine Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Lisinopril IP |
|
|
Eq. to Anhydrous Lisinopril ———- 5 mg |
|
|
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ——————–5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Olmesartan Medoxomil IP ———-40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Olmesartan Medoxomil IP ———- 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 5.0 mg |
|
|
Telmisartan IP ————–40 mg |
|
|
Hydrochlorothiazide IP —— 12.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine, and Indapamide Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 10.0 mg |
|
|
Indapamide (SR) IP —— 1.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan and Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————–40 mg |
|
|
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metoprolol Succinate Extended Release Tablets IP |
Each Extended Release Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Metoprolol Succinate IP 23.75 mg |
|
|
Eq. to Metoprolol Tartrate ———25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metoprolol Succinate Extended Release Tablets IP |
Each Extended Release Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Metoprolol Succinate IP 47.50 mg |
|
|
Eq. to Metoprolol Tartrate ———50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metoprolol Succinate Extended Release Tablets IP |
Each Extended Release Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Metoprolol Succinate IP 11.875 mg |
|
|
Eq. to Metoprolol Tartrate ——-12.50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rosuvastatin Calcium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rosuvastatin Calcium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rosuvastatin Calcium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Atenolol IP ———– 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Atenolol IP ———– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan and Hydrochlorothiazide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————–40 mg |
|
|
Hydrochlorothiazide IP —— 12.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————– 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————– 80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————– 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Telmisartan and Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————–80 mg |
|
|
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———-2.5 mg |
|
|
Telmisartan IP ————–20 mg |
|
|
Hydrochlorothiazide IP —— 6.25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Valsartan Tablet IP |
Each Film coated tablet contains: |
|
|
Antihypertensive |
Valsartan IP———- 80.0 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Valsartan Tablet IP |
Each Film coated tablet contains: |
|
|
Antihypertensive |
Valsartan IP———- 160.0 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Valsartan & Hydrochlorothiazide Tablet IP |
Each Film coated tablet contains: |
|
|
Antihypertensive |
Valsartan IP——————–80.0 mg |
|
|
Hydrochlorothiazide IP———12.5 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Valsartan & Amlodipine tablet |
Each Film coated tablet contains: |
|
|
Antihypertensive |
Valsartan IP ———————80.0 mg |
|
|
Amlodipine (As besylate) IP ——– 5.0 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Valsartan, Amlodipine Hydrochlorothiazide tablet |
Each Film coated tablet contains: |
|
|
Antihypertensive |
Valsartan IP ——————— 160.0 mg |
|
|
Amlodipine (As besylate) IP——– 5.0 mg |
|
|
Hydrochlorothiazide IP———– 12.5 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Losartan Potassium & Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Losartan Potassium IP ————— 25 mg |
|
|
Hydrochlorothiazide IP —————-12.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Losartan Potassium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Losartan Potassium IP ————— 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Losartan Potassium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Losartan Potassium IP ————— 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Carvedilol Tablet IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Carvedilol IP————- 3.125 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Carvedilol Tablet IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Carvedilol IP————- 6.25 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Carvedilol Tablet IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Carvedilol IP————- 12.5 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used |
|
|
Telmisartan & Metoprolol Succinate tablets IP |
Each uncoated Bilayer tablet contains: |
|
|
Antihypertensive |
Metoprolol Succinate 47.5 mg |
|
|
Eq. to Metoprolol Tartrate (SR)———50 mg |
|
|
Telmisartan IP ——————40.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Telmisartan & Metoprolol Succinate tablets IP |
Each uncoated Bilayer tablet contains: |
|
|
Antihypertensive |
Metoprolol Succinate 23.75 mg |
|
|
Eq. to Metoprolol Tartrate (SR)———25 mg |
|
|
Telmisartan IP ——————40.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Telmisartan & Chlorthalidone Tablets |
Each Uncoated Tablet contains: |
|
|
Antihypertensive |
Telmisartan IP ————– 40 mg |
|
|
Chlorthalidone IP————— 12.5 mg |
|
|
Excipients ————— q.s. |
|
|
Colour-Approved colour used. |
|
|
Methyldopa Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Methyldopa IP —————500 mg |
|
|
Excipients—————– q.s |
|
|
Atorvastatin &Fenofibrate Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Atorvastatin Calcium IP |
|
|
Eq. to Atorvastatin ———— 10 mg |
|
|
Fenofibrate IP ————- 160 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate …………….IP |
|
|
Eq. to Amlodipine ………………….10mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP |
Each Film coated Tablet contains: |
IP |
50 mg |
Antihypertensive |
Atenolol |
|
q. s. |
Excipients |
|
|
Atenolol Tablets IP |
Each Film coated Tablet contains: |
IP |
100 mg |
Antihypertensive |
Atenolol |
|
q. s. |
Excipients |
|
|
Aspirin & Rosuvastatin Capsules. |
Each Hard Gelatin capsule contains: |
IP |
150mg |
Antihypertensive |
Aspirin |
|
|
(As Enteric coated pellets ) |
IP |
10mg |
Rosuvastatin Calcium |
|
|
Eq. to Rosuvastatin |
|
q.s. |
(pellets) |
|
|
Excipients |
|
|
Approved colour used |
|
|
Atorvastatin Calcium & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive |
Atorvastatin Calcium |
|
|
eq. to Atorvastatin (As pellets) |
|
|
Aspirin (As Enteric coated pellets) |
IP |
150 mg |
Excipients |
|
q.s |
Approved colour used |
|
|
Rosuvastatin Calcium & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive |
Rosuvastatin Calcium |
|
|
eq. to Rosuvastatin (As pellets) |
IP |
75 mg |
Aspirin (As Enteric coated pellets) |
|
q.s |
Excipients |
|
|
Approved colour used |
|
|
Rosuvastatin Calcium & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
IP |
20 mg |
Antihypertensive |
Rosuvastatin Calcium |
|
|
eq. to Rosuvastatin (As pellets) |
IP |
75 mg |
Aspirin (As Enteric coated pellets) |
|
q.s |
Excipients |
|
|
Approved colour used |
|
|
Aspirin & Clopidogrel Capsule. |
Each hard gelatin capsule contain: |
IP |
75mg |
Antihypertensive |
Aspirin |
|
|
( As enteric coated Pellets ) |
IP |
|
Clopidogrel Bisulphate) |
|
75mg |
eq. to Clopidogrel |
|
|
Excipients |
|
qs |
Approved colour used |
|
|
Aspirin & Clopidogrel capsule |
Each hard gelatin capsule contain: |
IP |
75mg |
Antihypertensive |
Aspirin |
|
|
( As enteric coated Pellets ) |
IP |
|
Clopidogrel Bisulphate) |
|
150mg |
eq. to Clopidogrel |
|
|
(As pellets) |
|
qs |
Excipients |
|
|
Approved colour used |
|
|
Escitalopram Oxalate Tablets IP 10 mg |
Each film coated Tablet Contains:- |
IP |
10 mg |
Antihypertensive |
Escitalopram Oxalate |
|
q.s. |
Eq. to Escitalopram |
|
|
Excipients |
|
|
Colour- Approved colour used. |
|
|
Escitalopram Oxalate Tablets IP 20 mg |
Each film coated Tablet Contains:- |
IP |
20 mg |
Antihypertensive |
Escitalopram Oxalate |
|
q.s. |
Eq. to Escitalopram |
|
|
Excipients |
|
|
Colour- Approved colour used. |
|
|
Telmisartan and Hydrochlorothiazide Tablets I.P. |
Each Uncoated Bilayered Tablet Contains:- |
I.P. |
40 mg |
Antihypertensive |
Telmisartan |
I.P. |
12.5 mg |
Hydrochlorothiazide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used |
|
|
Telmisartan and Amlodipine Tablets I.P. |
Each Uncoated Tablet Contains:- |
I.P. |
40 mg |
Antihypertensive |
Telmisartan |
I.P. |
|
Amlodipine Besylate |
|
5 mg |
Eq. to Amlodipine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Telmisartan and Hydrochlorothiazide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Telmisartan IP ————– 80 mg |
|
|
Hydrochlorothiazide IP —— 12.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Atenolol IP ———– 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Bisoprolol Fumarate tablet |
Each Film Coated Tablet Contain: |
|
|
Antihypertensive |
Bisoprolol Fumarate ———– 5.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour: – Approved colour used |
|
|
Bisoprolol Fumarate tablet |
Each Film Coated Tablet Contain: |
|
|
Antihypertensive |
Bisoprolol Fumarate ———– 10.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour: – Approved colour used |
|
|
Metoprolol Extended Release Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Metoprolol Succinate IP |
|
|
Eq. to Metoprolol Tartrate ——–100 mg |
|
|
Excipients—————– q.s |
|
|
Colour: – Approved colour used |
|
|
Metoprolol ER&Amlopdipine Tablets IP |
Each Film Coated Tablet Contains:-: |
|
|
Antihypertensive |
Metoprolol Succinate IP ———47.5 mg |
|
|
Eq. to Metoprolol Tartrate ———50.0 mg |
|
|
Amlopdipine Besylate IP |
|
|
Eq. to Amlopdipine ——————5.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metoprolol ER& Amlodipine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Metoprolol Succinate IP ———23.75 mg |
|
|
Eq. to Metoprolol Tartrate ———25.0 mg |
|
|
Amlopdipine Besylate IP |
|
|
Eq. to Amlopdipine ——————5.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Telmisartan & Atorvastatin Tablets |
Each Film coated Tablets contains: |
IP |
20 mg |
Antihypertensive |
Telmisartan |
IP |
|
Atorvastatin Calcium |
|
10 mg |
eq. to. Atorvastatin |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Telmisartan & Atorvastatin Tablets |
Each Film coated Tablets contains: |
IP |
40 mg |
Antihypertensive |
Telmisartan |
IP |
|
Atorvastatin Calcium |
|
5 mg |
eq. to. Atorvastatin |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Torsemide & Spironolactone Tablets |
Each Uncoated Tablet Contains:- |
IP |
20 mg |
Antihypertensive |
Torsemide |
IP |
50 mg |
Spironolactone |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
IP |
2.5 mg |
Antihypertensive |
Amlodipine Besylate |
|
5 mg |
Eq. to Amlodipine |
IP |
12.5 mg |
Olmesartan Medoxomil |
IP |
q.s |
Hydrochlorothiazide |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP 25 mg |
Each Uncoated Tablet Contains:- |
IP |
25 mg |
Antihypertensive |
Atenolol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP 50 mg |
Each Uncoated Tablet Contains:- |
IP |
50 mg |
Antihypertensive |
Atenolol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Atenolol Tablets IP 100 mg |
Each Uncoated Tablet Contains:- |
IP |
100 mg |
Antihypertensive |
Atenolol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
IP |
10 mg |
Antihypertensive |
Amlodipine Besylate |
|
40 mg |
Eq. to Amlodipine |
IP |
25 mg |
Olmesartan Medoxomil |
IP |
q.s |
Hydrochlorothiazide |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Amlodipine Besylate |
|
40 mg |
Eq. to Amlodipine |
IP |
12.5 mg |
Olmesartan Medoxomil |
IP |
q.s |
Hydrochlorothiazide |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Amlodipine Besylate |
|
20 mg |
Eq. to Amlodipine |
IP |
12.5 mg |
Olmesartan Medoxomil |
IP |
q.s |
Hydrochlorothiazide |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Olmesartan Medoxomil, Hydrochlorothiazide & Amlodipine Tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Amlodipine Besylate |
|
5 mg |
Eq. to Amlodipine |
IP |
12.5 mg |
Olmesartan Medoxomil |
IP |
q.s |
Hydrochlorothiazide |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Azelnidipine Tablets IP 8 mg |
Each Uncoated Tablet Contains:- |
IP |
8 mg |
Antihypertensive |
Azelnidipine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Azelnidipine Tablets IP 16 mg |
Each Uncoated Tablet Contains:- |
IP |
16 mg |
Antihypertensive |
Azelnidipine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Bosentan Tablets IP 62.5mg |
Each Film Coated Tablet Contains:- |
IP |
62.5 mg |
Antihypertensive |
Bosentan Monohydrate |
|
q.s |
Eq. to Bosentan |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Bosentan Tablets IP 125mg |
Each Film Coated Tablet Contains:- |
IP |
125 mg |
Antihypertensive |
Bosentan Monohydrate |
|
q.s |
Eq. to Bosentan |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Minoxidil Topical solution USP |
Composition |
IP |
5.0%w/v |
Antihypertensive |
Minoxidil |
IP |
q.s. |
Iso propyl alcohol |
|
|
Minoxidil Topical lotion USP 2% |
Composition: |
IP |
2.0%w/v |
Antihypertensive |
Minoxidil |
|
qs |
In Adhesive base |
|
|
Lisinopril Tablets IP 5 mg |
Each Uncoated Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Lisinopril |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Lisinopril Tablets IP 2.5 mg |
Each Uncoated Tablet Contains:- |
IP |
2.5 mg |
Antihypertensive |
Lisinopril |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Losartan Potassium & Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
IP |
25 mg |
Antihypertensive |
Losartan Potassium |
IP |
5 mg |
Hydrochlorothiazide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Fenofibrate and Rosuvastatin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Fenofibrate IP ————- 160 mg |
|
|
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Olmesartan & Ramipril Tablets. |
Each uncoated tablet contains: |
|
|
Antihypertensive |
Olmesartan IP ————- 20.0 mg |
|
|
Ramipril IP ————–5.0 mg |
|
|
Excipients —————– q.s |
|
|
Colour: – Approved colour used |
|
|
Telmisartan and Amlodipine Tablets I.P. |
Each Uncoated Bilayered Tablet Contains:- |
I.P. |
40 mg |
Antihypertesnive |
Telmisartan |
I.P. |
5 mg |
Amlodipine Besylate |
|
|
Eq. to Amlodipine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Atorvastatin Calcium & Clopidogrel Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive |
Atorvastatin Calcium |
|
75 mg |
eq. to Atorvastatin (As pellets) |
IP |
q.s |
Clopidogrel (as Bisulphate) (As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Atorvastatin Calcium & Clopidogrel Capsules |
Each Hard Gelatin Capsule contains: |
IP |
20 mg |
Antihypertensive |
Atorvastatin Calcium |
|
|
eq. to Atorvastatin |
|
75 mg |
(As pellets) |
IP |
|
Clopidogrel (as Bisulphate) |
|
q.s. |
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Propranolol Sustained Release Capsules IP |
Each hard gelatin capsule contains: |
IP |
40.0 mg |
Antihypertensive |
Propranolol Hydrochloriode |
|
( As sustained Release pellets) |
q.s. |
Excipients |
|
Approved Colors Used. in Empty Shell & Pellet |
|
Propranolol Sustained Release Capsules IP |
Each hard gelatin capsule contains: |
IP |
60.0 mg |
Antihypertensive |
Propranolol Hydrochloriode |
|
( As sustained Release pellets) |
q.s. |
Excipients |
|
Approved Colors Used. in Empty Shell & Pellet |
|
Propranolol Sustained Release Capsules IP |
Each hard gelatin capsule contains: |
IP |
80 |
Antihypertensive |
Propranolol Hydrochloriode |
|
( As sustained Release pellets) |
q.s. |
Excipients |
|
Approved Colors Used. in Empty Shell & Pellet |
|
Prasugrel & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
USP |
10 mg |
Antihypertensive |
Prasugrel Hydrochlorode |
|
|
|
Equ. to Prasugrel |
|
75 mg |
(As pellets) |
IP |
q.s. |
Aspirin |
|
|
(As enteric coated Pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Prazosin Tablets IP 5 mg |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Prazosin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Chlorthalidone Tablets 6.25 mg |
Each Uncoated Tablet contains: |
IP |
6.25 mg |
Antihypertensive |
Chlorthalidone |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Ramipril and Hydrochlorothiazide Tablets |
Each Uncoated Sustained release Tablet Contains:- |
IP |
5 mg |
Antihypertensive |
Ramipril |
IP |
12.5 mg |
Hydrochlorothiazide |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Enalapril Maleate Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Enalapril Maleate IP.————–2.5mg |
|
|
Excipients———————–q.s. |
|
|
Colour-Approved colour used. |
|
|
Enalapril Maleate Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Enalapril Maleate I.P ————5- mg |
|
|
Excipients———————–q.s. |
|
|
Colour-Approved colour used. |
|
|
Enalapril Maleate Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Enalapril Maleate IP———-10mg |
|
|
Excipients———————q.s. |
|
|
Colour-Approved colour used. |
|
|
Enalapril Maleate Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Enalapril Maleate I.P———-20mg |
|
|
Excipients———————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Hydrochlorothiazide IP———25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Hydrochlorothiazide IP———50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lisinopril Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Lisinopril IP——— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Spironolactone Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Spironolactone IP——— 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Spironolactone Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Spironolactone IP——— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Spironolactone Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Spironolactone IP——— 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aspirin Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Aspirin IP——— 75 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Aspirin Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Aspirin IP——— 150 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ——— 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ——— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fenofibrate and Rosuvastatin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Fenofibrate IP ————- 145 mg |
|
|
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methyldopa Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensives |
Methyldopa IP |
|
|
(As Anhydrous) —————125 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methyldopa Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensives |
Methyldopa IP |
|
|
(As Anhydrous) —————250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Torsemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Torsemide IP ————– 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Torsemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Torsemide IP ————– 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Torsemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Torsemide IP ————– 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Torsemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Torsemide IP ————– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Propranolol Tablet IP |
Each uncoated tablet contains: |
|
|
Antihypertensive |
Propranolol HCl IP————–10.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Propranolol Tablet IP |
Each uncoated tablet contains: |
|
|
Antihypertensive |
Propranolol HCl IP————–40.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Atorvastatin & Ezetimibe Tablet |
Each Film Coated Tablet contain |
|
|
Antihypertensive |
Atorvastatin IP————40.0 mg |
|
|
Ezetimibe ——————–10.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Atorvastatin & Ezetimibe Tablet |
Each Film Coated Tablet contain |
|
|
Antihypertensive |
Atorvastatin IP————10.0 mg |
|
|
Ezetimibe ——————–10.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Fenofibrate and Rosuvastatin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Fenofibrate IP ————- 145 mg |
|
|
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———20.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour-approved colour used. |
|
|
Olmesartan & Ramipril Tablets. |
Each uncoated tablet contains: |
|
|
Antihypertensive |
Olmesartan IP ————- 40.0 mg |
|
|
Ramipril IP ————–5.0 mg |
|
|
Excipients —————– q.s |
|
|
Colour: – Approved colour used. |
|
|
Spironolactone and Furosemide Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Spironolactone IP——— 25.0 mg |
|
|
Furosemide IP ————40.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour :- Approved colour used |
|
|
Cilnidipine tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Clinidipine IP ————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour used |
|
|
Amitriptyline Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amitriptyline Hydrochloride IP ——— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour used |
|
|
Amitriptyline Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amitriptyline Hydrochloride IP ——— 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour use |
|
|
Amitriptyline Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amitriptyline Hydrochloride IP ——— 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour used |
|
|
Escitalopram Oxalate Tablets IP |
Each coated Tablet Contains:- |
|
|
Antihypertensive |
Escitalopram Oxalate I.P. |
|
|
Eq. to Escitalopram —————— 5 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Ramipril & Metoprolol Succinate Tablets |
Each Bilayered tablet contains: |
|
|
Antihypertensive |
Ramipril IP ———————— 2.5 mg |
|
|
Metoprolol Succinate IP ———–23.75 mg |
|
|
Eq. to Metoprolol Tartrate ———-25 mg |
|
|
(Extended Release) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cilnidipine & Telmisartan Tablets |
Each Film Coated Tablet contains: |
|
|
Antihypertensive |
Cilnidipine IP ————— 10.0 mg |
|
|
Telmisartan IP ————– 40 mg |
|
|
Excipients ——————- q.s. |
|
|
Colour-Approved colour used. |
|
|
Ramipril & Metoprolol Succinate Tablets |
Each Bilayered tablet contains: |
|
|
Antihypertensive |
Ramipril IP ———————— 5.0 mg |
|
|
Metoprolol Succinate IP ———– 47.5 mg |
|
|
Eq. to Metoprolol Tartrate ———-50 mg |
|
|
(Extended Release) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metoprolol Succinate (ER) & Cilnidipine Tablets |
Each Film Coated Tablet contains: |
|
|
Antihypertensive |
Metoprolol Succinate USP |
|
|
Eq. to Metoprolol Tartrate ——— 50 mg |
|
|
Cilnidipine IH ————— 10.0 mg |
|
|
Excipients ————— q.s. |
|
|
Approved Colour Used. |
|
|
Colour-Approved colour used. |
|
|
Metoprolol Succinate (ER) & Cilnidipine Tablets |
Each Film Coated Tablet contains: |
|
|
Antihypertensive |
Metoprolol Succinate USP |
|
|
Eq. to Metoprolol Tartrate ——— 25 mg |
|
|
Cilnidipine IH ————— 10.0 mg |
|
|
Excipients ————— q.s. |
|
|
Colour-Approved colour used. |
|
|
Azilsartan Medoximil Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Azilsartan Medoximil —————– 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Azilsartan Medoximil Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antihypertensive |
Azilsartan Medoximil —————– 80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Clopidogrel Bisulphate and Aspirin Tablets |
Each Film Coated Tablets Contains :- |
|
|
Antihypertensive |
Clopidogrel Bisulphate |
|
|
Eq. to Clopidogrel —————— 75 mg |
|
|
Aspirin IP —————— 75 mg |
|
|
(As Enteric coated Granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Clopidogrel Bisulphate and Aspirin Tablets |
Each Film Coated Tablets Contains :- |
|
|
Antihypertensive |
Clopidogrel Bisulphate |
|
|
Eq. to Clopidogrel —————— 75 mg |
|
|
Aspirin IP —————— 150 mg |
|
|
(As Enteric coated Granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 10.0 mg |
|
|
Telmisartan IP ————– 80 mg |
|
|
Hydrochlorothiazide IP —— 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Amlodipine, Telmisartan and Hydrochlorothiazide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ———- 2.5 mg |
|
|
Telmisartan IP ————– 20 mg |
|
|
Hydrochlorothiazide IP —— 12.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rosuvastatin & Fenofibrate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihypertensive |
Rosuvastatin Calcium IP |
|
|
Eq. to Rosuvastatin ———5.0 mg |
|
|
Fenofibrate IP ————- 67 mg |
|
|
Excipients—————– q.s |
|
|
Colour-approved colour used. |
|
|
Atorvastatin Calcium & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive |
Atorvastatin Calcium |
|
|
eq. to Atorvastatin (As pellets) |
|
75 mg |
Aspirin (As Enteric coated pellets) |
IP |
q.s |
Excipients |
|
|
Approved colour used |
|
|
Amlodipine & Atenolol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihypertesnive |
Amlodipine Besylate IP |
|
|
Eq. to Amlodipine ——— 5 mg |
|
|
Atenolol IP —————- 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nifedipine Sustained-Release Tablets I.P. |
Each Film Coated Sustained-Release Tablets:- |
|
|
Antihypertesive |
Nifedipine I.P————–10mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Nifedipine Sustained-Release Tablets I.P. |
Each Film Coated Sustained-Release Tablets:- |
|
|
Antihypertesive |
Nifedipine I.P—————20mg |
|
|
Excipients———————q.s. |
|
|
Colour-Approved colour used. |
|
|
Nicorandil Tablets I.P. |
Each Uncoated Tablet Contains:- |
|
|
Antihypertesive |
Nicorandil I.P.——– 5 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Nicorandil Tablets I.P. |
Each Uncoated Tablet Contains:- |
|
|
Antihypertesive |
Nicorandil I.P.————– 10 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Nicorandil Tablets I.P. |
Each Uncoated Tablet Contains:- |
|
|
Antihypertesive |
Nicorandil I.P.……………….. 20 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Midodrine Hydrochloride Tablets USP 2.5 mg |
Each Uncoated Tablet Contains:- |
USP |
2.5 mg |
Antihypotensive |
Midodrine Hydrochloride |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Anti acne & Anti fungal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Clindamycin Hydrochloride Capsule IP |
Each hard gelatin capsule contain: |
IP |
300 mg |
Anti acne & Anti fungal |
Clindamycin Hydrochloride |
q.s. |
Equivalent to Clindamycin |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule |
|
Terbinafine Tablets I.P. |
Each Uncoated Tablet Contains:- |
|
|
Anti Acne & Anti Fungal |
Terbinafine Hydrochloride I.P. |
|
|
Eq.to Terbinafine 250mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Analgesic & anti Inflammatory |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Diclofenac &thiocolchicoside Capsule |
Each Hard Gelatin Capsule contain: |
IP |
100 mg |
Analgesic & anti Inflammatory |
Diclofenac Sodium (EC) |
IP |
8 mg |
Thiocolchicoside |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used in capsule shells. |
|
|
Antihypertensive, Antithrombotic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Rosuvastatin and Aspirin Capsules |
Each Hard Gelatin Capsule contain: |
IP |
5.0 mg |
Antihypertensive, Antithrombotic |
Rosuvastatin calcium |
|
|
Equivalent to Rosuvastatin |
|
75 mg |
(As pellets) |
IP |
|
Aspirin |
|
q.s. |
(As enteric coated pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Rosuvastatin and Aspirin Capsules |
Each Hard Gelatin Capsule contain: |
IP |
10 mg |
Antihypertensive, Antithrombotic |
Rosuvastatin calcium |
|
|
Equivalent to Rosuvastatin |
|
|
(As pellets) |
IP |
150 mg |
Aspirin(As enteric coated pellets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Atorvastatin, Aspirin & Clopidogrel Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive, Antithrombotic |
Atorvastatin Calcium |
|
75 mg |
eq. to Atorvastatin (As pellets) |
IP |
|
Aspirin |
|
|
( As enteric coated Pellets ) |
IP |
75 mg |
Clopidogrel Bisulphate) |
|
q.s. |
equ. to Clopidogrel |
|
|
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Atorvastatin, Aspirin & Clopidogrel Capsules |
Each Hard Gelatin Capsule contains: |
IP |
20 mg |
Antihypertensive, Antithrombotic |
Atorvastatin Calcium |
|
75 mg |
eq. to Atorvastatin (As pellets) |
IP |
|
Aspirin |
|
|
( As enteric coated Pellets ) |
IP |
75 mg |
Clopidogrel Bisulphate) |
|
|
equ. to Clopidogrel |
|
q.s. |
(As pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Rosuvastatin, Clopidogrel & Aspirin Capsules |
Each Hard Gelatin Capsule contains: |
IP |
10 mg |
Antihypertensive, Antithrombotic |
Rosuvastatin Calcium |
|
|
eq. to Rosuvastatin |
|
75 mg |
(As pellets) |
IP |
|
Aspirin |
|
|
( As enteric coated Pellets ) |
IP |
75 mg |
Clopidogrel Bisulphate) |
|
q.s. |
equ. to Clopidogrel |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Rosuvastatin and Aspi rin Capsules |
Each Hard Gelatin Capsule contain: |
IP |
10 mg |
Antihypertensive, Antithrombotic |
Rosuvastatin calcium |
|
|
Equivalent to Rosuvastatin |
|
|
(As pellets) |
IP |
75 mg |
Aspirin (As enteric coated pellets) |
|
|
Excipients |
|
q.s. |
Approved colour used in empty hard gelatin capsule shell |
|
|
Clopidogrel Bisulphate Tablet IP |
Each Film coated tablet contains: |
|
|
Antihypertensive, antithrombotic |
Clopidogrel Bisulphate IP |
|
|
eq. to. Clopidogrel ——– 75.0 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Clopidogrel Bisulphate Tablet IP |
Each Film coated tablet contains: |
|
|
Antihypertensive, antithrombotic |
Clopidogrel Bisulphate IP |
|
|
eq. to. Clopidogrel ——– 150.0 mg |
|
|
Excipients ———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Ramipril Tablet IP |
Each uncoated tablet contains: |
|
|
Antihypertensive, antithrombotic |
Ramipril IP ————-5.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Ramipril Tablet IP |
Each uncoated tablet contains: |
|
|
Antihypertensive, antithrombotic |
Ramipril IP ————-10.0 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Ramipril Tablet IP 1.25 mg |
Each uncoated |
|
|
Antihypertensive, Antithrombotic |
tablet contains: |
|
|
Ramipril IP ————-1.25 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used |
|
|
Ramipril Tablet IP 2.5 mg |
Each uncoated |
|
|
Antihypertensive, Antithrombotic |
tablet contains: |
|
|
Ramipril IP ————-2.5 mg |
|
|
Excipients —————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Diclofenac Gel IP |
Composition: |
IP |
1.16%w/w |
Analgesic |
Diclofenac Dimethylamine |
1.0 %w/w |
equivalent to Diclofenac Sodium |
q.s. |
Water soluble Gel Base |
|
Lignocaine Cream |
Composition |
IP |
2.0 % w/w |
Analgesic |
Lignocaine |
q.s. |
Cream base |
|
Lignocaine Cream |
Composition |
IP |
1.0 % w/w |
Analgesic |
Lignocaine |
q.s. |
Cream base |
|
Aceclofenac Dispersible Tablets 100 mg |
Each Uncoated Dispersible Tablet Contains:- |
IP |
100 mg |
Analgesic |
Aceclofenac |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Paracetamol Sustained Release Tablets |
Each uncoated Bilayered Tablet Contains: |
IP |
300 mg |
Analgesic |
Paracetamol |
|
|
(As Immediate Release) |
IP |
700 mg |
Paracetamol |
|
|
(As Sustained Release) |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Nimesulide Tablets BP |
Each Uncoated Tablet Contains:- |
|
|
Analgesic |
Nimesulide BP ——— 100 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol (SR) 1000 mg Tablets |
Each Uncoated (SR) Tablet Contains:- |
|
|
Analgesic |
Paracetamol IP ————————–1000 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac Sustained Release Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Analgesic |
Aceclofenac IP ————— 200 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Methyl salicylate Ointment IP 10%w/w |
Composition: |
IP |
10.0 % w/w |
Analgesic |
Methyl salicylate |
|
qs |
Ointment base |
|
|
Antibacterial, Analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Nifedipine & Lignocaine Cream |
Composition: |
IP |
0.3%w/w |
Antibacterial, Analgesic |
Nifedipine |
IP |
1.5%w/w |
Lidocaine |
|
q.s. |
Cream base |
|
|
AntiInflammatory, Analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Etoricoxib, Linseed Oil, Methyl Salicylate & Menthol gel |
Composition: |
IP |
10 mg |
AntiInflammatory, Analgesic |
Each gram contains |
|
30 mg |
Etoricoxib |
BP |
100 mg |
Linseed Oil |
IP |
50 mg |
Methyl Salicylate |
IP |
q.s. |
Menthol |
|
|
Gel Base |
|
|
Antispasmodic & analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Mefenamic Acid &Paracetamol Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antispasmodic & analgesic |
Mefenamic Acid I.P. —————— 500 mg |
|
|
Paracetamol IP ————————– 325 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Muscle relaxant with anti-inflammatory and analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Thiocolchioside and Dexketoprofen Trometamol Tablets |
Each Film Coated Tablets Contains:- |
|
|
Muscle relaxant with anti-inflammatory and analgesic |
Thiocolchioside IP ————— 4 mg |
|
|
Dexketoprofen Trometamol ——-25 mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Gastric Resistance & Anti Emetics & analgesic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Rabeprazole (EC) Sodium & Diclofenac sodium Capsule(SR) |
Each Hard Gelatin capsule contains |
IP |
20mg |
Gastric Resistance & Anti Emetics & analgesic |
Rabeprazole Sodium |
|
|
(As enteric coated pellets) |
IP |
100mg |
Diclofenac sodium |
|
|
(as sustained release pellets) |
|
|
Approved coloured used Empty hard Gelatin capsule shells. |
|
|
Tranexamic Acid Tablets IP 250 mg |
Each Film coated Tablet Contains:- |
IP |
250 mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Tranexamic Acid |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Eperisone HCl tablets 50 mg |
Each Film coated Tablet Contains:- |
IP |
50 mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Eperisone HCl |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Flupirtine Maleate capsules |
Each hard gelatin capsule contains:- |
|
100mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Flupirtine Maleate |
q.s |
Excipients |
|
Colour: Approved colours used un empty capsule shells. |
|
Itopride Hydrochloride Sustained release capsules |
Each hard gelatin capsule contains:- |
|
150mg |
Gastric Resistance, |
Itopride Hydrochloride |
|
(As sustained release) |
q.s. |
Excipients |
|
Colour: Approved colours used in capsule shells & pellets. |
|
Antiinflammatory |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Indomethacin Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
25.0 mg |
Antiinflammatory |
Indomethacin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Piroxicam Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
20.0 mg |
Antiinflammatory |
Piroxicam |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Beclomethasone Dipropionate with salicyclic Acid Ointment |
Composition: |
IP |
0.025%w/w |
Antiinflammatory |
Beclomethasone Dipropionate |
IP |
3.00% |
Salicyclic Acid |
|
q.s. |
Ointment base |
|
|
Hydrocortisone Acetate cream IP |
Composition: |
IP |
1.0 %w/w |
Antiinflammatory |
Hydrocortisone Acetate |
q.s. |
cream base |
|
Hydrocortisone Acetate cream IP |
Composition: |
IP |
2.5 %w/w |
Antiinflammatory |
Hydrocortisone Acetate |
q.s. |
cream base |
|
White Soft Paraffin & Light Liquid Paraffin Cream |
Composition : |
IP |
13.2%w/w |
Antiinflammatory |
White Soft Paraffin |
IP |
10.2%w/w |
Light Liquid Paraffin |
|
q.s |
Cream Base |
|
|
Clindamycin Phosphate and benzoyl peroxide Gel |
Composition:- |
IP |
1.00% w/w |
Anti-Inflammatory |
Clindamycin Phosphate |
|
2.50% w/w |
Equivalent to Clindamycin |
IP |
q.s. |
Benzoyl Peroxide (as Anhydrous) |
|
|
Gel Base |
|
|
Mometasone Furoate & Terbinafine Hydrochloride Cream |
Composition:- |
IP |
0.1% w/w |
Anti-Inflammatory |
Mometasone Furoate |
IP |
1% w/w |
Terbinafine Hydrochloride |
|
q.s. |
Cream Base |
|
|
Clomiphene Citrate Tablet IP 50 mg |
Each uncoated Tablet Contains: – |
|
|
Antiinflammatory |
Clomiphene Citrate IP ————–50.0 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Diacerein & Aceclofenac Tablets |
Each Film coated tablet contains: |
|
|
Antiinflammatory |
Diacerein IP ————50 mg |
|
|
Aceclofenac IP ———–100 mg |
|
|
Excipients……………q.s. |
|
|
Colour-Approved colour used. |
|
|
Diclofenac sodium (As enteric coated) & Misoprostol Capsules |
Each hard gelatin capsule contains: |
IP |
50.0 mg |
Antinflammatory |
Diclofenac Sodium |
|
|
(As sustained release pellets) |
IP |
200 mcg |
Misoprostol |
|
q.s. |
Excipients |
|
|
Approved Colors Used. in Empty Shell & Pellet |
|
|
Diclofenac sodium (As enteric coated) & Misoprostol Capsules |
Each hard gelatin capsule contains: |
IP |
75.0 mg |
Antinflammatory |
Diclofenac Sodium |
|
|
(As sustained release pellets) |
IP |
200 mcg |
Misoprostol |
|
q.s. |
Excipients |
|
|
Approved Colors Used. in Empty Shell & Pellet |
|
|
Hydrocortisone butyrate cream USP |
Composition: |
USP |
0.1%w/w |
Anti-inflammatory |
Hydrocortisone butyrate |
|
In hydrophilic |
q.s. |
cream base |
|
Fluocinolone Acetonide Cream IP |
Composition : |
IP |
0.025 %w/w |
Anti-Inflammatory |
Fluocinolone Acetonide |
q.s |
Cream Base |
|
Dexamethasone Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anti-inflammatory |
Dexamethasone Sodium Phosphate IP |
|
|
Eq. to Dexamethasone ———— 0.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Analgesic & Antiinflammatory |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Diclofenac Potassium and Serratiopeptidase Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Diclofenac Potassium BP ——- 50 mg |
|
|
Serratiopeptidase IP ———–10 mg |
|
|
(20,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Sodium, Paracetamol &Serratiopeptidase Tablets |
Each Uncoated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Diclofenac Sodium IP ——— 50 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Serratiopeptidase IP ———–10 mg |
|
|
(20,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets |
Each Uncoated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Diclofenac Potassium BP ——- 50 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Chlorzoxazone USP ——— 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Potassium Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Diclofenac Potassium BP ——- 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Potassium, Paracetamol and Chlorzoxazone Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Diclofenac Potassium BP ——- 50 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Chlorzoxazone USP ——— 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac, Paracetamol and Serratiopeptidase Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antiinflammatory |
Aceclofenac IP —————- 100 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Serratiopeptidase IP ———–15 mg |
|
|
(30,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diacerein Capsules I.P. |
Each Hard Gelatin Capsule contains: |
IP |
50.0 mg |
Analgesic & Anti-Inflammatory |
Diacerein |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Thiocolchioside and Diclofenac sodium Capsules |
Each Hard Gelatin Capsule Contains:- |
IP |
4.0 mg |
Analgesic & Anti-Inflammatory |
Thiocolchioside |
IP |
50.0 mg |
Diclofenac sodium |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Thiocolchioside and Diclofenac sodium Capsules |
Each Hard Gelatin Capsule Contains:- |
IP |
16.0 mg |
Analgesic & Anti-Inflammatory |
Thiocolchioside |
IP |
100.0 mg |
Diclofenac sodium |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Thiocolchioside Capsules IP |
Each Hard Gelatin Capsules Contains: |
IP |
4.0 mg |
Analgesic & Anti-Inflammatory |
Thiocolchioside |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Thiocolchioside Capsules IP |
Each Hard Gelatin Capsules Contains: |
IP |
8.0 mg |
Analgesic & Anti-Inflammatory |
Thiocolchioside |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Oxaceprol Capsules |
Each hard gelatin capsule contains: |
|
200 mg |
Analgesic & Anti-Inflammatory |
Oxaceprol |
q.s. |
Excipients |
|
Approved colors used in Hard Gelatin Capsule shell. |
|
Aceclofenac along with Linseed oil Menthol, Methyl Salicylate & Capsaicin |
Composition: |
IP |
1.5 % w/w |
Analgesic & Anti-Inflammatory |
Aceclofenac |
BP |
3 % w/w |
Linseed oil |
IP |
5.0 % w/w |
Menthol |
IP |
10 % w/w |
Methyl Salicylate |
USP |
0.01% |
Capsaicin |
IP |
1% w/w |
Benzyl Alcohol |
|
q.s. |
Gel Base |
|
|
Diacerein & Glucosamine Sulphate Potassium Chloride Tablets |
Each Film coated tablet contains: |
|
|
Analgesic & Anti-Inflammatory |
Diacerein IP ————50.0 mg |
|
|
Glucosamine Sulphate |
|
|
Potassium Chloride IP ———–1500 mg |
|
|
Excipients……………q.s. |
|
|
Colour-Approved colour used. |
|
|
Trypsin Chymotrypsin Tablet IP |
Each Enteric coated Tablet Contains: – |
|
|
|
Trypsin Chymotrypsin IP ———(1,00,000 |
|
|
|
Armour Units of enzymatic activity) |
|
|
|
Excipients……………q.s. |
|
|
|
Colour : Approved Colour Used. |
|
|
|
Thiocolchicoside Capsule IP. |
Each Hard gelatin capsule Contains: |
IP |
4 mg |
Analgesic & anti-inflammatory |
Thiocolchicoside |
Approved colour used |
Thiocolchicoside Capsule IP. |
Each Hard gelatin capsule Contains: |
IP |
8 mg |
Analgesic & anti-inflammatory |
Thiocolchicoside |
Approved colour used |
Anti-Inflammatory Drug |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Apixaban Tablets 2.5 mg |
Each Film coated Tablet Contains:- |
|
2.5 mg |
Anti-Inflammatory Drug |
Apixaban |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Apixaban Tablets 5 mg |
Each Film coated Tablet Contains:- |
|
5 mg |
Anti-Inflammatory Drug |
Apixaban |
q.s |
Excipients |
|
Colour-Approved colour used. |
|
Anti-Inflammatory & Immuno Suppressant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Deflazacort Tablets |
Each Uncoated Tablet Contains:- |
|
|
Anti-Inflammatory & Immuno Suppressant |
Deflazacort —————- 24 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Deflazacort Tablets |
Each Uncoated Tablet Contains:- |
|
|
Anti-Inflammatory & Immuno Suppressant |
Deflazacort —————- 18 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Deflazacort Tablets |
Each Uncoated Tablet Contains:- |
|
|
Anti-Inflammatory & Immuno Suppressant |
Deflazacort —————- 1 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Deflazacort Tablets |
Each Uncoated Tablet Contains:- |
|
|
Anti-Inflammatory & Immuno Suppressant |
Deflazacort —————- 30 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Deflazacort Tablets |
Each Uncoated Tablet Contains:- |
|
|
Anti-Inflammatory & Immuno Suppressant |
Deflazacort —————- 6 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Carisoprodol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiinflamatory & Muscle relaxant |
Carisoprodol IP ————— 350 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Eperisone Hydrochloride (Sustained release) Capsule 150mg |
Each hard gelatin capsule contains:- |
|
150mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Eperisone Hydrochloride |
|
(As sustained release pellets) |
q.s. |
Excipients |
|
Colour: Approved colours used in empty capsule shells & pellets. |
|
Eperisone Hydrochloride (Sustained release) Capsule 150mg Diclofenac Sodium (Sustained Release) Capsules |
Each hard gelatin capsule contains:- |
IP |
150mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Eperisone Hydrochloride |
|
(As sustained release pellets) |
100mg |
Diclofenac Sodium |
|
(As sustained release pellets) |
q.s. |
Excipients |
|
Colour: Approved colours used in empty capsule shells & pellets. |
|
Choline salicylate & Lignocaine Hydrochloride Gel |
Composition: |
BP |
8.7% w/w |
Analgesic & Non-Steroidal Anti-Inflammatory |
Choline salicylate |
IP |
2.0% w/w |
Lignocaine Hydrochloride |
|
q.s. |
Water Soluble Gel Base in a purified water |
|
|
Diclofenac Diethylamine, Linseed Oil, Methyl Salicylate & Menthol gel |
Composition: |
IP |
1.16% w/w |
Analgesic & Non-Steroidal Anti-Inflammatory |
Diclofenac Diethylamine |
|
1.0% w/w |
eq. to Diclofenac sodium |
IP |
3.0% w/w |
Linseed Oil |
BP |
10.0% w/w |
Methyl Salicylate |
IP |
5.0%w/w |
Menthol |
IP |
1.0%w/w |
Benzyl Alcohol |
IP |
q.s. |
(as Preservative) |
|
|
Gel Base |
|
|
Virgin Linseed Oil, Diclofenac Diethylamine, Methyl Salicyclate, Menthol& Capsaicin Gel |
Composition: |
BP |
3.00%w/w |
Analgesic & Non-Steroidal Anti-Inflammatory |
Virgin Linseed Oil |
IP |
1.16%w/w |
Diclofenac Diethylamine |
IP |
1.00%w/w |
Equ. to Diclofenac Sodium |
IP |
10.00%w/w |
Methyl Salicylate |
IP |
5.00%w/w |
Menthol |
USP |
0.025%w/w |
Capsaicin |
|
|
Preservative : |
IP |
1.00%w/w |
Benzyl Alcohol |
|
q.s. |
Gel Base |
|
|
Choline Salicylate & Lignocaine Hydrochloride Gel |
Composition : |
BP |
8.7%w/w |
Analgesic & Non-Steroidal Anti-Inflammatory |
Choline Salicylate Solution |
|
|
Equ. to Choline Salicylate |
IP |
2.0%w/w |
Lignocaine Hydrochloride |
|
|
Preservative: |
IP |
0.01%w/w |
Benzalkonium Chloride |
|
q.s |
In Pleasant Flavoured Base |
|
|
Etodolac Extended Release Tablets 200 mg |
Each Film Coated Extended Release Tablet Contains:- |
BP |
200 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac |
|
q.s |
(As extended release) |
|
|
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Etodolac Extended Release Tablets 300 mg |
Each Film Coated Extended Release Tablet Contains:- |
BP |
300 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac(As extended release) |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Etodolac Extended Release Tablets 400 mg |
Each Film Coated Extended Release Tablet Contains:- |
BP |
400 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac |
|
|
(As extended release) |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Allopurinol Tablets IP 100 mg |
Each Film Coated Tablet Contains:- |
IP |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Allopurinol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam Tablets |
Each Film Coated Tablets Contains |
|
4 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam Tablets |
Each Film Coated Tablets Contains |
|
8 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Paracetamol Tablets |
Each Enteric Coated Tablets Contains |
IP |
4 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam |
|
325 mg |
Paracetamol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac, Paracetamol and Serratiopeptidase Tablets |
Each Film Coated Tablet Contains:- |
IP |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac |
IP |
325 mg |
Paracetamol |
IP |
15 mg |
Serratiopeptidase |
|
|
(30,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients |
|
q.s |
Colour-Approved colour used. |
|
|
Promethazine Tablets IP 25 mg |
Each Film Coated Tablets Contains |
IP |
25 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Promethazine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Promethazine Tablets IP 50 mg |
Each Film Coated Tablets Contains |
IP |
50 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Promethazine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets |
Each Film Coated Tablet Contains:- |
BP |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide |
IP |
10 mg |
Phenylephrine Hydrochloride |
IP |
5 mg |
Cetirizine Dihydrochloride |
IP |
30 mg |
Caffeine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Flavoxate Hydrochloride tablets IP 100 mg |
Each Film coated Tablets contains: |
IP |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Flavoxate Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Etoricoxib Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etoricoxib I.P 60mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Etoricoxib Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etoricoxib I.P 90mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Etoricoxib Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etoricoxib I.P 120mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Etodolac Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac I.P —–200mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Etodolac Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac I.P —–300mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Etodolac Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac I.P —–400mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Thicolchicoside and Etoricoxib Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Thicolchicoside IP ———— 4 mg |
|
|
Etoricoxib IP —————— 60 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ketorolac Tromethamine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Ketorolac Tromethamine IP———-10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Piroxicam-Beta-Cyclodextrin Tablets |
Each Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Piroxicam-Beta-Cyclodextrin |
|
|
Eq. to Piroxicam IP ————- 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac IP ————— 100 mg |
|
|
Thiocolchioside IP ———— –4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam ——————- 4 mg |
|
|
Thiocolchioside IP ———— –4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam ——————- 4 mg |
|
|
Thiocolchioside IP ———— –8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam ——————- 8 mg |
|
|
Thiocolchioside IP ———— –8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam ——————- 16 mg |
|
|
Thiocolchioside IP ———— –16 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tolperisone Hydrochloride and Diclofenac Sodium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Tolperisone Hydrochloride ———150 mg |
|
|
Diclofenac Sodium —————-50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tolperisone Hydrochloride and Diclofenac Sodium Sustained Release Tablets IP |
Each Sustained Release Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Tolperisone Hydrochloride ———450 mg |
|
|
Diclofenac Sodium —————100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Febuxostat Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Febuxostat —————- 80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Febuxostat Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Febuxostat —————- 120 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tadalafil Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Tadalafil IP —————- 2.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pirfenidone Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Pirfenidone IP ————— 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pirfenidone Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Pirfenidone IP ————— 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Paracetamol Tablets |
Each Enteric Coated Tablets Contains |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam —————– 4 mg |
|
|
Paracetamol IP—————-325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lornoxicam and Paracetamol Tablets |
Each Enteric Coated Tablets Contains |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Lornoxicam —————– 8 mg |
|
|
Paracetamol IP—————-325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine& Caffeine Tablets |
Each Uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol IP ————— 500 mg |
|
|
Phenylephrine Hydrochloride IP—— 5 mg |
|
|
Diphenhydramine IP—————— 25 mg |
|
|
Caffeine (Anhydrous) IP ————-30mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diacerein, Glucosamine &Methylsulfonylmethane Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diacerein IP —————– 50 mg |
|
|
Glucosamine Sulphate Potassium Chloride USP –750 mg |
|
|
Eq. to Glucosamine ———— 446 mg |
|
|
Methylsulfonylmethane USP ——-250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Etoricoxib & Paracetamol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Non-Steroidal Anti-Inflammatory |
Etoricoxib IP —————— 60 mg |
|
|
Paracetamol IP————– 325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Non-Steroidal Anti-Inflammatory |
Aceclofenac IP ————— 100 mg |
|
|
Thiocolchioside IP ———— — 8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac and Drotaverine hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Non-Steroidal Anti-Inflammatory |
Aceclofenac IP ————— 100 mg |
|
|
Drotaverine hydrochloride I.P.——-80 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac Sustained Release Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Analgesic & Non-Steroidal Anti-Inflammatory |
Aceclofenac IP ————— 200 mg |
|
|
(As Sustained Release) |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Trypsin, Bromelain, Rutoside Trihydrate & Diclofenac Sodium Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Trypsin BP ———————–48 mg |
|
|
Bromelain ————————90 mg |
|
|
Rutoside Trihydrate BP ————-100 mg |
|
|
Diclofenac Sodium IP————–50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol and Diclofenac Potassium Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol IP —————– 325 mg |
|
|
Diclofenac Potassium IP ——- 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Serratiopeptidase Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Serratiopeptidase IP ———–10 mg |
|
|
(Eq. to Enzyme Activity 20,000 units of enteric coated granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ketoprofen and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Ketoprofen IP ————— 50 mg |
|
|
Thiocolchioside IP ————–4 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour used |
|
|
Ketoprofen and Thiocolchioside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Ketoprofen IP ————— 100 mg |
|
|
Thiocolchioside IP ———— –8 mg |
|
|
Excipients—————– q.s |
|
|
Colour: Approved colour used |
|
|
Tolperisone Hydrochloride and paracetamol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, antipyretics, non-steroidal anti-inflammatory |
Tolperisone Hydrochloride ———150 mg |
|
|
Paracetamol IP —————- 325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol and Thicolchicoside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, antipyretics, non-steroidal anti-inflammatory |
Paracetamol IP ————— 325 mg |
|
|
Thiocolchioside IP ————–4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol and Thicolchicoside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, antipyretics, non-steroidal anti-inflammatory |
Paracetamol IP ————— 325 mg |
|
|
Thicolchicoside IP ————–8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Etodolac and Thicolchicoside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, antipyretics, non-steroidal anti-inflammatory |
Etodolac IP ————— 300 mg |
|
|
Thicolchicoside IP ————-4.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Etodolac and Thicolchicoside Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, antipyretics, non-steroidal anti-inflammatory |
Etodolac IP ————— 300 mg |
|
|
Thicolchicoside IP ————-8.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Flavoxate Hydrochloride Tablet |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Flavoxate Hydrochloride IP ———– 200mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Potassium and Drotaverine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium BP————- 50 mg |
|
|
Drotaverine hydrochloride I.P.——-80 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Tolperisone Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Tolperisone ————- 150 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac, Paracetamol and Serratiopeptidase Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac IP —————- 100 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Serratiopeptidase IP ———–10 mg |
|
|
(20,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Thicolchicoside and Etoricoxib Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Thicolchicoside IP ———— 8 mg |
|
|
Etoricoxib IP —————— 60 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Trypsin, Bromelain, &Rutoside Trihydrate Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Trypsin BP ———————– 96 |
|
|
Bromelain ———————— 180 mg |
|
|
Rutoside Trihydrate ————– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Trypsin, Bromelain, &Rutoside Trihydrate Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Trypsin BP ———————– 48 mg |
|
|
Bromelain BP ———————- 90 mg |
|
|
Rutoside Trihydrate IP ————– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Trypsin Chymotrypsin & Aceclofenac Tablet IP |
Each Enteric coated Tablet Contains: – |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
50,000 Armour Units of enzymatic activity supplied by a purified concentrate which has specific Trypsin and Chymotrypsin Activity in a ratio of approximately six to one. |
|
|
Aceclofenac IP ————————– 100 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used. |
|
|
Phenylephrine Hydrochloride, Paracetamol, Dextromethorphan Hydrobromide & Cetirizine Hydrochloride Tablets |
Each Uncoated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Phenylephrine Hydrochloride ——-5 mg |
|
|
Paracetamol IP ———– 325 mg |
|
|
Dextromethorphan Hydrobromide —- 10 mg |
|
|
Cetirizine Dihydrochloride IP ——–5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Drotaverine hydrochloride & Paracetamol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
|
Drotaverine hydrochloride I.P.——80 mg |
|
|
|
Paracetamol IP ———– 325 mg |
|
|
|
Excipients q.s. |
|
|
|
Colour-Approved colour used. |
|
|
Aceclofenac, Paracetamol and Chlorzoxazone Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac IP ——- 100 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Chlorzoxazone USP ——— 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine Hydrochloride, Guaiphenesin, Cetirizine Dihydrochloride & Ambroxol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol IP ———– 325 mg |
|
|
Phenylephrine Hydrochloride ——-5 mg |
|
|
Guaiphenesin IP ——————–50 mg |
|
|
Cetirizine Dihydrochloride IP —— 5 mg |
|
|
Ambroxol Hydrochloride IP ————-15 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol and Diclofenac Potassium Tablets |
Each Uncoated bilayeredtablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol …………………………IP 325mg |
|
|
Diclofenac Potassium ………….BP 50mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Diclofenac Potassium & Paracetamol |
Each uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium………….BP 50mg |
|
|
Paracetamol…………………………IP 325mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Nimesulide & Paracetamol tablets |
Each uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide l…………………………BP 100mg |
|
|
Paracetamol…………………………IP 325mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Aceclofenac & Paracetamol tablets |
Each uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac…………………………IP 100mg |
|
|
Paracetamol…………………………IP 325mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Nimesulide Phenylephrine Hydrochloride Cetirizine Dihydrochloride & Caffeine Tablets |
Each uncoated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide BP………………….………… 100 mg |
|
|
Phenylephrine Hydrochloride IP…10 mg |
|
|
Cetirizine Dihydrochloride IP………. 5 mg |
|
|
Caffeine IP…………………..………………30 mg |
|
|
Excipients ……………………………………..q. s. |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine Hydrochloride, Caffeine & Chlorpheniramine Maleate Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol IP………………………………………..325 mg |
|
|
Phenylephrine Hydrochloride IP …………….12.5 mg |
|
|
Caffeine IP ……………………………………………… 30 mg |
|
|
Chlorpheniramine Maleate IP ………………..2 mg |
|
|
Excipients………………………………………………..q.s. |
|
|
Colour: Approved colours used. |
|
|
Paracetamol, Chlorpheniramine Maleate & Phenylephrine Hydrochloride Tablets |
Each uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol IP………………………………………..500 mg |
|
|
Chlorpheniramine Maleate IP ………………… 2 mg |
|
|
Phenylephrine Hydrochloride IP ……………. 10 mg |
|
|
Excipients ………………………………………………..q.s. |
|
|
Colour-Approved colours used |
|
|
Diclofenac Potassium, Paracetamol, Cetirizine hydrochloride & Magnesium Trisilicate Tablets |
Each uncoated tablet contains: |
|
|
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium BP……………………….. 50 mg |
|
|
Paracetamol IP ………………………………………325 mg |
|
|
Cetirizine hydrochloride IP …………………… 5 mg |
|
|
Magnesium Trisilicate IP ………………………. 100 mg |
|
|
Excipients ……………………………………………….q.s. |
|
|
Colour-Approved colours used |
|
|
Diclofenac Potassium Paracetamol & Chlorzoxazone Tablets |
Each Film Coated Tablet contains: |
BP |
50 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium |
IP |
325 mg |
Paracetamol |
USP |
250 mg |
Chlorzoxazone |
|
q. s. |
Excipients |
|
|
Thiocolchicoside and Dexketoprofen Trometamol Tablets |
Each Film coated Tablet contains: |
IP |
4 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Thiocolchicoside |
|
25 mg |
Dexketoprofen Trometamol |
|
q. s. |
Excipients |
|
|
Approved Colour used |
|
|
Eperisone Hydrochloride 75 Sustained release |
Each Hard gelatin capsule Contains: |
|
75mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Eperisone Hydrochloride |
|
q. s. |
Excipients |
|
|
Approved colour used |
|
|
Nimesulide, Paracetamol, Phenylephrine Hydrochloride & Caffeine Tablets |
Each Uncoated Tablet Contains:- |
BP |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide |
IP |
325 mg |
Paracetamol |
IP |
10 mg |
Phenylephrine Hydrochloride |
|
|
Caffeine (Anhydrous) |
IP |
25 mg |
Excipients |
|
q. s. |
Colour: Approved colours used. |
|
|
Diclofenac Potassium, Paracetamol& Serratiopeptidase Tablets |
Each film coated tablet contains:- |
BP |
50 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium |
IP |
325 mg |
Paracetamol |
IP |
10 mg |
Serratiopeptidase |
|
|
(20,000 units of Serratiopeptidase) |
|
|
Excipients |
|
q.s. |
Approved colour used |
|
|
Diclofenac potassium, Paracetamol & Serratiopeptidase Tablets |
Each film coated tablet contains:- |
BP |
50 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Potassium |
IP |
325 mg |
Paracetamol |
IP |
15 mg |
Serratiopeptidase |
|
|
(As Enteric coated granules) |
|
|
(Eq. to 30,000 Enzymatic Units of serratiopeptidase) |
|
|
Excipients |
|
|
Colour- Approved colour Used. |
|
|
Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets |
Each uncoated tablet contains:- |
IP |
500 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol |
IP |
5 mg |
Phenylephrine Hydrochloride |
IP |
5 mg |
Cetirizine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour : Approved colour used. |
|
|
Nimesulide & Paracetamol tablets |
Each uncoated Bilayered tablet contains: |
B.P. |
100mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide |
I.P. |
325mg |
Paracetamol |
|
q.s |
Excipients. |
|
|
Colour: Approved colour used. |
|
|
Etodolac & Thiocolchicoside Tablets |
Each film coated Tablets Contains: |
I.P. |
400 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Etodolac |
I.P. |
4 mg |
Thiocolchicoside |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine HCI, Chlorpheniramine Maleate & Caffeine Tablets |
Each Uncoated Tablet Contains :- |
I.P. |
500 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Paracetamol |
I.P. |
5 mg |
Phenylephrine hydrochloride |
I.P. |
2 mg |
Chlorpheniramine Maleate |
I.P. |
16 mg |
Caffeine (Anhydrous) |
|
q.s. |
Excipie nts |
|
|
Colour-Approved colour used. |
|
|
Trypsin, Bromelain, Rutoside Trihydrate & Aceclofenac Tablets |
Each Enteric Coated Tablet Contains:- |
B.P. |
48 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Trypsin |
|
90 mg |
Bromelain |
B.P. |
100 mg |
Rutoside Trihydrate |
|
|
Aceclofenac |
I.P. |
100 mg |
Excipients |
|
q. s. |
Colour-Approved colour used. |
|
|
Aceclofenac, Paracetamol and Thiocolchicoside Tablets |
Each film coated tablets contains: |
I.P. |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Aceclofenac |
I.P. |
325 mg |
Paracetamol |
I.P. |
4 mg |
Thiocolchicoside |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Nimesulide, Paracetamol and Serratiopeptidase Tablets |
Each Film Coated Tablet Contains:- |
B.P. |
100 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Nimesulide |
I.P. |
325 mg |
Paracetamol |
I.P. |
15 mg |
Serratiopeptidase |
|
|
(30,000 units of Serratiopeptidase as enteric coated granules) |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
q.s. |
Diclofenac Sodium & Paracetamol Tablets I.P. |
Each film coated tablet contains:- |
I.P. |
50 mg |
Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory |
Diclofenac Sodium |
I.P. |
325 mg |
Paracetamol |
|
q.s. |
Excipients |
|
|
Colour- Approved colour used. |
|
|
Antiallergic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Cinnarizine & Dimenhydrinate Tablets |
Each Uncoated Sustained release Tablet Contains:- |
IP |
20 mg |
Antiallergic |
Cinnarizine |
USP |
40 mg |
Dimenhydrinate |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Loratadine Dispersible Tablet |
Each Uncoated Dispersible tablet contains: |
USP |
10 mg |
Antiallergic |
Loratadine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Betahistine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Betahistine Hydrochloride I.P.——8 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Betahistine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Betahistine Hydrochloride I.P.……16 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Cetirizine Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Cetirizine Hydrochloride IP ———-20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fexofenadine Hydrochloride and Montelukast Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Fexofenadine Hydrochloride IP — 120 mg |
|
|
Montelukast Sodium IP |
|
|
Eq. to Montelukast —————10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levocetirizine Dihydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic |
Levocetirizine Dihydrochloride—— 5 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic |
Montelukast Sodium I.P. |
|
|
eq. to Montelukast 4mg |
|
|
Levocetirizine Dihydrochloride I.P —2.5mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Montelukast Sodium And Levocetirizine Dihydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic |
Montelukast Sodium I.P. |
|
|
eq. to Montelukast 10mg |
|
|
Levocetirizine Dihydrochloride I.P — 5mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Betahistine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Betahistine Hydrochloride I.P.——24 mg |
|
|
Excipients q.s. |
|
|
Colour: Approved colour used |
|
|
Montelukast Sodium, Fexofenadine and Acebrophyline (SR) tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Montelukast Sodium IP |
|
|
Eq. to Montelukast —————10 mg |
|
|
Fexofenadine Hydrochloride IP — 120 mg |
|
|
Acebrophyline (SR)————– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cinnarizine & Dimenhydrinate Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic |
Cinnarizine USP ————————– 20 mg |
|
|
Dimenhydrinate ————————40 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Montelukast Orally Disintegrating Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic |
Montelukast Sodium I.P. |
|
|
Eq.to Montelukast——— 4 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Loratadine Tablet USP |
Each film coated tablet contains: |
|
|
Antiallergic |
Loratadine USP ———– 10 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Domperidone & Cinnarizine Tablet |
Each uncoated Tablet |
IP |
20 mg |
Antiallergic |
Cinnarizine |
IP |
10 mg |
Domperidone |
|
q. s. |
Excipients |
|
|
Approved coloured used |
|
|
Loratadine Tablets I.P. |
Each uncoated tablet contains:- |
I.P. |
10 mg |
Antiallergic |
Loratadine |
|
q.s. |
Excipients |
|
|
Colour- Approved colour used. |
|
|
antiallergic, antiasthamatic & mucolvtic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Levocetirizine &Ambroxol Capsule |
Each Hard Gelatin Capsule Contains: |
IP |
5 mg |
antiallergic, antiasthamatic & mucolvtic |
Levocetirizine Hydrochloride |
|
|
Ambroxol Hydrochloride |
IP |
75 mg |
(As Sustain Release) |
|
q.s |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Hydroxyzine Hydrochloride tablet IP 25 mg |
Each Film coated Tablets contains: |
IP |
25 mg |
Antiallergic, Antiasthamatic & Mucolvtic |
Hydroxyzine Hydrochloride |
|
q.s. |
Excipients |
|
|
Colour: Approved ColourUsed |
|
|
Levocetirizine Hydrochloride, Phenylephrine Hydrochloride & Paracetamol Tablets |
Each Film coated Tablet Contains:- |
IP |
5 mg |
Antiallergic, Antiasthamatic & Mucolvtic |
Levocetirizine Hydrochloride |
IP |
5 mg |
Phenylephrine Hydrochloride |
IP |
500 mg |
Paracetamol |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Cetirizine Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiallergic, Antiasthamatic & Mucolvtic |
Cetirizine Hydrochloride IP ———-10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydroxyzine Hydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic, Antiasthamatic & Mucolvtic |
Hydroxyzine Hydrochloride IP |
|
|
Eq. to Hydroxyzine ——— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydroxyzine Hydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiallergic, Antiasthamatic & Mucolvtic |
Hydroxyzine Hydrochloride IP |
|
|
Eq. to Hydroxyzine ——— 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antidiabetic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Repaglinide Tablets IP 0.5 mg |
Each Uncoated Tablet Contains:- |
IP |
0.5 mg |
Antidiabetic |
Repaglinide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Repaglinide & Metformin Hydrochloride Tablets IP |
Each Film coated Tablet Contains:- |
IP |
1 mg |
Antidiabetic |
Repaglinide |
IP |
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Repaglinide & Metformin Hydrochloride Tablets IP |
Each Film coated Tablet Contains:- |
IP |
2 mg |
Antidiabetic |
Repaglinide |
IP |
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin Tablets 10 mg |
Each Film Coated Tablet Contains:- |
|
10 mg |
Antidiabetic |
Empagliflozin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin Tablets 25 mg |
Each Film Coated Tablet Contains:- |
|
25 mg |
Antidiabetic |
Empagliflozin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Gliclazide Tablets I.P. |
Each Uncoated Modified Release Tablet Contains:- |
|
|
Antidiabetic |
Gliclazide I.P—————80mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. |
Each Film Coated Extended Release Tablet Contains:- |
|
|
Antidiabetic |
Gliclazide (MR) I.P—————30mg |
|
|
Metformin Hydrochloride (ER) IP -500 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Gliclazide and Metformin Hydrochloride Extended Release Tablets I.P. |
Each Film Coated Extended Release Tablet Contains:- |
|
|
Antidiabetic |
Gliclazide (MR)I.P—————60mg |
|
|
Metformin Hydrochloride (ER) IP -500 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride and Alpha Lipoic Acid Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride I.P——–500mg |
|
|
Alpha Lipoic Acid ————— 200 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP ——500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP ——850 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride Sustained Release Tablets IP |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP ——1000 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used |
|
|
Metformin Hydrochloride Sustained Release Tablets IP |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP ——500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. |
Each Uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP |
|
|
(Prolonged Release) ———500 mg |
|
|
Glimepiride IP ——————1 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. |
Each Uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP |
|
|
(Prolonged Release) ———500 mg |
|
|
Glimepiride IP ——————2 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin HCl (Extended Release) Fenofibrate Tablets IP |
Each uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin HCl (Extended Release) IP-500 mg |
|
|
Fenofibrate IP ————- 80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin HCl (Extended Release) Fenofibrate Tablets IP |
Each uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin HCl (Extended Release) IP-500 mg |
|
|
Fenofibrate IP ————- 160 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. |
Each Uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP |
|
|
(Prolonged Release) ———500 mg |
|
|
Glimepiride IP —————— 0.5 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet |
Each uncoated Bilayered tablet contains: |
|
|
Antidiabetic |
Metformin HCl ————-500 mg |
|
|
(SR/ER/PR) |
|
|
Voglibose IP ————– 0.2 mg |
|
|
Glimepiride IP —————1 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Metformin HCl (SR/ER/PR) Voglibose& Glimepiride Tablet |
Each uncoated Bilayered tablet contains: |
|
|
Antidiabetic |
Metformin HCl ————-500 mg |
|
|
(SR/ER/PR) |
|
|
Voglibose IP ————– 0.2 mg |
|
|
Glimepiride IP ————— 2 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Glimepiride, Pioglitazone & Metformin Tablets |
Each Uncoated Bilayered Tablet contains: |
|
|
Antidiabetic |
Glimepiride IP ————– 1 mg |
|
|
Pioglitazone IP ————— 15mg |
|
|
Metformin Hydrochloride (ER) IP —-500 mg |
|
|
Excipients ————— q.s. |
|
|
Colour-Approved colour used. |
|
|
Glimepiride, Pioglitazone & Metformin Tablets |
Each Uncoated Bilayered Tablet contains: |
|
|
Antidiabetic |
Glimepiride IP ————– 2 mg |
|
|
Pioglitazone IP ————— 15mg |
|
|
Metformin Hydrochloride (ER) IP—–500 mg |
|
|
Excipients ————— q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin HCl (Sustained Release) Voglibose& Glimepiride Tablet |
Each uncoated Bilayered tablet contains: |
IP |
500 mg |
Antidiabetic |
Metformin HCl |
|
|
(As Sustained Release) |
IP |
0.2 mg |
Voglibose |
IP |
1 mg |
Glimepiride |
|
q. s. |
Excipients |
|
|
Colour-Approved colours used |
|
|
Gliclazide & Metformin Hydrochloride Tablets |
Each uncoated tablets contains: |
I.P. |
80 mg |
Antidiabetic |
Gliclazide |
|
|
Metformin Hydrochloride |
I.P. |
500 mg |
Excipients |
|
q.s. |
Colour-Approved colour used. |
|
|
Dapagliflozin Tablet |
Each film coated tablet contains: |
|
|
Antidiabetic |
Dapagliflozin propandiol monohydrate IH |
|
|
eq. to Dapagliflozin—————10 mg |
|
|
Excipients ————— q.s |
|
|
Colour-Approved colour used. |
|
|
Dapagliflozin Tablet |
Each film coated tablet contains: |
|
|
Antidiabetic |
Dapagliflozin propandiol monohydrate IH |
|
|
q. to Dapagliflozin—————5.0 mg |
|
|
Excipients ————— q.s |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. |
Each Uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP |
|
|
(Prolonged Release) ———1000 mg |
|
|
Glimepiride IP ——————1 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Metformin Hydrochloride (Prolonged Release) and Glimepiride Tablets I.P. |
Each Uncoated Bilayer Tablet Contains:- |
|
|
Antidiabetic |
Metformin Hydrochloride IP |
|
|
(Prolonged Release) ———1000 mg |
|
|
Glimepiride IP ——————2 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Glimepiride Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Glimepiride IP —————-1 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-approved colour used. |
|
|
Glimepiride Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Glimepiride IP —————-2 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-approved colour used. |
|
|
Glimepiride Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Glimepiride IP —————-3 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-approved colour used. |
|
|
Glimepiride Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Glimepiride IP —————-4 mg |
|
|
Excipients——————-q.s. |
|
|
Colour-approved colour used. |
|
|
Pioglitazone HCl & Glimepiride tablets |
Each Uncoated SR tablet contains: |
|
|
Antidiabetic |
Pioglitazone HCl IP ————–15 mg |
|
|
Glimepiride IP —————-1 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour: Approved Colour Used |
|
|
Vildagliptin Tablet |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Vildagliptin IH ————– 50.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Vildagliptin and Metformin HCL Tablets |
Each film coated tablet contains: |
|
|
Antidiabetic |
Vildagliptin IH ————– 50.0 mg |
|
|
Metformin HCL IP ———- 500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Vildagliptin & Metformin SR Tablets. |
Each uncoated Bilayer tablet contains: |
|
|
Antidiabetic |
Vildagliptin IH ————– -50.0 mg |
|
|
Metformin HCL IP ———- 1000.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Sitagliptin tablet |
Each film coated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin (As phosphate) IH — -50.0 mg |
|
|
Excipients……………q.s. |
|
|
Approved colour used. |
|
|
Sitagliptin & Metformin tablets |
Each film coated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin (As phosphate)IH— -50.0 mg |
|
|
Metformin HCl IP — 500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour: Approved Colour Used |
|
|
Sitagliptin & Metformin tablets |
Each film coated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin (As phosphate)—– 50 mg |
|
|
Metformin HCl IP———- 1000.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour: Approved Colour Used |
|
|
Teneligliptin tablets IP |
Each uncoated Tablet Contains: |
|
|
Antidiabetic |
Teneligliptin Hydrobromide Hydrate IP |
|
|
eq. to. Teneligliptin— 20.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets |
Each uncoated Tablet Contains: |
|
|
Antidiabetic |
Tenegliptin Hydrobromide Hydrate IP |
|
|
eq. to. Tenegliptin IP — 20.0 mg |
|
|
Metformin HCl ————-500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Tenegliptin Hydrobromide Hydrate & Metformin HCl Tablets |
Each uncoated Tablet Contains: |
|
|
Antidiabetic |
Tenegliptin Hydrobromide Hydrate IP |
|
|
eq. to. Tenegliptin IP—– 20.0 mg |
|
|
Metformin HCl ————-1000.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Voglibose Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Voglibose IP ————- 0.3 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Voglibose Tablet IP |
Each uncoated tablet contains: |
|
|
Antidiabetic |
Voglibose IP ————- 0.2 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Voglibose& Metformin HCl Tablet |
Each uncoated (SR) tablet contains: |
|
|
Antidiabetic |
Voglibose IP ————– 0.2 mg |
|
|
Metformin HCl (SR) ———500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Voglibose& Metformin HCl Tablet |
Each uncoated (SR) tablet contains: |
|
|
Antidiabetic |
Voglibose IP————– 0.3 mg |
|
|
Metformin HCl (SR) IP ———500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Glibenclamide& Metformin HCl (SR) tablet |
Each uncoated (SR) tablet contains: |
|
|
Antidiabetic |
Glibenclamide ———2.5 mg |
|
|
Metformin HCl (SR) IP ———500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Glibenclamide& Metformin HCl (SR) tablet |
Each uncoated (SR) tablet contains: |
|
|
Antidiabetic |
Glibenclamide ———5.0 mg |
|
|
Metformin HCl (SR) IP ———500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Saxagliptin HCl tablet |
Each Film coated tablet contains: |
|
|
Antidiabetic |
Saxagliptin HCl eq. |
|
|
to. Saxagliptin ——————-2.5 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Saxagliptin HCl tablet |
Each Film coated tablet contains: |
|
|
Antidiabetic |
Saxagliptin HCl eq. |
|
|
to. Saxagliptin ——————-5.0 mg |
|
|
Colour-Approved colour used |
|
|
Saxagliptin HCl & Metformin tablet |
Each Film coated tablet contains: |
|
|
Antidiabetic |
Saxagliptin HCl eq. |
|
|
to. Saxagliptin———-2.5 mg |
|
|
Metformin HCl IP———1000.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Saxagliptin HCl & Metformin tablet |
Each Film coated tablet contains: |
|
|
Antidiabetic |
Saxagliptin HCl eq. |
|
|
to. Saxagliptin———- 5.0 mg |
|
|
Metformin HCl IP———500.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used |
|
|
Metformin Hydrochloride Prolonged Release Tablets IP 850 mg |
Each Uncoated Prolonged Release Tablet Contains:- |
IP |
850 mg |
Antidiabetic |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Sitagliptin tablet IP |
Each Uncoated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin phosphate IP |
|
|
Eq. to Sitagliptin——- 25.0 mg |
|
|
Excipients……………q.s. |
|
|
Approved colour used. |
|
|
Sitagliptin tablet IP |
Each Uncoated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin phosphate IP |
|
|
Eq. to Sitagliptin——- 50.0 mg |
|
|
Excipients……………q.s. |
|
|
Approved colour used. |
|
|
Sitagliptin tablet IP |
Each Uncoated tablet Contains: |
|
|
Antidiabetic |
Sitagliptin phosphate IP |
|
|
Eq. to Sitagliptin——- 100.0 mg |
|
|
Excipients……………q.s. |
|
|
Approved colour used. |
|
|
Repaglinide Tablets IP 2 mg |
Each Uncoated Tablet Contains:- |
IP |
2 mg |
Antidiabetic |
Repaglinide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Voglibose Dispersible Tablet IP 0.2 mg |
Each uncoated Dispersible tablet contains: |
IP |
0.2 mg |
Antidiabetic |
Voglibose |
|
q.s |
Excipients . |
|
|
Colour-Approved colour used |
|
|
Voglibose Dispersible Tablet IP 0.3 mg |
Each uncoated Dispersible tablet contains: |
IP |
0.3 mg |
Antidiabetic |
Voglibose |
|
q.s |
Excipients . |
|
|
Colour-Approved colour used |
|
|
Empagliflozin and Linagliptin tablets |
Each Film Coated Tablet Contains:- |
|
25 mg |
Antidiabetics |
Empagliflozin |
|
5 mg |
Linagliptin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antidiabetic |
Empagliflozin |
|
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antidiabetic |
Empagliflozin |
|
850 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antidiabetic |
Empagliflozin |
|
1000 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
12.5 mg |
Antidiabetic |
Empagliflozin |
|
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
12.5 mg |
Antidiabetic |
Empagliflozin |
|
850 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Linagliptin tablets |
Each Film Coated Tablet Contains:- |
|
10 mg |
Antidiabetics |
Empagliflozin |
|
5 mg |
Linagliptin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Empagliflozin and Metformin Hydrochloride tablets |
Each Film Coated Tablet Contains:- |
IP |
12.5 mg |
Antidiabetic |
Empagliflozin |
|
1000 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Metformin HCl (Sustained Release) Glimepiride &Voglibose Tablet |
Each Film Coated tablet contains: |
IP |
500 mg |
Antidiabetic |
Metformin HCl |
IP |
3 mg |
(As Sustained Release) |
IP |
0.3 mg |
Glimepiride |
|
q.s |
Voglibose |
|
|
Excipients |
|
|
Colour-Approved colour used |
|
|
Dapagliflozin &Metformin Hydrochloride Tablet |
Each film coated tablet contains: |
IP |
10 mg |
Antidiabetic |
Dapagliflozin |
|
500 mg |
Metformin Hydrochloride |
|
q.s |
(Extended Release) |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Dapagliflozin &Metformin Hydrochloride Tablet |
Each film coated tablet contains: |
IP |
10 mg |
Antidiabetic |
Dapagliflozin |
|
1000 mg |
Metformin Hydrochloride |
|
q.s |
(Extended Release) |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Gliclazide and Metformin Hydrochloride Tablets |
Each Film Coated Extended Release Tablet Contains:- |
IP |
80 mg |
Antidiabetic |
Gliclazide |
IP |
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Gliclazide and Metformin Hydrochloride Tablets |
Each Uncoated Tablet Contains:- |
IP |
80 mg |
Antidiabetic |
Gliclazide |
IP |
500 mg |
Metformin Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Repaglinide Tablets IP 1 mg |
Each Uncoated Tablet Contains:- |
IP |
1 mg |
Antidiabetic |
Repaglinide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Antiemetics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pantoprazole Sodium (Enteric Coated) & Itopride Hydrochloride (Sustained Release) Capsule |
Each Hard Gelatin Capsule contain: |
IP |
40 mg |
Antiemetics |
Pantoprazole Sodium Sesquihydrate |
|
Equivalent to Pantoprazole |
|
(As enteric coated pellets) |
150 mg |
Itopride Hydrochloride |
|
(As sustained release pellets) |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Palonosetron melt in mouth Tablets 0.5 mg |
Each Uncoated Tablets contains: |
|
0.5 mg |
antiemetics |
Palonosetron Hydrochloride |
|
q.s |
Eq. to Palonosetron |
|
|
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Ondansetron Orally Disintegrating Tablets IP |
Each Uncoated Orally Disintegrating Tablet Contains:- |
|
|
Antiemetic |
Ondansetron Hydrochloride IP |
|
|
Eq. to Ondansetron ——— 4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ondansetron Orally Disintegrating Tablets IP |
Each Uncoated Orally Disintegrating Tablet Contains:- |
|
|
Antiemetic |
Ondansetron Hydrochloride IP |
|
|
Eq. to Ondansetron ——— 8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Metclopramide Hydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiemetic |
Metclopramide Hydrochloride IP |
|
|
Eq. to Metclopramide Anhydrous —- 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cinnarizine & Domperidone Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antiemetic |
Cinnarizine IP ————————– 20 mg |
|
|
Domperidone IP ———————— 15 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Gastric resistant Antiemetics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pantoprazole sodium & Domperidone capsule |
Each hard gelatin capsule contains: |
IP |
40 mg |
Gastric resistant Antiemetics |
Pantoprazole sodium sesquihydrate |
|
|
eq. to Pantoprazole |
|
10 mg |
(as enteric coated pellets) |
IP |
q.s. |
Domperidone |
|
|
(As Sustained release) |
|
|
Excipients |
|
|
Approved colour used in |
|
|
Empty capsule shells. |
|
|
Omeprazole & Domperidone capsule IP |
Each hard gelatin capsule contains |
IP |
20 mg |
Gastric resistant Antiemetics |
Omeprazole |
|
|
(As Enteric coated pallets) |
IP |
30 mg |
Domperidone |
|
|
(As Sustain Release pallets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty capsule shell |
|
|
Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP |
Each hard gelatin capsule contains |
IP |
40 mg |
Gastric resistant Antiemetics |
Pantoprazole Sodium |
|
|
(As Enteric coated pallets) |
IP |
30 mg |
Domperidone |
|
|
(10 mg as immediate release & 20 mg As Sustain Release pallets) |
|
q. s. |
Excipients |
|
|
Approved colour used in empty capsule shell |
|
|
Rabeprazole Sodium (EC)&Levosulpride (SR) Capsule |
Each hard gelatin capsules contains: |
IP |
20 mg |
Gastric resistant Antiemetics |
Rabeprazole Sodium |
|
|
(As enteric coated pellets) |
IP |
75 mg |
Levosulpride |
|
|
(As sustained release pellets) |
|
q.s. |
Excipients |
|
|
Approved Colours Used in Capsule Shell & Pellets |
|
|
Rabeprazole Sodium (EC) & Domperidone (SR)capsules |
Each hard gelatin capsule contains |
IP |
20 mg |
Gastric resistant Antiemetics |
Rabeprazole Sodium |
|
|
(As Enteric coated pallets) |
IP |
30 mg |
Domperidone |
|
|
(As Sustained Release pallets) |
|
q. s. |
Excipients |
|
|
Approved colour used in empty capsule shell |
|
|
Omeprazole Capsule IP |
Each Hard gelatin capsule contains |
IP |
20 mg |
Gastric resistant Antiemetics |
Omeprazole |
|
(As Enteric coated pallets) |
q.s. |
Excipients |
|
Approved colour used. in empty capsule shell |
|
Esomeprazole & Itopride Capsules |
Each hard gelatin capsule contains: |
IP |
40 mg |
Gastric resistant Antiemetics |
Esomeprazole magnesium |
|
(As enteric Coated pellets) |
150 mg |
Itopride |
q.s. |
(As SR pellets) |
|
Excipients |
|
Approved colour used in |
|
empty capsule shells. |
|
Esomeprazole (Enteric-coated) & Levosulpiride(Sustained-release) Capsules |
Each hard gelatin Capsule contains : |
IP |
40mg |
Gastric resistant Antiemetics |
Esomeprazole Magnesium Trihydrate |
|
|
Equ. to Esomeprazole |
|
75mg |
(as enteric coated pellets) |
IP |
|
Levosulpiride |
|
q.s |
(as sustained release pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Omeprazole & Domperidone Capsules |
Each hard gelatin capsule Contains: |
IP |
20 mg |
Gastric resistant Antiemetics |
Omeprazole |
IP |
10 mg |
(Enteric Coated pellets) |
|
q.s. |
Domperidone |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Aceclofenac& Rabeprazole Capsule |
Each hard gelatin Capsule contain: |
IP |
200 mg |
Gastric resistant Antiemetics |
Aceclofenac (SR) |
IP |
10 mg |
Rabeprazole sodium |
|
|
(As enteric coated pellets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Aceclofenac& Rabeprazole Capsule |
Each hard gelatin Capsule contain: |
IP |
200 mg |
Gastric resistant Antiemetics |
Aceclofenac (SR) |
IP |
20 mg |
Rabeprazole sodium |
|
q.s. |
(As enteric coated pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Pantoprazole Sodium (EC) &Itopride (ER) Capsules |
Each hard gelatin capsule contains: |
IH |
40 mg |
Gastric resistant Antiemetics |
Pantoprazole Sodium (as EC pellets) |
IP |
150 mg |
Itopride (ER pellets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Pantoprazole Sodium (EC) &Cinitapride (ER) Capsules |
Each hard gelatin capsule contains: |
IP |
40 mg |
Gastric resistant Antiemetics |
Pantoprazole Sodium (as EC pellets) |
IH |
3 mg |
Cinitapride (ER pellets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Omeprazole (EC) &Cinitapride (ER) Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Gastric resistant Antiemetics |
Omeprazole (EC pellets) |
IH |
3 mg |
Cinitapride (ER pellets) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Pantoprazole sodium &Levosulpride capsule |
Each hard gelatin capsule contains: |
IP |
40 mg |
Gastric resistant Antiemetics |
Pantoprazole sodium |
|
eq. to Pantoprazole |
75 mg |
(as enteric coated pellets) |
q.s. |
Levosulpride |
|
(As Sustained release) |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Rabeprazole sodium & Itopride Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Gastric resistant Antiemetics |
Rabeprazole sodium |
|
(As enteric Coated pellets) |
150 mg |
Itopride |
|
(As SR pellets) |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Dexlansoprazole delayed release capsules |
Each hard gelatin capsule contains: |
IP |
30.0 mg |
Gastric Resistance & Anti Emetics |
Dexlansoprazole |
q.s. |
(As delayed release) |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Dexlansoprazole delayed release capsules |
Each hard gelatin capsule contains: |
IP |
60.0 mg |
Gastric Resistance & Anti Emetics |
Dexlansoprazole |
q.s. |
(As delayed release) |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Cinitapride Extended Release Tablets |
Each Uncoated Extended Release Tablets contains: |
|
3 mg |
Gastric Resistance & Anti Emetics |
Cinitapride Hydrogen Tartarate |
|
q.s |
Eq. to Cinitapride |
|
|
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Domperidone Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance & Anti Emetics |
Domperidone Maleate I.P. |
|
|
Eq. to Domperidone ———-10 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Pantoprazole Gastro Resistant Tablets IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric resistance & anti emetics |
Pantoprazole Sodium IP |
|
|
Eq. to Pantoprazole ————–20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rabeprazole Sodium Gastro Resistant Tablets IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric resistance & anti emetics |
Rabeprazole Sodium IP ——— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Esomeprazole Gastro resistant Tablet IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric resistance & anti emetics |
Esomeprazole magnesium Trihydrate IP |
|
|
Eq. to Esomeprazole ———— 20 mg |
|
|
Excipients———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Esomeprazole Gastro resistant Tablet IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric resistance & anti emetics |
Esomeprazole magnesium Trihydrate IP |
|
|
Eq. to Esomeprazole ———— 30 mg |
|
|
Excipients———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Pantoprazole sodium& Ondansetron Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric Resistance & Anti Emetics |
Pantoprazole sodium |
|
|
Eq. to Pantoprazole…………………………IP 40mg |
|
|
Ondansetron Hydrochloride |
|
|
Eq. to Ondansetron…………………………IP 4mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Pantoprazole Sodium (EC) & Domperidone (SR)capsule IP |
Each hard gelatin capsule contains:- |
|
|
Gastric Resistance & Anti Emetics |
Pantoprazole Sodium IP—– 40 mg |
|
|
(As Enteric coated pallets) |
|
|
Domperidone IP ————-30 mg |
|
|
(As Sustained Release pallets) |
|
|
Excipients |
|
|
Approved colour used in empty capsule shell |
|
|
Lansoprazole capsule IP 30 mg |
Each Hard Gelatin capsule contains: |
IP |
30mg |
Gastric Resistance & Anti Emetics |
Lansoprazole |
|
q. s. |
Excipients |
|
|
Approved colour used |
|
|
Pantoprazole Sodium (Enteric Coated) & Domperidone (Sustained Release) Capsules |
Each Hard Gelatin Capsule contains: |
IP |
40 mg |
Gastric Resistance & Anti Emetics |
Pantoprazole Sodium |
|
|
eq. to Pantoprazole |
|
|
(As Enteric Coated pellets) |
|
30 mg |
Domperidone |
IP |
|
(As Sustained Release pellets) |
|
|
Excipients |
|
|
Approved colour used |
|
|
Lansoprazole Gastro Resistant capsules IP |
Each hard gelatin capsule contains: |
IP |
30 mg |
Gastric Resistance & Anti Emetics |
Lansoprazole |
|
qs |
Excipients |
|
|
Approved colour used |
|
|
Lansoprazole Orally Disintegrating Tablets |
Each uncoated orally disintegrating tablets contains: |
I.P. |
30 mg |
Gastric Resistance & Anti Emetics |
Lansoprazole |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Omeprazole Gastro resistant Capsules IP |
Each hard gelatin capsule contains:- |
IP |
40mg |
Gastic Resistance, & Anti Emetic |
Omeprazole |
|
(As enteric coated pellets) |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells & pellets. |
|
Rabeprazole sodium &Itopride( SR) Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Gastic Resistance, & Anti Emetic |
Rabeprazole sodium |
|
(As enteric Coated pellets) |
150 mg |
Itopride (As SR pellets) |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Esomeprazole & domperidone Capsules |
Each Hard Gelatin Capsule Contains:- |
IP |
40 mg |
Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate |
|
30.0 mg |
Eq. to Esomeprazole |
IP |
|
( as enteric coated pellets ) |
|
q.s. |
Domperidone |
|
|
(as sustained release pellets ) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Esomeprazole & domperidone Capsules |
Each Hard Gelatin Capsule Contains:- |
IP |
20 mg |
Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate |
|
30.0 mg |
Eq. to Esomeprazole |
IP |
|
( as enteric coated pellets ) |
|
q.s. |
Domperidone |
|
|
(as sustained release pellets ) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Esomeprazole & Itopride Capsules |
Each hard gelatin capsule contains: |
IP |
20 mg |
Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate |
|
150 mg |
Eq. to Esomeprazole |
IP |
q.s. |
( as enteric coated) |
|
|
Itopride (As SR pellets) |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Esomeprazole Gastro- Resistant Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
20.0 mg |
Gastric Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate |
q.s. |
Eq. to Esomeprazole |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell0 |
|
Esomeprazole Gastro- Resistant Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
40.0 mg |
Gastic Resistance, & Anti Emetic |
Esomeprazole Magnesium Trihydrate |
q.s. |
Eq. to Esomeprazole |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Lansoprazole OrallyDisintegratingTablets |
EachUncoatedorallyDisintegratingTabletContains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Lansoprazole IP———-15mg |
|
|
Excipients q.s. |
|
|
Colour-Approvedcolour used. |
|
|
Tranexamic acid and Mefenamic Acid Tablets |
Each Uncoated Tablet Contains: – |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Tranexamic acid IP ———–500 mg |
|
|
Mefenamic Acid IP ——– 250 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Sodium Bicarbonate IP |
Each film Coated Tablet Contains: |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Sodium Bicarbonate IP —————- 1000 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Lansoprazole Gastro- Resistant Capsules |
Each Hard Gelatin Capsule Contains: |
IP |
15.0 mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Lansoprazole |
q.s. |
(As Enteric Coated Granules) |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Mefenamic Acid Capsules I.P. |
Each Hard Gelatin Capsule Contains: |
IP |
250 mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Mefenamic Acid |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Mefenamic Acid Capsules I.P. |
Each Hard Gelatin Capsule Contains: |
IP |
500 mg |
Gastric Resistance, Antispasmodic & Anti Emetic |
Mefenamic Acid |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Esomeprazole Gastro resistant Tablet IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Esomeprazole magnesium Trihydrate IP |
|
|
Eq. to Esomeprazole ————40 mg |
|
|
Excipients———-q.s. |
|
|
Colour-Approved colour used. |
|
|
Rabeprazole Gastro Resistant Tablets IP |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Rabeprazole Sodium IP ——— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rabeprazole and Domperidone Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Rabeprazole Sodium IP ——— 20 mg |
|
|
Domperidone IP —————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Dicyclomine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Dicyclomine Hydrochloride ——— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ondansetron Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Ondansetron Hydrochloride IP |
|
|
Eq. to Ondansetron ——— 4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ondansetron Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Ondansetron Hydrochloride IP |
|
|
Eq. to Ondansetron ——— 8 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tranexamic Acid Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Tranexamic Acid IP ———— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cimetidine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Cimetidine IP————- 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Famotidine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Famotidine IP ——- 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Famotidine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Famotidine IP ——- 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Solifenacin Succinate Tablets |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Solefenacin Succinate ——- 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Solefenacin Succinate Tablets |
Each Film Coated Tablet Contains:- |
|
|
Gastric Resistance, Antispasmodic & Anti Emetic |
Solefenacin Succinate ——- 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Analgesic & antiemetics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Domperidone & Paracetamol Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Analgesic & antiemetics |
Domperidone IP —————— 10 mg |
|
|
Paracetamol IP —————— 325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antiviral |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Aciclovir Cream IP |
Compositions |
IP |
5% w/w |
Antiviral |
Aciclovir |
q.s. |
In a cream base |
|
Aciclovir Tablet IP 200 mg |
Each uncoated tablet Contains |
IP |
200 mg |
Antiviral |
Aciclovir |
|
q.s. |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Aciclovir Tablets IP 200 mg |
Each Film Coated Tablet Contains:- |
IP |
200mg |
Antiviral |
Aciclovir |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Aciclovir Tablets IP 800 mg |
Each Film Coated Tablet Contains:- |
IP |
800mg |
Antiviral |
Aciclovir |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Griseofulvin Tablets IP |
Each Uncoated Tablet Contains:- |
IP |
250 mg |
Antiviral |
Griseofulvin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Griseofulvin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Griseofulvin IP——— 125 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Griseofulvin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Griseofulvin IP——— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lopinavir and Ritonavir Tabl ets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Lopinavir IP —————200 mg |
|
|
Ritonavir IP ————–50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Lopinavir and Ritonavir Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Lopinavir IP —————100 mg |
|
|
Ritonavir IP ————– 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aciclovir DispersibleTablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP 200mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aciclovir DispersibleTablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP 400mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aciclovir DispersibleTablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP 800mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Rifaximin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Rifaximin BP ———– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rifaximin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Rifaximin BP ———– 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rifaximin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Rifaximin BP ———– 550 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Rifaximin Dispersible Tablets |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Antiviral |
Rifaximin BP ———– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Valacyclovir Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Valacyclovir Hydrochloride USP—1000 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Valacyclovir Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Valacyclovir Hydrochloride USP—500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Entecavir Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antiviral |
Entecavir IP—————- 0.5 mg |
|
|
(As monohydrate) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Entecavir Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antiviral |
Entecavir IP—————- 0.1 mg |
|
|
(As monohydrate) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nitrofurantoin SR Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Antiviral |
Nitrofurantoin BP ————– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Doxycycline Hyclate Tablet IP |
Each film coated tablet contains: |
|
|
Antiviral |
Doxycycline Hyclate |
|
|
Eq. to Doxycycline——— 100 mg. |
|
|
Excipients —————– q.s |
|
|
Colour-approved colour used. |
|
|
Tenofovir Disoproxil Fumarate tablet IP 300 mg |
Each Film Coated Tablet contain: |
|
|
Antiviral |
Tenofovir Disoproxil Fumarate IP—–300 mg |
|
|
Excipients —————–q.s |
|
|
Colour: approved colour used |
|
|
Nitrofurantoin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiviral |
Nitrofurantoin IP ————– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aciclovir Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP 200mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aciclovir Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP 400mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Aciclovir Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiviral |
Aciclovir IP ——— 800mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Nitrofurantoin Tablets IP 50 mg |
Each Uncoated Tablet Contains:- |
IP |
50 mg |
Antiviral |
Nitrofurantoin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Nitrofurantoin Tablets IP 100 mg |
Each Uncoated Tablet Contains:- |
IP |
100 mg |
Antiviral |
Nitrofurantoin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Analgesics And Antipyretics |
Ibuprofen Tablets IP 600 mg |
Each Film Coated Tablet Contains:- |
IP |
600 mg |
Analgesics And Antipyretics |
Ibuprofen |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Ibuprofen and Paracetamol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics And Antipyretics |
Ibuprofen IP ———— 400 mg |
|
|
Paracetamol ————-325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ibuprofen Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics And Antipyretics |
Ibuprofen IP —————-400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ibuprofen Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics And Antipyretics |
Ibuprofen IP —————- 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Analgesics And Antipyretics |
Aceclofenac IP ————— 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Aceclofenac And Paracetamol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antipyretic |
Aceclofenac IP —————- 100 mg |
|
|
Paracetamol IP ————— 325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nimesulide and Paracetamol (Not for below 12 Years) |
Each Film Coated Tablet Contains:- |
|
|
Analgesic & Antipyretic |
Nimesulide BP ————-100 mg |
|
|
Paracetamol IP ————–325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Anticoagulant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Dabigatran Etexilate capsule 150 mg |
Each hard gelatin capsule contains: |
IH |
150 mg |
Anticoagulant |
Dabigatran etexilatemesilate |
q.s. |
eq. to Dabigatran |
|
Excipients |
|
Approved colours used in Empty capsules shells. |
|
Heparin Sodium , Benzyl nicotinate and Sorbic Acid ointment |
Composition: |
IP |
50 IU |
Anticoagulant |
Heparin Sodium |
IP |
2.0 mg |
Benzyl Nicotinate |
|
1.97 mg |
Sorbic Acid |
|
q.s. |
Ointment base |
|
|
Nicoumalone Tablets IP 2 mg |
Each uncoated tablet Contains: |
IP |
2 mg |
Anticoagulant |
Nicoumalone |
|
q.s. |
Excipients |
|
|
Colour: Approved ColourUsed |
|
|
Nicoumalone Tablets IP 4 mg |
Each uncoated tablet Contains: |
IP |
4 mg |
Anticoagulant |
Nicoumalone |
|
q.s. |
Excipients |
|
|
Colour: Approved ColourUsed |
|
|
Rivaroxaban Tablets 2.5 mg |
Each Film coated Tablet Contains:- |
|
2.5 mg |
Anticoagulant |
Rivaroxaban |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Warfarin Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anticoagulant |
Warfarin Sodium Clathrate IP |
|
|
Eq. to Warfarin —————5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nicoumalone Tablets IP |
Each uncoated Tablet Contains:- |
|
|
Anticoagulant |
Nicoumalone IP ———— 2 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Nicoumalone Tablets IP |
Each uncoated Tablet Contains:- |
|
|
Anticoagulant |
Nicoumalone IP ———— 4 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Warfarin sodium tablet IP 5.0 mg |
Each uncoated tablet contains: |
|
|
Anti-Coagulants |
Wafarin sodium clathrate IP |
|
|
Equivalent to Warfarin sodium—–5.0 mg |
|
|
Excipients ————–q.s. |
|
|
Colour: Approved colour used |
|
|
Anticanvalsant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pregabalin &Methylcobalamin Capsule IP |
Each hard gelatin capsule contains: |
IP |
75 mg |
Anticanvalsant |
Pregabalin |
750 mcg |
Methylcobalamin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Pregabalin (Sustained Release) & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Pregabalin IP |
|
|
(As Sustained Release) ———-–75 mg |
|
|
Methylcobalamin IP ————– 1500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pregabalin, Nortriptyline & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Pregabalin IP |
|
|
(As Sustained Release) ———-–75 mg |
|
|
Nortriptyline IP ———————- 10 mg |
|
|
Methylcobalamin IP ————– 1500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Carbamazepine Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anticonvulsants. |
Carbamazepine IP—– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Phenobarbitone tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anticanvalsant |
Phenobarbitone IP—– 30 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Phenobarbitone tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anticanvalsant |
Phenobarbitone IP—– 60 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nortriptyline IP Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Nortriptyline Hydrochloride |
|
|
Eq. to Nortriptyline IP ————-25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Sodium Valproate & Valproic Acid |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Sodium Valproate IP————- 333 mg |
|
|
Valproic Acid IP ——————- 145 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Oxcarbazepine Tablet |
Each uncoated Tablet Contains:- |
|
|
Anticanvalsant |
Oxcarbazepine ———— 300 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Oxcarbazepine Tablet |
Each uncoated Tablet Contains:- |
|
|
Anticanvalsant |
Oxcarbazepine ———— 600 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Piracetam with Citicoline Sodium Tablets |
Each film coated tablet contains: |
|
|
Anticanvalsant |
Citicoline Sodium IP |
|
|
equivalent to Citicoline ———– 500 mg |
|
|
Piracetam———– 800 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Pregabalin & Nortriptyline Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Pregabalin IP —————–75 mg |
|
|
Nortriptyline IP ———————- 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin Tablets IP 100 mg |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Gabapentin…………………………IP 100mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin & Nortriptyline Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticanvalsant |
Gabapentin…………………………IP 100mg |
|
|
Nortriptyline Hydrochloride |
|
|
Eq. to Nortriptyline…………………………IP 10mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Sodium Picosulfate tablets 10 mg |
Each uncoated Tablet Contains:- |
BP |
10 mg |
Anticanvalsant |
Sodium Picosulfate |
|
q. s. |
Excipients |
|
|
Colour-Approved colours used. |
|
|
Sodium Valproate Controlled release tablets 200 mg |
Each film coated controlled release tablet contains:- |
IP |
133.5 mg |
Anticanvalsant |
Sodium Valproate |
IP |
58 mg |
Valproic Acid |
|
|
(Both together corresponds to Sodium Valproate IP 200 mg) |
|
|
Excipients |
|
q. s. |
Colour-Approved colours used. |
|
|
Sodium Valproate Controlled release tablets 300 mg |
Each film coated controlled release tablet contains:- |
IP |
200 mg |
Anticanvalsant |
Sodium Valproate |
IP |
87 mg |
Valproic Acid |
|
|
(Both together corresponds to sodium valproate IP 300 mg) |
|
|
Excipients |
|
q. s. |
Colour-Approved colours used. |
|
|
Sodium Valproate Controlled release tablets 500 mg |
Each film coated controlled release tablet contains:- |
IP |
133 mg |
Anticanvalsant |
Sodium Valproate |
IP |
145 mg |
Valproic Acid |
|
|
(Both together corresponds to sodium valproate IP 500 mg) |
|
|
Excipients |
|
q. s. |
Colour-Approved colours used. |
|
|
Pregabalin capsule IP |
Each hard gelatin capsule contains: |
IP |
75mg |
Anticanvalsant |
Pregabalin |
|
qs |
Excipients |
|
|
Approved colour used |
|
|
Pregabalin Capsules I.P. |
Each hard gelatin capsule contains:- |
I.P. |
300 mg |
Anticanvalsant |
Pregabalin |
|
q.s. |
Excipients |
|
|
Colour – Approved colour used. |
|
|
Gabapentin & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticonvulsant |
Gabapentin IP —————– 300 mg |
|
|
Methylcobalamin IP ————500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Divalproex Sodium Extended Release Tablets IP |
Each Film Coated Extended Release Table Contains:- |
|
|
Anticonvulsant |
Divalproex Sodium IP |
|
|
Eq. to Valproic Acid ———- 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Divalproex Sodium Extended Release Tablets IP |
Each Film Coated Extended Release Tablet Contains:- |
|
|
Anticonvulsant |
Divalproex Sodium IP |
|
|
Eq. to Valproic Acid ———- 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Phenytoin Sodium Tablet IP |
Each Film Coated Tablet Contains:- |
|
|
Anticonvulsant |
Phenytoin Sodium IP ——100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Sodium Valproate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Anticonvulsant |
Sodium Valproate IP ———– 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Sodium Valproate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Anticonvulsant |
Sodium Valproate IP ———– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pregabalin Sustained Release Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Anticonvulsant |
Pregabalin IP ———– 75 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
anticonvulsants |
Gabapentin IP ————— 300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
anticonvulsants |
Gabapentin IP ————— 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
anticonvulsants |
Gabapentin IP ————— 800 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Gabapentin & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Anticonvulsants |
Gabapentin IP —————– 100 mg |
|
|
Methylcobalamin IP ————500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Perampanel Tablets 2 mg |
Each Film coated Tablet Contains:- |
|
2 mg |
Anticonvulsants |
Perampanel |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Perampanel Tablets 4 mg |
Each Film coated Tablet Contains:- |
|
4 mg |
Anticonvulsants |
Perampanel |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Perampanel Tablets 6 mg |
Each Film coated Tablet Contains:- |
|
6 mg |
Anticonvulsants |
Perampanel |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Perampanel Tablets 10 mg |
Each Film coated Tablet Contains:- |
|
10 mg |
Anticonvulsants |
Perampanel |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Perampanel Tablets 12 mg |
Each Film coated Tablet Contains:- |
|
12 mg |
Anticonvulsants |
Perampanel |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Brivaracetam Tablets 50 mg |
Each Film Coated Tablet Contains:- |
|
50 mg |
Anticonvulsants |
Brivaracetam |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Brivaracetam Tablets 75 mg |
Each Film Coated Tablet Contains:- |
|
75 mg |
Anticonvulsants |
Brivaracetam |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Brivaracetam Tablets 100 mg |
Each Film Coated Tablet Contains:- |
|
100 mg |
Anticonvulsants |
Brivaracetam |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Zonisamide Capsule IP 25mg |
Each hard gelatin capsule contains:- |
IP |
25mg |
Anticonvulsants |
Zonisamide |
q.s. |
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Zonisamide Capsule IP 50mg |
Each hard gelatin capsule contains:- |
IP |
50mg |
Anticonvulsants |
Zonisamide |
q.s. |
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Zonisamide Capsule IP 100mg |
Each hard gelatin capsule contains:- |
IP |
100mg |
Anticonvulsants |
Zonisamide |
q.s. |
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Antimigrain |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Propranolol & Flunarizine Capsules |
Each Hard gelatin capsule contain: |
IP |
40 mg |
Antimigrain |
Propranolol HCl IP |
IH |
5 mg |
Eq. to Propranolol (as SR pellets) |
|
q.s. |
Flunarizine |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Propranolol & Flunarizine Capsules |
Each Hard gelatin capsule contain: |
IP |
40 mg |
Antimigrain |
Propranolol HCl IP |
IH |
10 mg |
Eq. to Propranolol (as SR pellets) |
|
q.s. |
Flunarizine |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Naproxen Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimigrain |
Naproxen IP ———– 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimigrain |
Naproxen IP ———– 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Flunarizine Tablets |
Each uncoated tablet contains: |
|
|
Antimigrain |
Flunarizine Dihydrochloride |
|
|
Eq. to Flunarizine——————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen SR Tablets IP |
Each Uncoated sustained Release Tablet Contains:- |
|
|
Antimigrain |
Naproxen IP ———– 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen SR Tablets IP |
Each Uncoated sustained Release Tablet Contains:- |
|
|
Antimigrain |
Naproxen IP ———– 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cinnarizine Tablet IP |
Each Uncoated Tablet Contains:- |
|
|
Antimigrain |
Cinnarizine IP ———– 25 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen Sodium & Domperidone Tablets |
Each Film coated Tablet |
|
|
Antimigrain |
Contains:- |
|
|
Naproxen Sodium……………………… USP 500mg |
|
|
Domperidone Maleate………………….IP |
|
|
Eq. to Domperidone……………………….10mg |
|
|
Excipients………………………………………..q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen Sodium & Domperidone Tablets |
Each film coated tablet contains: |
BP |
500 mg |
Antimigrain |
Naproxen Sodium |
IP |
10 mg |
Domperidone |
|
q.s. |
Excipients |
|
|
Approved colour used |
|
|
Eletriptan Tablets 20 mg |
Each Film Coated Tablet Contains:- |
IP |
20 mg |
Antimigraine |
Eletriptan Hydrobromide |
|
q.s |
Eq. to Eletriptan |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Eletriptan Tablets 40 mg |
Each Film Coated Tablet Contains:- |
IP |
40 mg |
Antimigraine |
Eletriptan Hydrobromide |
|
q.s |
Eq. to Eletriptan |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Naproxen Sodium & Domperidone tablets |
Each Film coated Tablet Contains:- |
|
|
Antimigrain |
Naproxen Sodium ………………USP 250mg |
|
|
Domperidone Maleate……………..IP |
|
|
Eq. to Domperidone………………10mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Naproxen Prolonged – Release Tablets |
Each Film Coated Prolonged – Release Tablets Contains:- |
|
|
Antimirgrain |
Naproxen IP ————— 375 mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Propranolol (SR) & Flunarizine Tablets |
Each uncoated Bilayered tablet contains: |
|
|
anti-migraine |
Propranolol HCl |
|
|
(in Sustained Release) IP ————–40 mg |
|
|
Flunarizine Dihydrochloride BP |
|
|
Eq. to Flunarizine——————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antispasmodic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Hyoscine Butylbromide Tablets 10 mg |
Each Uncoated Tablet Contains:- |
IP |
10 mg |
Antispasmodic |
Hyoscine Butylbromide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Drotaverine hydrochloride & Mefenamic Acid Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antispasmodic |
Drotaverine hydrochloride I.P.——80 mg |
|
|
Mefenamic Acid I.P. ………………250 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Dicyclomine HCl and Mefenamic Acid Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antispasmodic |
Dicyclomine HCl IP ——— 10 mg |
|
|
Mefenamic Acid ————250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Mefenamic Acid & Dicyclomine Hydrochloride Tablets IP |
Each uncoated tablet Contains:- |
|
|
Antispasmodic |
Mefenamic Acid…………………………IP 250mg |
|
|
Dicyclomine Hydrochloride…………………………IP 10mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Mefenamic Acid & Drotaverine Hydrochloride Tablets |
Each uncoated tablet contains: |
I.P. |
250 mg |
Antispasmodic |
Mefenamic Acid |
I.P. |
80 mg |
Drotaverine Hydrochloride |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules |
Each hard gelatin capsule contains:- |
IP |
0.4mg |
Antispasmodic |
Tamsulosin Hydrochloride |
|
|
(As Modified release pellets) |
IP |
2mg |
Tolteridone Tartrate(As Extended release pellets) |
|
|
Excipients |
|
q.s. |
Colour: Approved colours used in empty capsule shells & Pellets. |
|
|
Tamsulosin Hydrochloride (Modified Release) &Tolteridone Tartrate (Extended release) Capsules |
Each hard gelatin capsule contains:- |
IP |
0.4mg |
Antispasmodic |
Tamsulosin Hydrochloride |
|
|
(As Modified release pellets) |
IP |
4mg |
Tolteridone Tartrate |
|
|
(As Extended release pellets) |
|
q.s. |
Excipients |
|
|
Colour: Approved colours used in empty capsule shells & Pellets. |
|
|
Tamsulosin Hydrochloride (Prolonged Release) & Dutasteride Capsules IP |
Each hard gelatin capsule contains:- |
IP |
0.4mg |
Antispasmodic |
Tamsulosin Hydrochloride |
|
|
(As Prolonged release pellets) |
IP |
0.5mg |
Dutasteride |
|
q.s. |
Excipients |
|
|
Colour: Approved colours used in empty capsule shells & Pellets. |
|
|
Mirabegron Extended Release Tablets 25 mg |
Each Film Coated Extended Release Tablet Contains:- |
|
25 mg |
Antispasmodics |
Mirabegron |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Pinaverium Bromide Tablets 50 mg |
Each Film Coated Tablet Contains:- |
|
50 mg |
Antispasmodic agents |
Pinaverium Bromide |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Antiameanic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ferrous Ascorbate & Folic Acid Ta blets |
Each Film Coated Tablet Contains:- |
|
|
Antiameanic |
Ferrous Ascorbate |
|
|
Eq. to Elemental Iron ———– 100 mg |
|
|
Folic Acid IP ——————– 1.5 mg |
|
|
Excipients—————– q.s. |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid & Zinc Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antiameanic |
Ferrous Ascorbate |
|
|
Eq. to Elemental Iron ———– 100 mg |
|
|
Folic Acid IP ——————– 1.5 mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc———- 22.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Anthelmintic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Diethylcarbamazine Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anthelmintic |
Diethylcarbamazine Citrate IP—– 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Diethylcarbamazine Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anthelmintic |
Diethylcarbamazine Citrate IP—- 100 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Albendazole chewable Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Anthelmintic |
Albendazole IP ———— 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Albendazole Tablets IP |
Each uncoated chewable tablet Contains:- |
|
|
Anthelmintic |
Albendazole …………………………IP 400mg |
|
|
Excipients……………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Albendazole Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anthelmintic |
Albendazole IP ———— 400 mg |
|
|
Excipients—————– q.s |
|
|
Albendazole and Ivermectin Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Anthelmintic |
Albendazole IP ———— 400 mg |
|
|
Ivermectin ————— 6 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ivermectin tablet |
Each uncoated dispersible tablet contains: |
|
|
Anthelmintics |
Ivermectin IP———–12.0 mg |
|
|
Excipients ————–q.s. |
|
|
Colour: Approved colour used |
|
|
Antiamaemic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Folic acid, Mecobalamin, Pyridoxine HCl, Docosahexaenoic acid Capsule |
Each Hard Gelatin Capsule Contains: |
IP |
5 mg |
Antiamaemic |
Folic acid |
IP |
1500 mcg |
Mecobalamin |
IP |
1.5 mg |
Pyridoxine HCl |
IH |
200 mg |
Docosahexaenoic acid |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Ferrous Ascorbate & Folic Acid Tablets I.P. |
Each Film Coated Tablet Contains:- |
I.P. |
100 mg |
Antiamaemic |
Ferrous Ascorbate |
|
|
Eq. to Elemental Iron |
I.P. |
1.5 mg |
Folic Acid |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Ferrous Bisglycinate, Zinc Bisglycinate, Folic Acid & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
IP |
60 mg |
Antiamaemic |
Ferrous Bisglycinate |
IP |
|
Eq. to elemental Iron |
|
15 mg |
Zinc Bisglycinate |
|
1 mg |
Eq. to elemental Zinc |
|
500 mcg |
Folic Acid |
|
q.s |
Methylcobalamin |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid & Zinc Tablets |
Each film coated tablet contains: |
IP |
100 mg |
Antiamaenic |
Ferrous Ascorbate |
IP |
1.5 mg |
Folic Acid |
IP |
61.8 mg |
Zinc Sulphate Monohydrate |
|
22.5 mg |
Eq. to Elemental Zinc |
|
q.s. |
Excipients |
|
|
Approved colour used |
|
|
Carbonyl Iron, folic acid & Zinc Capsules |
Each hard gelatin capsule contain: |
IP |
50 mg |
Antiamaenic |
Carbonyl Iron |
|
0.5 mg |
Equivalent to Elemental Iron |
IP |
|
Folic acid |
IP |
61.8 mg |
Zinc sulphate monohydrate |
|
22.5 mg |
Equivalent to elemental zinc |
|
|
Excipients |
|
|
Approved colour used |
|
q.s. |
Ferrous Ascorbate & Folic Acid Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianaemia |
Ferric Ascorbate |
|
|
Eq. to Elemental Iron ————– 100 mg |
|
|
Folic Acid IP ———————- 1.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid & Zinc Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianaemia |
Ferric Ascorbate |
|
|
Eq. to Elemental Iron ————– 100 mg |
|
|
Folic Acid IP ———————- 1.5 mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc———— 22.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Paracetamol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Paracetamol —————- 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Paracetamol —————- 650 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levocetirizine Hcl& Montelukast tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Levocetirizine Hcl…………………………IP 5mg |
|
|
Montelukast Sodium IP |
|
|
Eq. to Montelukast ………………………… 10mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Levocetirizine Dihydrochloride tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Levocetirizine Dihydrochloride…………………………IP 5mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Levocetirizine Dihydrochloride Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Sympathomimetic |
Levocetirizine Dihydrochloride…………………………IP 10mg |
|
|
Excipients…………………………………………………………………q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine Hcl, Caffeine & Diphenhydramine Hcl Tablets |
Each uncoated tablet contains: |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Paracetamol…………………………IP 325mg |
|
|
Phenylephrine Hcl l………………………… IP 5mg |
|
|
Caffeine (Anhydrous) l…………………………IP 30mg |
|
|
Diphenhydramine Hcl l…………………………IP 25mg |
|
|
Excipients ……………………………….q.s |
|
|
Colour: Approved colour used. |
|
|
Levocetirizine Dihydrochloride and Ambroxol Hydrochloride Tablets IP |
Each Film coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Levocetirizine Dihydrochloride IP —— 5 mg |
|
|
Ambroxol Hydrochloride IP ————- 60 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Levocetirizine, Phenylephrine, Ambroxol and Paracetamol Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Levocetirizine Dihydrochloride IP —— 5 mg |
|
|
Phenylephrine Hydrochloride ——-5 mg |
|
|
Ambroxol Hydrochloride IP ————- 30 mg |
|
|
Paracetamol IP ———– 325 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Acebrophylline& Acetylcysteine Tablets |
Each Film Coated Bilayered Tablet Contains:- |
BP |
100 mg |
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Acebrophylline |
|
600 mg |
Acetylcysteine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Terbutaline Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Terbutaline Sulphate IP ———— 2.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Cetirizine Dihydrochloride & Phenylephrine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Paracetamol IP ———– 325 mg |
|
|
Cetirizine Dihydrochloride IP ——–5 mg |
|
|
Phenylephrine Hydrochloride ——-5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine &Cetirizine Tablets |
Each Uncoated Tablet Contains:- |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Paracetamol IP ———– 325 mg |
|
|
Phenylephrine IP ——- 10 mg |
|
|
Cetirizine IP ——– 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenlephrine Hydrochloride & Chlopheniramine Maleate Tablets |
Each Uncoated Tablets Contains : |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Paracetamol IP—————–500 mg |
|
|
Phenlephrine Hydrochloride—– 10 mg |
|
|
Chlopheniramine Maleate ——-2 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Paracetamol, Phenylephrine Hydrochloride & Chlopheniramine Maleate Tablets |
Each Uncoated Tablets Contains : |
|
|
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Paracetamol IP—————–325 mg |
|
|
Phenylephrine Hydrochloride—– 5 mg |
|
|
Chlopheniramine Maleate ——-2 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levofloxacin & Ambroxol (Sustained Release) Tablets |
Each Film Coated Tablet Contains:- |
IP |
500 mg |
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Levofloxacin Hemihydrate |
|
75 mg |
Eq. to Levofloxacin |
IP |
q.s |
Ambroxol Hydrochloride |
|
|
(Sustained Release) |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Acebrophyline (Sustained Release) & Montelukast Sodium, tablets |
Each Film Coated Bilayered Tablet Contains:- |
|
200 mg |
Antihistaminic, Cough Suppressant & Svmpathomimetic |
Acebrophyline (Sustained Release) |
IP |
|
Montelukast Sodium |
|
10 mg |
Eq. to Montelukast |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
antimalarials |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Melfloquine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
antimalarials |
Melfloquine Hydrochloride IP ——- 250mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pyrimethamine and Sulphadoxine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
antimalarials |
Pyrimethamine IP ——- 25mg |
|
|
Sulphadoxine IP ——–500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Artmether and Lumefantrine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimalarials |
Artmether IP —————20 mg |
|
|
Lumefantrine IP ————– 120 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydroxychloroquine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimalarial |
Hydroxychloroquine IP——— 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Artmether and Lumefantrine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimalarial |
Artmether IP ————— 80 mg |
|
|
Lumefantrine IP ————– 480 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Artmether and Lumefantrine Dispersible Tablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
antimalarials |
Artmether IP ————— 40 mg |
|
|
Lumefantrine IP ————– 480 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydroquinone,Tretinoin & Allantoin Gel |
Composition: |
|
|
Antimalarial |
Hydroquinone USP2.0%w/w |
|
|
Tretinoin USP0.025%w/w |
|
|
Allantoin USP1.0% w/w |
|
|
GelBase q.s |
|
|
Quinine Bisulphate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antimalaria |
Quinine Bisulphate IP ————— 300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antidepressant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Doxepin capsules IP |
Each hard gelatin capsule contains:- |
IP |
10mg |
Antidepressant |
Doxepin HCl |
q.s. |
Eq. to Doxepin |
|
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Doxepin capsules IP |
Each hard gelatin capsule contains:- |
IP |
25mg |
Antidepressant |
Doxepin HCl |
q.s. |
Eq. to Doxepin |
|
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Amitriptyline Hydrochloride & Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
IP |
5 mg |
Antidepressant |
Amitriptyline Hydrochloride |
IP |
1500 mcg |
Methylcobalamin |
|
q.s |
Excipients |
|
|
Colour: Approved colour used |
|
|
Amitriptyline Hydrochloride & Methylcobalamin Tablets |
Each Film Coated Bilayered Tablet Contains:- |
IP |
10 mg |
Antidepressant |
Amitriptyline Hydrochloride |
IP |
1500 mcg |
Methylcobalamin |
|
|
(As Sustained Release) |
|
q.s |
Excipients |
|
|
Colour: Approved colour used |
|
|
Sertraline Tablets IP 25 mg |
Each Film Coated Tablet Contains:- |
IP |
25 mg |
Antidepressant |
Sertraline Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Gabapentin & Nortriptyline Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antidepressant |
Gabapentin IP ———— 400 mg |
|
|
Nortriptyline Hydrochloride |
|
|
Eq. to Nortriptyline IP ————-10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fluoxetine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antidepressant |
Fluoxetine Hydrochloride IP |
|
|
Eq. to Fluoxetine ————— 20 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Citicoline Sodium Tablet IP |
Each film coated tablet contains: |
|
|
Antidepressant |
Citicoline Sodium IP |
|
|
equivalent to Citicoline———– 500 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Piracetam with Citicoline Tablets |
Each film coated tablet contains: |
|
|
Antidepressant |
Citicoline Sodium IP |
|
|
equivalent to Citicoline ———– 500 mg |
|
|
Piracetam———– 400 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Venlafaxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Antidepressant |
Venlafaxine Hydrochloride BP ——– 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Citicoline Sodium (PR) Tablet IP |
Each film coated prolonged release tablet contains: |
|
|
Antidepressant |
Citicoline Sodium IP |
|
|
equivalent to Citicoline———– 1000 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Sertraline Tablets IP 50 mg |
Each Film Coated Tablet Contains:- |
|
|
Antidepressant |
Sertraline Hydrochloride IP |
|
|
Eq. to Sertraline……………………………….. 50 mg |
|
|
Excipients ……………………………………………q.s. |
|
|
Colour-Approved colours used. |
|
|
Sertraline Tablets IP 100 mg |
Each Film Coated Tablet Contains:- |
|
|
Antidepressant |
Sertraline Hydrochloride IP |
|
|
Eq. to Sertraline………………………………. 100 mg |
|
|
Excipients ………………………………………….q.s. |
|
|
Colour-Approved colours used. |
|
|
Propranolol(SR) & Flunarizine capsule |
Each Hard gelatin capsule Contains: |
IP |
40 mg |
Antidepressant |
Propranolol Hydrochloride |
|
10 mg |
Eq to Propranolol(SR pellets) |
|
|
Flunarizine |
|
|
Approved colour used |
|
|
Antidiarrheal |
|
|
|
|
Loperamide Capsules IP |
Each Hard Gelatin Capsule Contains:- |
IP |
2.0 mg |
Antidiarrheal |
Loperamide Hydrochloride |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Loperamide Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antidiarrheal |
Loperamide Hydrochloride IP ——2 mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Rececadotril capsules IP100. |
Each Hard Gelatin capsule contains |
IP |
100mg |
Antidiarrheal |
Rececadotril |
|
q. s. |
Excipients |
|
|
Approved colour used |
|
|
Antacid, Anti Ulcer And Antispasmodic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Calcium Carbonate and Simethicone Chewable Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antacid, Anti Ulcer And Antispasmodic |
Calcium Carbonate IP ————- 600 mg |
|
|
Simethicone IP ———————80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Dicyclomine Tablets IP |
Each Film coated Tablet contains: |
IP |
20 mg |
Antacid, Anti Ulcer And Antispasmodic |
Dicyclomine Hydrochloride |
|
q. s. |
Excipients |
|
|
White Soft Paraffin & Liquid Paraffin Cream |
Composition: |
IP |
15.0%w/w |
Antacid, Anti Ulcer And Antispasmodic |
White Soft Paraffin |
IP |
6.0%w/w |
Liquid Paraffin |
|
q.s |
Cream Base |
|
|
Antiseptic, Antiulcer |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Povidone Iodine, & Sucralfate Ointment |
Composition: |
IP |
5.0 % w/w |
Antiseptic, Antiulcer |
Povidone Iodine (available iodine 1.0% w/w) |
IP |
7.0 % w/w |
Sucralfate |
|
q.s. |
Ointment base |
|
|
Povidone-Iodine, Ointment USP |
Composition: |
IP |
5.0% w/w |
Antiseptic |
Povidone-Iodine (available iodine 0.5% w/w) |
|
Water Soluble Ointment base |
q.s. |
Silver Nitrate, Chlorhexidine Gluconate, Aloevera& Allantoin Cream |
Composition : |
IP |
0.2%w/w |
Antiseptic |
Silver Nitrate |
IP |
0.2%w/w |
Chlorhexidine Gluconate Solution |
|
0.1%w/w |
Allantoin |
IP |
15.0%w/w |
Aloe Vera extract |
|
|
Preservatives: |
IP |
0.1%w/w |
Chlorocresol |
|
q.s |
Cream Base |
|
|
Povidone-Iodine, Ointment USP |
Composition: |
IP |
5.0% w/w |
Antiseptic |
Povidone-Iodine (available iodine 0.5% w/w) |
|
Water Soluble Ointment base |
q.s. |
Povidone-Iodine, Ointment USP |
Composition: |
IP |
10.0% w/w |
Antiseptic |
Povidone-Iodine (available iodine 1.0% w/w) |
q.s. |
Ointment base |
|
Povidone-Iodine solution IP |
Composition: |
IP |
10.0% w/v |
Antiseptic |
Povidone-Iodine (available iodine 1.0% w/w) |
q.s. |
Ointment base |
|
Zinc oxide cream IP |
Composition: |
IP |
32.00% |
Antiseptic |
Zinc oxide |
q.s. |
Cream Base |
|
Misoprostol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Misoprostol IP ———–200 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ranitidine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Ranitidine Hydrochloride IP |
|
|
Eq. to Ranitidine —————150 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pantoprazole and Domperidone Tablets |
Each Enteric Coated Tablet Contains:- |
|
|
Antiulcer |
Pantoprazole Sodium (Sesquihydrate) IP |
|
|
Eq. to Pantoprazole ————– 40 mg |
|
|
Domperidone IP —————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Carbonate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———–400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Carbonate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———–500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Carbonate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———–625 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Carbonate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———-1000 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ranitidine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiulcer |
Ranitidine Hydrochloride IP |
|
|
Eq. to Ranitidine —————300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Chlorhexidine Gluconate sodium Fluoride & Zinc chloride mouth wash. |
Composition: |
IP |
0.2%w/v |
Antiulcer |
Each 100 ml contains: |
|
|
Chlorhexidine Gluconate |
IP |
0.05%w/v |
( As Chlorhexidine Gluconate solution IP) |
IP |
0.09%w/v |
Sodium Fluoride |
IP |
qs |
Zinc chloride |
|
|
Colour Approved colour used |
|
|
Antihistamines |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Desloratadine Tablet |
Each film coated tablet contains: |
|
|
Antihistamines |
Desloratadine BP ———– 5 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Desloratadine & Montelukast Tablet |
Each film coated tablet contains: |
|
|
Antihistamines |
Desloratadine BP ———– 5 mg |
|
|
Montelukast Sodium IP |
|
|
eq. to Montelukast ————- 10 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablet |
Each Film Coated Tablet Contains:- |
|
|
Antihistamines |
Doxylamine Succinate USP —- 10 mg |
|
|
Pyridoxine Hydrochloride IP —— 10 mg |
|
|
Folic Acid IP —————————- 2.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Fexofenadine Hydrochloride Tablets IP 30 mg |
Each Film coated Tablet contains: |
IP |
30 mg |
antihistamines |
Fexofenadine Hydrochloride |
|
q. s. |
Excipients |
|
|
Approved Colour used |
|
|
Fexofenadine Hydrochloride Tablets IP 60 mg |
Each Film coated Tablet contains: |
IP |
60 mg |
antihistamines |
Fexofenadine Hydrochloride |
|
q. s. |
Excipients |
|
|
Approved Colour used |
|
|
Doxylamine Succinate, Pyridoxine Hydrochloride & Folic Acid Tablets |
Each Enteric Coated Tablet Contains:- |
B.P. |
10 mg |
Antihistamines |
Doxylamine Succinate |
I.P. |
10 mg |
Pyridoxine Hydrochloride |
I.P. |
2.5 mg |
Folic Acid |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Fexofenadine Hydrochloride Tablet I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihistamine |
Fexofenadine Hydrochloride I.P——-120mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Fexofenadine Hydrochloride Tablet I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihistamine |
Fexofenadine Hydrochloride I.P——180mg |
|
|
Excipients—————————q.s. |
|
|
Colour-Approved colour used. |
|
|
Chlorpheniramine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihistamine |
Chlorpheniramine Maleate I.P. ———4mg |
|
|
Excipients—————————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Chlorpheniramine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antihistamine |
Chlorpheniramine Maleate I.P———8mg |
|
|
Excipients————————–q.s. |
|
|
Colour-Approved colour used. |
|
|
antimuscarinics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Trihexyphenidyl Hydrochloride Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antimuscarinics |
Trihexyphenidyl Hydrochloride IP—- 1 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Solifenacin Succinate Tablets |
Each Film coated Tablet Contain: |
IP |
10 mg |
antimuscarinics. |
Solifenacin Succinate |
|
q. s. |
Excipients |
|
|
Antifibrotic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Silymarin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antifibrotic |
Silymarin ————– 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
SilymarinTablets |
Each Film Coated Tablet contains: |
IP |
140 mg |
Antifibrotic |
Silymarin |
|
q. s. |
Excipients |
|
|
Antipsychotic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Quetiapine Fumarate Tablets IP 25 mg |
Each Film Coated Tablets Contains |
IP |
25 mg |
Antipsychotics |
Quetiapine Fumarate |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Quetiapine Fumarate Tablets IP 50 mg |
Each Film Coated Tablets Contains |
IP |
50 mg |
Antipsychotics |
Quetiapine Fumarate |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Flupentixol Tablets BP 1 mg |
Each Film Coated Tablet Contains:- |
BP |
1 mg |
antipsychotic |
Flupentixol Dihydrochloride |
|
q.s |
Eq. to Flupentixol |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Flupentixol Tablets BP 3 mg |
Each Film Coated Tablet Contains:- |
BP |
3 mg |
antipsychotic |
Flupentixol Dihydrochloride |
|
q.s |
Eq. to Flupentixol |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Chlorpromiazine Hydrochloride, Trifluoperazine And Trihexyphenidyl Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antipsychotic |
ChlorpromiazineHydrochloride I.P–50mg |
|
|
Trifluoperazine Hydrochloride I.P. |
|
|
Eq. to Trifluoperazine 5mg |
|
|
Trihexyphenidyl Hydrochloride I.P…—2mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Olanzapine Tablets IP |
Each uncoated Tablet Contains:- |
|
|
Antipsychotics |
Olanzapine IP ———————-2.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Olanzapine Tablets IP |
Each uncoated Tablet Contains:- |
|
|
Antipsychotics |
Olanzapine IP ———————-5.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Olanzapine Tablets IP |
Each uncoated Tablet Contains:- |
|
|
Antipsychotics |
Olanzapine IP ———————-10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levosulpiride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antipsychotic |
Levosulpiride ——————– 75 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Levosulpiride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antipsychotic |
Levosulpiride ——————– 150 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Levosulpiride Tablets |
Each Film Coated Tablet Contains:- |
|
|
antipsychotic |
Levosulpiride ——————– 200 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Haloperidol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antipsychotics |
Haloperidol IP ———– 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Prochlorperazine Maleate Mouth Dissolving Tablet |
Each uncoated mouth |
|
|
Antipsychotic |
dissolving tablet Contains: |
|
|
Prochlorperazine Maleate…………..IP 5mg |
|
|
Excipients…………………………………….q.s |
|
|
Colour-Approved colour used. |
|
|
Antianginal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Nitroglycerine Sustained Release Tablets (Glyceryl Trinitrate Controlled Release Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Antianginal |
Nitroglycerine IP——– 2.6 mg |
|
|
(As Diluted Nitroglycerine IP) |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) |
Each Film Coated Prolonged Release Tablet Contains:- |
|
|
Antianginal |
Nifedipine IP—————— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Nifedipine Prolonged Release Tablets IP ( Nifedipine Sustained release Tablets IP) |
Each Film Coated Prolonged Release Tablet Contains:- |
|
|
Antianginal |
Nifedipine IP—————— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Verapamil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Verapamil Hydrochloride IP ——– 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Verapamil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Verapamil Hydrochloride IP ——– 80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Verapamil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Verapamil Hydrochloride IP —— 120 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Verapamil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Verapamil Hydrochloride IP —— 160 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ivabradine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Ivabradine Hydrochloride ———- 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ivabradine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianginal |
Ivabradine Hydrochloride ———7.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Isosorbide Mononitrate Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Anti-Anginal |
Diluted Isosorbide Dinitrate I.P.—-20mg |
|
|
Excipients—————————q.s. |
|
|
Colour-Approved colour used. |
|
|
Anti-spasmodic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) |
Each Film Coated Tablet Contains:- |
|
|
Anti-spasmodic |
Benzhexol Hydrochloride IP——– 2 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Benzhexol Tablets IP (Trihexyphenidyl Hydrochloride Tablets IP) |
Each Film Coated Tablet Contains:- |
|
|
Anti-spasmodic |
Benzhexol Hydrochloride IP——–5 mg |
|
|
Excipients—————–q.s |
|
|
Colour-Approved colour used. |
|
|
Hyoscine Butylbromide Tablets IP |
Each Sugar Coated Tablet Contains:- |
|
|
Antisapsmodic |
Hyoscine Butylbromide IP ——10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Anti-Rheumatic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Azathioprine tablets IP 50 mg |
Each Uncoated Tablet Contains:- |
IP |
50 mg |
Anti-Rheumatic |
Azathioprine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Azathioprine tablets IP 50 mg |
Each Uncoated Tablet Contains:- |
IP |
50 mg |
Anti-Rheumatic |
Azathioprine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Hydroxychloroquine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Anti-Rheumatic |
Hydroxychloroquine IP——— 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Anti Gallstones |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ursodeoxycholic Acid Tablets I.P |
Each film coated tablet contains: |
|
|
Anti Gallstones |
Ursodeoxycholic Acid I.P———–450 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Ursodeoxycholic Acid Tablets I.P |
Each film coated tablet contains: |
|
|
Anti Gallstones |
Ursodeoxycholic Acid I.P———–300 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Ursodeoxycholic Acid Tablets I.P |
Each film coated tablet contains: |
|
|
Anti Gallstones |
Ursodeoxycholic Acid I.P———- 150 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Ursodeoxycholic Acid Sustained Release Tablets I.P |
Each Sustained Release Tablet contains: |
|
|
Anti Gallstones |
Ursodeoxycholic Acid I.P———–300 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Ursodeoxycholic Acid Sustained Release Tablets I.P |
Each Sustained Release Tablet contains: |
|
|
Anti Gallstones |
Ursodeoxycholic Acid I.P———–600 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Anticold |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pheniramine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Anticold |
Pheniramine Maleate I.P 25mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Pheniramine Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Anticold |
Pheniramine Maleate I.P 50mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Antiparkinsonism agents |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pramipexol Dihydrochloride Tablets 0.125 mg |
Each Uncoated Tablets contains: |
USP |
0.125 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Tablets 0.25 mg |
Each Uncoated Tablets contains: |
USP |
0.25 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Tablets 0.5 mg |
Each Uncoated Tablets contains: |
USP |
0.5 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Tablets 1 mg |
Each Uncoated Tablets contains: |
USP |
1 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Tablets 1.5 mg |
Each Uncoated Tablets contains: |
USP |
1.5 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Extended Release Tablets 0.375 mg |
Each Uncoated extended release Tablets contains: |
USP |
0.375 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Extended Release Tablets 0.75 mg |
Each Uncoated extended release Tablets contains: |
USP |
0.75 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Extended Release Tablets 1.5 mg |
Each Uncoated extended release Tablets contains: |
USP |
1.5 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Extended Release Tablets 3 mg |
Each Uncoated extended release Tablets contains: |
USP |
3 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pramipexol Dihydrochloride Extended Release Tablets 4.5 mg |
Each Uncoated extended release Tablets contains: |
USP |
4.5 mg |
Antiparkinsonism agents |
Pramipexol Dihydrochloride Monohydrate |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Febuxotat Tablet 40 mg |
Each Film coated Tablets contains: |
IH |
40 mg |
Antihyperuricemic agents |
Febuxotat |
|
q.s. |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Amantadine hydrochloride Capsules IP |
Each hard gelatin capsule Contains: |
IP |
100 mg |
Antiparkinson agent |
Amantadine Hydrochloride |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Piribedil (SR) Tablets |
Each Sustained Release Tablets Contains |
|
50 mg |
Antiparkinsonian agent |
Piribedil |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Antiarrhythmics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Amiodarone HCl Tablets IP 100 mg |
Each Uncoated Tablet Contains:- |
IP |
100 mg |
Antiarrhythmic |
Amiodarone HCl |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Amiodarone HCl Tablets IP 200 mg |
Each Uncoated Tablet Contains:- |
IP |
200 mg |
Antiarrhythmic |
Amiodarone HCl |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Mexiletine Hydrochloride Capsules IP |
Each hard gelatin capsule contains: |
IP |
50 mg |
Antiarrhythmics |
Mexiletine Hydrochloride |
q.s. |
Excipients |
|
Approved colors used in Hard Gelatin Capsule shell. |
|
Mexiletine Hydrochloride Capsules IP |
Each hard gelatin capsule contains: |
IP |
150 mg |
Antiarrhythmics |
Mexiletine Hydrochloride |
q.s. |
Excipients |
|
Approved colors used in Hard Gelatin Capsule shell. |
|
Digoxin tablet IP 250 µg |
Each uncoated tablet contains |
IP |
250 µg |
Antiarrhythmics |
Digoxin |
|
q.s. |
Excipients |
|
|
Colour: Approved Colour used |
|
|
Antidepresant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Fluoxetine Tablets IP 10 mg |
Each Film Coated Tablet Contains:- |
IP |
10 mg |
Antidepresant |
Fluoxetine Hydrochloride |
|
|
Eq. to Fluoxetine |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Citicoline Tablet IP 250 mg |
Each film coated tablet contains: |
IP |
250 mg |
Antidepresant |
Citicoline Sodium |
|
|
equivalent to Citicoline |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Mirtazapine Tablets IP 15 mg |
Each Film Tablet Contains:- |
IP |
15 mg |
Antideprresant |
Mirtazapine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Mirtazapine Tablets IP 30 mg |
Each Film Tablet Contains:- |
IP |
30 mg |
Antidepresant |
Mirtazapine |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Cyclobenzaprine Extended Release capsules |
Each hard gelatin capsule contains: |
IP |
15 mg |
Antidepressants |
Cyclobenzaprine |
|
(As sustained release pellets) |
q.s. |
Excipients |
|
Approved Colors Used. in Empty Shell & Pellet |
|
Cyclobenzaprine Extended Release capsules |
Each hard gelatin capsule contains: |
IP |
30 mg |
Antidepressants |
Cyclobenzaprine |
|
(As sustained release pellets) |
q.s. |
Excipients |
|
Approved Colors Used. in Empty Shell & Pellet |
|
Trazodone Hydrochloride Tablets USP 50 mg |
Each Uncoated Tablets contains: |
USP |
50 mg |
Antideprresant |
Trazodone Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Trazodone Hydrochloride Tablets USP 100 mg |
Each Uncoated Tablets contains: |
USP |
100 mg |
Antideprresant |
Trazodone Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Trazodone Hydrochloride Tablets USP 25 mg |
Each Uncoated Tablets contains: |
USP |
25 mg |
Antideprresant |
Trazodone Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Antianeamic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Folic Acid Tablets IP 10 mg |
Each Uncoated Tablet Contains:- |
IP |
10 mg |
Antianeamic |
Folic Acid |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Folic Acid Tablets IP 5 mg |
Each Uncoated Tablet Contains:- |
IP |
5 mg |
Antianeamic |
Folic Acid |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianeamic |
Ferrous Ascorbate |
|
|
Eq. to Elemental Iron————–100 mg |
|
|
Folic Acid IP————————-1.5 mg |
|
|
Zinc Sulphate USP |
|
|
Eq. to Elemental Zinc ————–22.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid, Cyanocobalamin & Zinc Sulphate Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianeamic |
Ferrous Ascorbate |
|
|
Eq. to elemental Iron ————– 100 mg |
|
|
Folic Acid IP ——————— 1.5 mg |
|
|
Cyanocobalamin IP —————-15 mcg |
|
|
Zinc Sulphate monohydrate IP |
|
|
Eq. to Elemental Zinc ————–22.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ferrous Ascorbate, Folic Acid and Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Antianeamic |
Ferrous Ascorbate IP |
|
|
eq. to elemental Iron—————- 100 mg |
|
|
Folic Acid IP ——————- 1.5mg |
|
|
Methylcobalamin IP ————– 1500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ferrous Bisglycinate, Folic Acid, Zinc Bisglycinate&Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
IP |
60 mg |
Anti-anemic |
Ferrous Bisglycinate |
|
1 mg |
Folic Acid |
|
15 mg |
Zinc Bisglycinate |
IP |
500 mcg |
Methylcobalamin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Antioxidant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ascorbic Acid Tablets IP |
Each UncoatedChewableTablet Contains:- |
|
|
Antioxidant |
Ascorbic Acid IP ———– 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Ascorbic Acid Tablets IP 100 mg |
Each Chewable Tablet Contains : |
IP |
100 mg |
Antioxidants |
Ascorbic Acid |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Vitamin C Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antioxidants |
Vitamin C IP ————— 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Vitamin C Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antioxidants |
Vitamin C IP ————— 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antipsoriatic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Acitretin Capsules IP. |
Each Hard Gelatin Capsule Contains: |
IP |
25mg |
Antipsoriatic |
Acitretin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Acitretin Capsules I.P. |
Each Hard Gelatin Capsule Contains: |
IP |
10mg |
Antipsoriatic |
Acitretin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Antiepileptic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Gabapentin Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
100.0 mg |
Antiepileptic |
Gabapentin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Gabapentin Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
300.0 mg |
Antiepileptic |
Gabapentin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Gabapentin Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
400.0 mg |
Antiepileptic |
Gabapentin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Gabapentin Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antiepileptic |
Gabapentin IP ———— 600 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levetiracetam Tablet IP 750 mg |
Each film Coated Tablet Contains: |
|
|
anticonvulsants/antiepileptics |
Levetiracetam IP ——————-750 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Levetiracetam Tablet IP 1000 mg |
Each film Coated Tablet Contains: |
|
|
anticonvulsants/antiepileptics |
Levetiracetam IP ——————-1000 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Levetiracetam Sustained Release Tablets |
Each Sustained Release Tablet Contains:- |
|
|
Anticonvulsants/Antiepileptics |
Levetiracetam USP ————1000 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levetiracetam Tablet IP 500 mg |
Each film Coated Tablet Contains: |
|
|
Anticonvulsants/Antiepileptics |
Levetiracetam IP ——————-500 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Antihistamins |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Diphenhydramine Capsules IP |
Each Hard Gelatin Capsules Contains: |
IP |
25.0 mg |
Antihistamins |
Diphenhydramine Hydrochloride |
q.s. |
Excipients q.s |
|
Approved colour used in empty hard gelatin capsule shell |
|
Diphenhydramine Capsules IP |
Each Hard Gelatin Capsules Contains: |
IP |
50.0 mg |
Antihistamins |
Diphenhydramine Hydrochloride |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Antineoplastics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Isotretinoin Capsule USP |
Each Hard Gelatin Capsule contains: |
IP |
20 mg |
Antineoplastics |
Isotretinoin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Anti Scabies |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Permethrin Cream |
Composition : |
|
5.0%w/w |
Anti Scabies |
Permethrin |
q.s |
Cream Base |
|
Alzheimer’s disease |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Donepzil Hydrochloride &Memantadine Hydrochloride Tablets |
Each Film coated Tablets contains: |
IP |
5 mg |
Alzheimer’s disease |
Donepzil Hydrochloride |
IP |
5 mg |
Memantadine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Donepzil Hydrochloride &Memantadine Hydrochloride Tablets |
Each Film coated Tablets contains: |
IP |
5 mg |
Alzheimer’s disease |
Donepzil Hydrochloride |
IP |
10 mg |
Memantadine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Antiparkinson |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Levodopa And Carbidopa Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Antiparkinson |
Levodopa I.P ——————– 250mg |
|
|
Carbidopa IP 25mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Levodopa And Carbidopa Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
AntiParkinson |
Levodopa I.P ——————– 100mg |
|
|
Carbidopa IP 25mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Levodopa And Carbidopa Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
AntiParkinson |
Levodopa I.P ——————– 100mg |
|
|
Carbidopa IP 10mg |
|
|
Excipients——————q.s. |
|
|
Colour-Approved colour used. |
|
|
Antiaginal |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Isosorbide Dinitrate Tablets IP. |
Each Film Coated Tablet Contains:- |
|
|
Antiaginal |
Diluted Isosorbide Dinitrate I.P. |
|
|
Eq. to Isosorbide Dinitrate———-20mg |
|
|
Excipients—————————q.s. |
|
|
Colour-Approved colour used. |
|
|
Antidiuretic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Furosemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antidiuretic |
Furosemide IP ————— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Furosemide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antidiuretic |
Furosemide IP ————— 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antidotes |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Calcium Gluconate Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antidotes |
Calcium Gluconate IP ————500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Gluconate Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antidotes |
Calcium Gluconate IP ————325 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Gluconate Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antidotes |
Calcium Gluconate IP ————650 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antacids |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pantoprazole Gastro Resistant Tablets IP |
Each Enteric Coated Tablet Contains:- |
|
|
Antacids |
Pantoprazole Sodium IP |
|
|
Eq. to Pantoprazole ————– 40 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Alcohol Antagonist |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Disulfiram Tablets IP 200 mg |
Each Uncoated Tablet Contains: – |
|
|
Alcohol Antagonist |
Disulfiram IP———————-200 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Anti-Fibrinolytic Agents |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ethamsylate& Tranexamic acid Tablets |
Each Uncoated Tablet Contains: – |
|
|
Anti-Fibrinolytic Agents |
Ethamsylate BP ————– 250.0 mg |
|
|
Tranexamic acid IP ———–250.0 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Antihemorrhagic |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ethamsylate Tablets |
Each Uncoated Tablet Contains: – |
|
|
Antihemorrhagic |
Ethamsylate BP ————– 250 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved colour used |
|
|
Ethamsylate Tablets |
Each Uncoated Tablet Contains: – |
|
|
Antihemorrhagic |
Ethamsylate BP ————– 500 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Antigout agents |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Probenecid Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Antigout agents |
Probenecid IP ————— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antiglaucoma |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Acetazolamide Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Antiglaucoma |
Acetazolamide IP—– 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antidysrhythmics |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Digoxin Tablet IP |
Each uncoated Tablet Contains:- |
|
|
|
Digoxin IP ———— 250 µg |
|
|
|
Excipients —————— q.s. |
|
|
|
Colour-Approved colour used. |
|
|
|
antiplatelet |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Cilostazole Tablet IP |
Each uncoated tablet contains: |
|
|
antiplatelet |
Cilostazole IP —————— 50.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Cilostazole Tablet IP |
Each uncoated tablet contains: |
|
|
antiplatelet |
Cilostazole IP —————— 200.0 mg |
|
|
Excipients ——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Benign Prostatic Hyperplasia |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Silodosin Capsules |
Each hard gelatin capsules contain: |
IH |
4 mg |
Benign Prostatic Hyperplasia |
Silodosin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Silodosin Capsules |
Each hard gelatin capsules contain: |
IH |
8 mg |
Benign Prostatic Hyperplasia |
Silodosin |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Dutasteride Capsules IP |
Each hard gelatin capsule contains: |
IP |
0.5 mg |
Benign Prostatic Hyperplasia |
Dutasteride |
q.s. |
Excipients |
|
Approved colors used in Hard Gelatin Capsule shell. |
|
Silodosin & Dutasteride Capsules |
Each hard gelatin capsules contain: |
IH |
8 mg |
Benign Prostatic Hyperplasia |
Silodosin ( as pellets ) |
IP |
0.5 mg |
Dutasteride( as pellets ) |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Tamsulosin HCl Prolonged release |
Each hard gelatin capsule contains:- |
IP |
200mcg |
Benign Prostatic Hyperplasia |
Capsules IP |
Tamsulosin HCl |
|
|
(As prolonged release pellets) |
q.s. |
|
Excipients |
|
|
Colour: Approved colours used in empty capsule shells & pellets. |
|
Tamsulosin HCl Prolonged release |
Each hard gelatin capsule contains:- |
IP |
400mcg |
Benign Prostatic Hyperplasia |
Capsules IP |
Tamsulosin HCl |
|
|
(As prolonged release pellets) |
q.s. |
|
Excipients |
|
|
Colour: Approved colours used in empty capsule shells & pellets. |
|
Tamsulosin HCl (Sustained Release) and Deflazacort tablets |
Each Film Coated Bilayered Tablet Contains:- |
IP |
0.4 mg |
Benign Prostatic Hyperplasia |
Tamsulosin HCl |
|
|
(As Sustained Release) |
|
30 mg |
Deflazacort |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Tamsulosin HCl and Dutasteride tablets |
Each Film Coated Tablet Contains:- |
|
|
Benign Prostatic Hyperplasia |
|
Tamsulosin HCl IP————- 0.4 mg |
|
|
|
Dutasteride IP ——————- 0.5 mg |
|
|
|
Excipients q.s. |
|
|
|
Colour-Approved colour used. |
|
|
Bronchodilator |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Acebrophylline Capsules |
Each Hard Gelatin Capsules Contains: |
|
100.0 mg |
Bronchodilator |
Acebrophylline |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Theophylline Prolonged – release Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Bronchodilator |
Theophylline IP ——- 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Acebrophylline Sustained Release Tablets |
Each Film Coated Sustained Release Tablet Contains:- |
|
|
Broncodilator |
Acebrophylline ——————- 200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Salbutamol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Bromcholdialtor |
Salbutamol Sulphate IP |
|
|
Eq. to Salbutamol ————— 4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Etofylline & Theophylline Tablets |
Each Uncoated Sustained Release Tablet Contains:- |
|
|
Bromcholdialtor |
Etofylline —————– 231 mg |
|
|
Theophylline —————— 69 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium & Vitamins |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Methylcobalamin, Calcium carbonate, Calcitriol, folic acid and Pyridoxin Hydrochloride Capsules |
Each Hard Gelatin Capsule contains: |
IP |
1500 mcg |
Calcium & Vitamins |
Methylcobalamin |
|
|
Calcium carbonate equivalent to elemental Calcium |
IP |
200 mg |
Calcitriol |
IP |
0.25 mcg |
Folic Acid |
IP |
1.5 mg |
Pyridoxine Hydrochloride |
IP |
3.0 mg |
Excipients |
|
q.s. |
Approved colored used in Hard Gelatin Capsule shell |
|
|
Methylcobalamin, Alpha lipoic Acid, Inositol, Folic acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules |
Each hard gelatin Capsules contains: |
IP |
1500mcg |
Calcium & Vitamins drug |
Methylcobalamin |
USP |
100mg |
Alpha Lipoic Acid |
BP |
100mg |
Inositol |
IP |
1.5mg |
Folic Acid |
USP |
200mcg |
Chromium Polynicotinate |
USP |
55mcg |
Selenium Dioxide |
|
150mg |
Benfotiamine |
|
q.s |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Calcium, Magnesium, Vitamin D3 and Zinc Sulphate |
Each Uncoated Tablet Contains:- |
|
|
Calcium & Vitamins |
Calcium citrate USP |
|
|
Eq. to Elemental calcium———— 200mg |
|
|
Vitamin D3 Granules |
|
|
Eq. to Vitamin D3 IP—————– 200 IU |
|
|
Magnesium Hydroxide IP |
|
|
Eq. to Elemental Magnesium ———50mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc—————–4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Vitamin K2-7, Calcitriol, Calcium, Zinc and Magnesium Tablets |
Each Film Coated Tablet Contains:- |
|
|
Calcium & Vitamins |
Vitamin K2-7 ———————– 50 mcg |
|
|
Calcium Carbonate IP |
|
|
Eq. to Elemental calcium———— 500mg |
|
|
Calcitriol IP ———————- 0.25 mcg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc—————7.5 mg |
|
|
Magnesium Sulphate IP |
|
|
Eq. to elemental Magnesium ——- 50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Citrate, Magnesium, Zinc with Vitamin D3 Tablets |
Each Film Coated Tablet Contains:- |
|
|
Calcium & vitamins |
Calcium citrate USP ————1000mg |
|
|
Magnesium Hydroxide IP——– 100mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc—————–4 mg |
|
|
Vitamin D3 IP—————– 200 IU |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium and Vitamin D3 Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Calcium & vitamins |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———-500mg |
|
|
Vitamin D3 IP—————– 250 IU |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Zinc & Vitamin C Chewable Tablet |
Each uncoated chewable tablet contains: – |
|
|
Calcium & vitamins |
Zinc Gluconate 87.1 mg |
|
|
eq. to. Elemental zinc 12.5 mg) |
|
|
Ascorbic acid 100 mg + Sodium Ascorbate 170 mg |
|
|
eq. to ascorbic acid 150 mg |
|
|
Excipients —————–q.s. |
|
|
Colour:- Approved colour used |
|
|
Calcium, Calcitriol, Vitamin K2-7 Tablets |
Each Film Coated Tablet Contains:- |
|
|
Calcium & Vitamins |
Calcium Carbonate IP |
|
|
Eq. to Elemental calcium———— 500mg |
|
|
Calcitriol IP ———————- 0.25 mcg |
|
|
Vitamin K2-7 ———————– 1000 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Carbonate and Vitamin D3 Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Calcium & Vitamins |
Calcium Carbonate IP |
|
|
Eq. to Elemental Calcium———- 250mg |
|
|
Vitamin D3 IP—————– 125 IU |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium and Vitamin D3 Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Calcium & vitamins |
Calcium Carbonate 1.25 gm IP |
|
|
Eq. to elemental calcium (Derived From an Organic source oyster shell) ———- 500mg |
|
|
Vitamin D3 IP—————– 500 IU |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Citrate Maleate, Magnesium, Zinc, Vit. D3, Methylcobalamin, L- Methyl Folate & Pyridoxal Phosphate |
Each Film Coated Tablet contains: |
|
|
Calcium & Vitamin |
Calcium Citrate Maleate USP 12.50 mg |
|
|
Eq. to elemental Calcium ———- 250 mg |
|
|
Magnesium Hydroxide IP———- 100 mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to Elemental Zinc —————- 10 mg |
|
|
Vitamin D3 ———————————- 2000 IU |
|
|
Methylcobalamin IP —————–1500 mcg |
|
|
L- Methyl Folate IP —————— 1 mg |
|
|
Pyridoxal Phosphate IP —————– 20 mg |
|
|
Excipients ——————- q.s. |
|
|
Colour-Approved colour used. |
|
|
Calcium Citrate, Vitamin D3 &Zinc Tablets |
Each Uncoated Tablet Contains:- |
|
|
Calcium & Vitamin |
Calcitriol Citrate USP————-1000 mg |
|
|
Vitamin D3 IP ——————200 IU |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc————– 4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium, Magnesium Vitamin D3 &Zinc Tablets |
Each Uncoated Tablet Contains:- |
|
|
Calcium & Vitamins |
Calcium Citrate USP————-1000 mg |
|
|
Vitamin D3 IP ——————200 IU |
|
|
Magnesium Hydroxide IP |
|
|
Eq. to Elemental Magnesium ——-100 mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc————– 4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium citrate, Vitamin D3, Magnesium Hydroxide and Zinc Sulphate |
Each Film Coated Tablet Contains:- |
|
|
Calcium & Vitamins |
Calcium citrate USP |
|
|
Eq. to Elemental calcium———— 1000mg |
|
|
Vitamin D3 Granules |
|
|
Eq. to Vitamin D3 IP—————– 400 IU |
|
|
Magnesium Hydroxide IP |
|
|
Eq. to Elemental Magnesium ———100mg |
|
|
Zinc Sulphate Monohydrate IP |
|
|
Eq. to elemental Zinc—————–4 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Calcium Pantothenate Tablets IP 100 mg |
Each Film Coated Tablet Contains:- |
IP |
100 mg |
Calcium & Vitamin |
D- Calcium Pantothenate |
|
q.s |
Excipients |
|
|
Colour-Approved colour used |
|
|
Calcium Carbonate, Vitamin D3, Methylcobalamin, L- Methyl Folate Calcium & Pyridoxal 5 Phosphate |
Each Film Coated Tablet contains: |
IP |
1250 mg |
Calcium & Vitamin |
Calcium Carbonate |
|
|
Eq. to Elemental Calcium |
IP |
2000 IU |
Vitamin D3 |
IP |
1500 mcg |
Methylcobalamin |
|
1 mg |
L- Methyl Folate |
|
20 mg |
Pyridoxal 5 Phosphate |
|
|
Excipients . |
|
q.s |
Colour-Approved colour used. |
|
|
Calcium Dobesilate capsules |
Each Hard Gelatin Capsule contains: |
IP |
500 mg |
Calcium & Vitamins |
Calcium dobesilate Monohydrate |
q.s. |
Excipients |
|
Approved colored used in Hard Gelatin Capsule shell |
|
Cholecalciferol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Calcium & Vitamin |
Cholecalciferol IP ———–60000 IU |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Cholinesterase inhibitor |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Rivastigmine Capsules USP |
Each hard gelatin capsule contains:- |
USP |
1.5mg |
Cholinesterase inhibitor. |
Rivastigmine Tartrate |
q.s. |
Eq. to Rivastigmine |
|
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Rivastigmine Capsules USP |
Each hard gelatin capsule contains:- |
USP |
3mg |
Cholinesterase inhibitor. |
Rivastigmine Tartrate |
q.s. |
Eq. to Rivastigmine |
|
Excipients |
|
Colour: Approved colours used in empty capsule shells. |
|
Corticosteroid & Bronchodilator |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Doxofylline MR Tablets 650 mg |
Each Uncoated Modified Release Tablet Contains:- |
IP |
650 mg |
Corticosteroid & Bronchodilator |
Doxofylline |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Deflazacort Tablets 12 mg |
Each Uncoated Tablet Contains:- |
|
12 mg |
Corticosteroid & Bronchodilator |
Deflazacort |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Montelukast And Olopatadine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Montelukast Sodium I.P. |
|
|
eq. to Montelukast 10mg |
|
|
Olopatadine Hydrochloride I.P—-5mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Montelukast Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Montelukast Sodium I.P. |
|
|
Eq.to Montelukast——— 5mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Montelukast Tablets I.P. |
Each Film Coated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Montelukast Sodium I.P. |
|
|
Eq.to Montelukast———- 10mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Ambroxol Hydrochloride And Olopatadine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Ambroxol Hydrochloride I.P——-30mg |
|
|
Olopatadine Hydrochloride USP—-5mg |
|
|
Excipients————————q.s. |
|
|
Colour-Approved colour used. |
|
|
Prednisolone Tablets I.P |
Each film coated tablet contains: |
|
|
Corticosteroid & Bronchodilator |
Prednisolone Acid I.P———– 5 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Prednisolone Tablets I.P |
Each film coated tablet contains: |
|
|
Corticosteroid & Bronchodilator |
Prednisolone Acid I.P———– 10 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Prednisolone Tablets I.P |
Each film coated tablet contains: |
|
|
Corticosteroid & Bronchodilator |
Prednisolone Acid I.P———– 20 mg |
|
|
Excipients————————–q.s |
|
|
Colour-Approved colour used. |
|
|
Doxofylline Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Doxofylline IP ——— 400 mg |
|
|
Excipients—————– q.s |
|
|
Methylprednisolone Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Methylprednisolone 4mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Methylprednisolone Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Methylprednisolone 2mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Methylprednisolone Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Methylprednisolone 16mg |
|
|
Excipients q.s. |
|
|
MethylprednisoloneTablets IP |
Each Uncoated Tablet Contains:- |
|
|
Corticosteroid & Bronchodilator |
Methylprednisolone 8.0mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Calcium supplement |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Cholecalciferol Chewable tablets 60,000 I.U. |
Each uncoated chewable tablet contains: |
IP |
60,000 IU |
Calcium supplement |
Cholecalciferol (As Stabilized) |
|
q. s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Alfacalcidol, Calcium Carbonate and Betacarotene Tablets |
Each Film Coated Tablet Contains:- |
|
|
Calcium supplement |
Alfacalcidol I.P.————– 0.25 mcg |
|
|
Calcium Carbonate IP 625 mg |
|
|
(From an Organic Source Oyster Shell) |
|
|
Eq. to Elemental Calcium —- 250 mg |
|
|
Betacarotene (30%)————– 2500 IU |
|
|
Excipients—————————q.s. |
|
|
Colour-Approved colour used. |
|
|
Diagestive enzyme |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pancreatin and Activated Dimethicone Tablets |
Each Enteric Coated Tablets Contains |
|
|
Diagestive enzyme |
Pancreatin IP ———— 170 mg |
|
|
Activated Dimethicone IP —–80 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Erectile Dysfunction |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Tadalafil Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Erectile Dysfunction |
Tadalafil IP —————- 5.0 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tadalafil Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Erectile Dysfunction |
Tadalafil IP —————- 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tadalafil Tablets IP |
Each Uncoated Tablet Contains:- |
|
|
Erectile Dysfunction |
Tadalafil IP —————- 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Labeltalol Hydrochloride Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile Dysfunction |
Labeltalol Hydrochloride IP ——-50 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Labeltalol Hydrochloride Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile Dysfunction |
Labeltalol Hydrochloride IP ——-100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Labeltalol Hydrochloride Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile Dysfunction |
Labeltalol Hydrochloride IP ——-200 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Labeltalol Hydrochloride Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile Dysfunction |
Labeltalol Hydrochloride IP ——- 400 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Sildenafil Citrate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile dysfunction |
Sildenafil Citrate IP |
|
|
Eq. to Sildenafil ————— 50 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Sildenafil Citrate Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Erectile dysfunction |
Sildenafil Citrate IP |
|
|
Eq. to Sildenafil ————— 100 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Gastrointestinal Agent |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Acotiamide Hydrochloride Hydrate Tablets 100 mg |
Each Film coated Tablets contains: |
|
100 mg |
Gastrointestinal Agent |
Acotiamide Hydrochloride Hydrate Excipients |
|
q.s |
Colour: Approved Colour Used |
|
|
Hydrating agent |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Urea, Lactic acid, Propylene Glycol & Liquid Paraffin Cream |
Composition : |
IP |
10%w/w |
Hydrating agent |
Urea |
IP |
10%w/w |
Lactic Acid |
IP |
10%w/w |
Propylene Glycol |
IP |
10%w/w |
Liquid Paraffin |
|
|
Preservatives: |
IP |
0.16%w/w |
Methyl Paraben |
IP |
0.04%w/w |
Propyl Paraben |
|
q.s |
Cream Base |
|
|
Histamine Hl-Receptor Antagonist |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Cyproheptadine Hydrochloride 4 mg IP |
Each uncoated tablet contains : – |
|
|
Histamine Hl-Receptor Antagonist |
Cyproheptadine Hydrochloride IP ——4.0 mg |
|
|
Excipients……………q.s. |
|
|
Colour : Approved Colour Used |
|
|
Hypothyroidism |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Thyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Thyroxine Sodium IP ————- 12.5 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Thyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Thyroxine Sodium IP ————- 100 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Thyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Thyroxine Sodium IP ————- 25 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Thyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Thyroxine Sodium IP ————- 50 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Thyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Thyroxine Sodium IP ————- 75 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Levothyroxine Tablets |
Each uncoated Tablet Contains:- |
|
|
Hypothyroidism |
Levothyroxine Sodium IP |
|
|
Eq. to Levothyroxine ————- 25 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Immunosuppresant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Tacrolimus Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
0.5 mg |
Immunosuppresant |
Tacrolimus |
q.s. |
Eq. to Anhydrous Tacrolimus |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Tacrolimus Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
1.0 mg |
Immunosuppresant |
Tacrolimus |
q.s. |
Eq. to Anhydrous Tacrolimus |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Cyclosporine Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
25.0 mg |
Immunosuppresant |
Cyclosporine |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Cyclosporine Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
50.0 mg |
Immunosuppresant |
Cyclosporine |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Cyclosporine Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
250.0 mg |
Immunosuppresant |
Cyclosporine |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Mycophenolate Mofetil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Immunosuppressants |
Mycophenolate Mofetil IP——— 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Mycophenolate Mofetil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Immunosuppressants |
Mycophenolate Mofetil IP——— 360 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Mycophenolate Mofetil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Immunosuppressants |
Mycophenolate Mofetil IP——— 500 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Mycophenolate Mofetil Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Immunosuppressants |
Mycophenolate Mofetil IP——— 750 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Tacrolimus ointment 0.1% w/w |
Composition: |
U.S.P. |
0.1%w/w |
Immunosuppressive |
Tacrolimus |
|
q.s |
Ointment Base |
|
|
Tacrolimus Ointment |
Composition:- |
IP |
0.03%w/w |
Immunosuppressive Agents |
Tacrolimus |
q.s. |
Excipients |
|
Iron, Calcium & Vitamin |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Zinc Acetate Tablets |
Each Film coated Tablet Contains:- |
USP |
50 mg |
Iron, Calcium & Vitamin |
Zinc Acetate (As Dihydrate) |
|
q.s |
Eq. to. Zinc |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Zinc Sulphate Dispersible Tablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
IRON, CALCIUM & VITAMIN D |
Zinc Sulphate Monohydrate IP |
|
|
Eq. to Elemental Zinc ———— 20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Zinc Sulphate Dispersible Tablets IP |
Each Uncoated Dispersible Tablet Contains:- |
|
|
IRON, CALCIUM & VITAMIN D |
Zinc Sulphate Monohydrate IP |
|
|
Eq. to Elemental Zinc ———— 10 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Laxative |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Prucalopride Tablet 1 mg |
Each Film coated Tablet Contains:- |
|
1 mg |
Laxative |
Prucalopride Succinate |
|
q.s |
Eq. to Prucalopride |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Prucalopride Tablet 2 mg |
Each Film coated Tablet Contains:- |
|
2 mg |
Laxative |
Prucalopride Succinate |
|
q.s |
Eq. to Prucalopride |
|
|
Excipients |
|
|
Colour-Approved colour used. |
|
|
Activated Dimethicone, Magnesium Hydroxide, Dried Aluminium Hydroxide Gel and Magnesium Aluminum Silicate Hydrate Tablets |
Each Uncoated chewable tablet Contains:- |
|
|
laxatives |
Activated Dimethicone IP ——50 mg |
|
|
Magnesium Hydroxide IP ——— 250 mg |
|
|
Dried Aluminium Hydroxide Gel IP —250 mg |
|
|
Magnesium Aluminum Silicate Hydrate —————————————- 250 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Multivitamins |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Carbonyl Iron, folic acid, Vitamin B12 and Zinc Sulphate Capsules |
Each hard gelatin capsule contain: |
IP |
100 mg |
Multivitamins |
Carbonyl Iron |
|
1.5 mg |
Equivalent to Elemental Iron |
IP |
15 mcg |
Folic acid |
IP |
61.8 mg |
Vitamin B12 |
IP |
22.5 mg |
Zinc sulphate monohydrate |
|
q.s. |
Equivalent to elemental zinc |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Multivatamin, Multiminerals with lycopene Capsules |
Each Hard Gelatin capsule contains: |
USP |
5 mg |
Multivatamin |
Lycopene 6 % |
USP |
6 mg |
Lutien 8 % |
USP |
10 mg |
Beta carotene (10 % Dispersion) |
IP |
5 mcg |
Vitamin B6 |
IP |
200 IU |
Vitamin B12 |
IP |
|
Vitamin D3 |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Alpha Lipoic acid, Methylcobalamin, Vitamin B6, Folic acid, Benfotiamine ,Biotin, Chromium Picolinate Capsules |
Each Hard Gelatin capsule contains: |
USP |
100 mg |
Mutivitamins |
Alpha Lipoic Acid |
IP |
1500mcg |
Methylcobalamin |
IP |
3 mg |
Vitamin B6 |
IP |
1.5 mg |
Folic acid |
IH |
50 mg |
Benfotiamine |
USP |
5 mg |
Biotin |
USP |
200 mcg |
Chromium Picolinate USP |
|
q.s. |
Eq. to Chromium |
|
|
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Methylcobalamin, Alpha lipoic acid, Benzothiazine, Vit B6, calcium Pantothenate, Nicotinamide & Folic acid capsule |
Each Hard gelatin capsule contain: |
IP |
750 mcg |
Multivitamin |
Methylcobalamin |
USP |
100 mg |
Alpha lipoic acid |
IH |
7.5 mg |
Benfothiamine |
IP |
1.5 mg |
Vit B6 |
IP |
25 mg |
Calcium Pantothenate |
IP |
50 mg |
Nicotinamide |
IP |
0.75 mg |
Folic acid |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Mecobalamin, Vitamin B1, B6, Alpha lipoic Acid & Folic Acid Capsule |
Each hard gelatin capsule contains: |
IP |
1500 mcg |
Multivitamin |
Mecobalamin |
IP |
10 mg |
Vitamin B1(Thiamine Mononitrate) |
IP |
3 mg |
Vitamin B6(Pyridoxine HCL) |
USP |
100 mg |
Alpha Lipoic Acid |
IP |
1.5 mg |
Folic Acid |
|
q. s |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Alpha lipoic Acid &Methylcobalamin capsules |
Each Hard gelatin Capsule contains: |
IP |
1500 mcg |
Multivitamins |
Methylcobalamin |
IP |
300 mg |
Alphalipoic Acid |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Methylcobalamin, Folic Acid, Alpha Lipoic Acid Vitamin B1 & vitamin B6 |
Each Hard Gelatin Capsule Contains: |
IP |
500 mcg |
Mutivitamins |
Methylcobalamin |
IP |
1.5 mg |
Folic Acid |
USP |
100 mg |
Alpha Lipoic Acid |
IP |
10.0 mcg |
Vitamin B1 Mononitrate |
IP |
3.0 mg |
Vitamin B6 HCl |
|
q.s. |
Excipients |
|
|
Approved colour used in empty hard gelatin capsule shell |
|
|
Alpha Lipoic acid, Pyridoxine HCl, Methylcobalamin, Folic acid, Benfothiamine, Biotin & Chromium Capsules |
Each hard gelatin capsule contains:- |
USP |
100mg |
Mutlivitamin |
Alpha Lipoic Acid |
IP |
3mg |
Pyridoxine Hydrochloride |
IP |
1500mcg |
Methylcobalamin |
IH |
50mg |
Benfothiamine |
USP |
5mg |
Biotin |
IP |
1.5mg |
Folic Acid |
USP |
|
Chromium Picolinate |
|
200mcg |
Eq. to Chromium |
|
q.s. |
Excipients |
|
|
Approved colours used in empty capsule shells. |
|
|
Methylcobalamin, Pregabalin, Vitamin B6, Folic Acid &Benfothiamine Capsules |
Each hard gelatin capsule contains: |
IP |
750 mcg |
Multivitamin |
Methylcobalamin |
IP |
75 mg |
Pregabalin |
IP |
1.5 mg |
Vitamin B6 |
IP |
0.75 mg |
Folic Acid |
IH |
7.5 mg |
Benfothiamine |
|
q.s. |
Excipients |
|
|
Approved colours used in empty capsule shells. |
|
|
Sodium Feredetate, Folic Acid & Vitamin B12 Tablets |
Each Film Coated Tablet Contains:- |
BP |
231 mg |
Mutivitamin |
Sodium Feredetate |
|
33 mg |
Eq. to Elemental Iron |
|
1.5 mg |
Folic Acid |
|
15 mcg |
Vitamin B12 |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Vitamin C, Sodium Ascorbate & Zinc Citrate Tablets |
Each Uncoated Tablet Contains:- |
IP |
100 mg |
Mutivitamin |
Ascorbic Acid |
IP |
|
Sodium Ascorbate (450 mg) |
|
400 mg |
Eq. to Ascorbic Acid |
IP |
|
Zinc Citrate |
|
5 mg |
Eq. to Elemental Zinc |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin, L- Methylfolate, Pyridoxal Phosphate, Vitamin D3 & DHA Tablets |
Each Film coated Tablet Contains:- |
IP |
1500 mcg |
Multivitamin |
Methylcobalamin |
|
1 mg |
L- Methylfolate |
|
0.5 mg |
Pyridoxal Phosphate |
|
1000 IU |
Vitamin D3 |
|
100 mg |
Doscosahexaneoic Acid (DHA ) |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
L- Methylfolate, Pyridoxal 5 Phosphate & Methylcobalamin Tablets |
Each Film coated Tablet Contains:- |
IP |
5 mg |
Multivitamin |
L- Methylfolate |
|
3 mg |
Pyridoxal 5 Phosphate |
|
1500 mcg |
Methylcobalamin |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin, L- Methyl Folate Calcium, & Pyridoxal-5 Phosphate Tablets |
Each Film Coated Tablet contains: |
|
|
Mutivitamin |
Methylcobalamin IP —————–1500 mcg |
|
|
L- Methyl Folate Calcium ———- 1 mg |
|
|
Pyridoxal-5 Phosphate —————– 0.5 mg |
|
|
Excipients ——————- q.s. |
|
|
Colour-Approved colour used. |
|
|
Calcium Citrate Malate, Calcitriol, Vitamin K2-7 Tablets |
Each Film Coated Tablet Contains:- |
|
|
Mutivitamin |
Calcium Citrate Malate IP |
|
|
Eq. to Elemental calcium———— 250mg |
|
|
Calcitriol ————————— 0.25 mcg |
|
|
Vitamin K2-7 ———————– 50 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Antioxidant Multivitamins &Multiminerals Tablets |
Each Film Coated Tablet Contains:- |
|
|
Multivitamin |
Vitamin A Acetate IP ————— 5000 IU |
|
|
Vitamin E Acetate IP —————- 25 IU |
|
|
Ascorbic Acid IP ——————- 100 mg |
|
|
Thiamine Monohydrate IP ——– 10 mg |
|
|
Riboflavin IP ————————–10 mg |
|
|
Pyridoxine Hydrochloride IP —— 3 mg |
|
|
Cyanocobalamin IP—————— 5 mcg |
|
|
Niacinamide IP ———————— 50 mg |
|
|
Folic Acid IP —————————–1 mg |
|
|
Calcium Pantothenate IP ————12.5 mg |
|
|
Zinc Oxide IP |
|
|
Eq. to Elemental Zinc ————– 15 mg |
|
|
Cupric Oxide USP |
|
|
Eq. to Elemental Cupric ————– 2.5 mg |
|
|
Sodium Selenate BP |
|
|
Eq. to Elemental Sodium ————– 60 mcg |
|
|
Magnesium Chloride USP |
|
|
Eq. to Magnesium ——————-1.5 mg |
|
|
Chromium Chloride USP |
|
|
Eq. to Elemental Chromium ——— 65 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used |
|
|
Adenosylcobalamin, Iron, Folic Acid and Zinc Tablets |
Each Film Coated Tablet Contains:- |
|
|
Mutivitamin |
Adenosylcobalamin ———- 15 mcg |
|
|
Ferrous Ascorbate |
|
|
Eq. to Elemental Iron————–100 mg |
|
|
Folic Acid IP————————-1.5 mg |
|
|
Zinc Sulphate USP |
|
|
Eq. to Elemental Zinc —————-22.5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Sodium Feredetate, Folic Acid and Vitamin B12 Tablets |
Each Film Coated Tablet Contains:- |
|
|
Multivitamins |
Sodium Feredetate BP ————- 231mg |
|
|
(Eq. to 33 mg. Elemental Iron) |
|
|
Folic Acid IP ———————– 1.5 mg |
|
|
Vitamin B12 IP ——————- 15 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin, Alpha Lipoic Acid, Vitamin D3, Pyridoxine Hydrochloride, Folic Acid Tablets |
Each Film Coated Tablet Contains:- |
|
|
Mutivitamins |
Methylcobalamin IP ————– 1500 mcg |
|
|
Alpha Lipoic Acid USP ————- 100 mg |
|
|
Vitamin D3 IP—————– —1000 IU |
|
|
Pyridoxine Hydrochloride IP —— 3 mg |
|
|
Folic Acid IP ——————- 1.5mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin, Alpha Lipoic Acid, Gabapentin & Pyridoxine Hydrochloride Tablets |
Each Film Coated Tablet Contains:- |
|
|
Mutivitamins |
Methylcobalamin IP ————– 750 mcg |
|
|
Alpha Lipoic Acid USP ————- 100 mg |
|
|
Gabapentin IP——————— 300 mg |
|
|
Pyridoxine Hydrochloride IP —— 3 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin, Alpha Lipoic Acid, Vitamin B6, Folic Acid, Zinc, Chromium, Selenium, Biotin & Inositol Tablets |
Each Film Coated Tablet Contains:- |
|
|
Multivitamin |
Methylcobalamin IP ————– 1500 mcg |
|
|
Alpha Lipoic Acid USP ————- 100 mg |
|
|
Vitamin B6 ——————– 3 mg |
|
|
Folic Acid IP ——————- 1.5mg |
|
|
Zinc ——————————– 15 mg |
|
|
Chromium ———————– 60 mcg |
|
|
Selenium ————————- 65 mcg |
|
|
Biotin —————————– 100 mcg |
|
|
Inositol ————————- 2 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Biotin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Multivitamin |
Biotin USP ————————— 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Muscle Relaxant |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Baclofen Extended Release Capsules |
Each hard gelatin capsule contains: |
IP |
30 mg |
Muscle Relaxant |
Baclofen |
|
( As extended Release pellets ) |
q.s. |
Excipients |
|
Approved colours used in empty capsule shells & pellets. |
|
Alfuzosin HCl (ER) and Dutasteride Tablets |
Each Film Coated Tablet Contains :- |
|
|
Muscle Relaxant |
Alfuzosin Hydrochloride I.P—— 10mg |
|
|
Dutasteride I.P. — 0.5mg |
|
|
Excipients——————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Drotaverine Tablets IP |
Each film coated tablet contains: |
|
|
Muscle Relaxant |
Drotaverine Hydrochloride IP——40mg |
|
|
Excipients—————————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Drotaverine Tablets IP |
Each film coated tablet contains: |
|
|
Muscle Relaxant |
Drotaverine Hydrochloride IP——-80mg |
|
|
Excipients————————–q.s. |
|
|
Colour-Approved colour used. |
|
|
Carisoprodol Tablets USP 500 mg |
Each Uncoated Tablets contains: |
USP |
500 mg |
Skeletal Muscle Relaxants |
Carisoprodol |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used. |
|
|
Baclofen Tablets IP 10 mg |
Each Uncoated Tablets contains: |
IP |
10 mg |
Skeletal Muscle Relaxants |
Baclofen |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Baclofen Tablets IP 25 mg |
Each Uncoated Tablets contains: |
IP |
25 mg |
Skeletal Muscle Relaxants |
Baclofen |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Pancreatic Enzymes |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pancreatin 300 mg Capsule |
Each Hard Gelatin capsule contains: |
IP |
300 mg |
Pancreatic Enzymes |
Pancreatin (Enteric coated pellets) |
q.s. |
Eq. to. Pancreatin |
|
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
L-Ornithine L-Aspartate and Pancreatin Tablets |
Each Enteric Coated Tablets Contains |
|
|
Pancreatic Enzymes |
L-Ornithine L-Aspartate——– 150 mg |
|
|
Pancreatin IP——————- 100 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Pancreatin Tablets |
Each Enteric Coated Tablets Contains |
|
|
Pancreatin Enzyme Deficiency |
Pancreatin IP ———— 212.5 mg |
|
|
Eq. to Lipase activity ———-6000 FIP units |
|
|
Amylase Activity ————4500 FIP units |
|
|
Protease Activity —— 300 FIP units |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Protease Inhibitors |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ritonavir Capsules IP |
Each Hard Gelatin Capsule Contains: |
IP |
10.0 mg |
Protease Inhibitors |
Ritonavir |
q.s. |
Excipients |
|
Approved colour used in empty hard gelatin capsule shell |
|
Skin lightening agent |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Hydroquinone |
Composition: |
USP |
4.0% w/w |
Skin lightening agent |
Cream USP |
Hydroquinone |
q.s. |
|
In a Cream Base |
|
Sedative |
|
|
|
|
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Melatonin Tablets 3 mg |
Each Uncoated Tablets contains: |
|
3 mg |
Sedative |
Melatonin |
|
q.s |
Excipients |
|
|
Colour: Approved Colour Used |
|
|
Treatment osteoporosis |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ibandronic Acid Tablets 150 mg |
Each Film coated Tablets contains: |
|
|
Treatment osteoporosis |
Ibandronic Acid monosodium Monohydrate |
|
|
Eq. to Ibandronic Acid 150 mg |
|
|
Excipients q.s |
|
|
Colour: Approved Colour Used |
|
|
Alendronic Acid Tablets USP |
Each Film Coated Tablet Contains:- |
|
|
Treatment osteoporosis |
Alendronate Sodium USP |
|
|
Eq.to Alendronic Acid 10 mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Treat iron overload |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Deferasirox Dispersible Tablets |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Treat iron overload |
Deferasirox 500mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Deferasirox Dispersible Tablets |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Treat iron overload |
Deferasirox 250mg |
|
|
Excipients q.s. |
|
|
Colour-Approved colour used. |
|
|
Transfusional hemosiderosis |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Deferasirox Dispersible Tablets |
Each Uncoated Dispersible Tablet Contains:- |
|
|
Transfusional hemosiderosis |
Deferasirox———–500mg |
|
|
Excipients————————-q.s. |
|
|
Colour-Approved colour used. |
|
|
Treatment vitamin B6 deficiency |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Pyridoxine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Treatment vitamin B6 deficiency |
Pyridoxine Hydrochloride IP——– 5 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
uterine relaxants |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Ritodrine Hydrochloride Tablets IP 10 mg |
Each Film Coated Tablet Contains:- |
IP |
10 mg |
uterine relaxants |
Ritodrine Hydrochloride |
|
q.s |
Excipients. |
|
|
Colour-Approved colour used. |
|
|
Uricosuric Agent |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Allopurinol Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
Uricosuric Agent |
Allopurinol IP ———— 300 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Vitamins |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Vitamins |
Methylcobalamin IP —————-500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Vitamins |
Methylcobalamin IP —————-1000 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Methylcobalamin Tablets |
Each Film Coated Tablet Contains:- |
|
|
Vitamins |
Methylcobalamin IP —————-1500 mcg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Biotin Tablets USP |
Each Film Coated Tablet Contains: |
U.S.P. |
5 mg |
Vitamin Supplement |
Biotin |
|
q.s. |
Excipients |
|
|
Colour-Approved colour used |
|
|
Vasodilator |
Generic Name |
Composition |
Ph. Ref. |
Str. |
Category |
Isoxsuprine HCl Sustained Release Tablets 40 mg |
Each Uncoated Sustained release Tablet Contains:- |
IP |
40 mg |
Vasodilator |
Isoxsuprine Hydrochloride |
|
q.s |
Excipients |
|
|
Colour-Approved colour used. |
|
|
Isoxsuprine Tablets IP |
Each Film Coated Tablet Contains:- |
|
|
vasodilators |
Isoxsuprine IP———20 mg |
|
|
Excipients—————– q.s |
|
|
Colour-Approved colour used. |
|
|
Hydroquinoine, Octyl Methoxycinnamate & Oxybenzone Cream |
Composition : |
USP |
2.0 %w/w |
|
Hydroquinoine |
USP |
5.0 %w/w |
Octyl Methoxycinnamate |
USP |
3.0 %w/w |
Oxybenzone |
|
q.s. |
Cream base |
|
|
Doxofylline Tablets IP |
Each Uncoated Tablet |
|
|
|
Contains:- |
|
|
Doxofylline………………………….IP 400mg |
|
|
Excipients |
|
|
Colour-Approved colour used…………..q.s |
|
|
Mefenamic Acid and Paracetamol Tablets |
Each Uncoated Tablet Contains:- |
I.P. |
250 mg |
|
Mefenamic Acid |
I.P. |
325 mg |
Paracetamol |
|
q.s |
Excipients . |
|
|
Colour-Approved colour used. |
|
|